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Abstract   
Advances in imaging technology have led to a variety of available clinical and investigational 
systems. In this collection of studies, we tested the relevance of morphological image feature 
quantification on several imaging systems and epithelial tissues. Quantification carries the 
benefit of creating numerical baselines and thresholds of healthy and abnormal tissues, to 
potentially aid clinicians in determining a diagnosis, as well as providing researchers with 
standardized, unbiased results for future dissemination and comparison.  
Morphological image features in proflavine stained oral cells were compared qualitatively to 
traditional Giemsa stained cells, and then we quantified the nuclear to cytoplasm ratio.  We 
determined that quantification of proflavine stained cells matched our hypothesis, as the nuclei in 
oral carcinoma cells were significantly larger than healthy oral cells.  
Proflavine has been used in conjunction with translational fluorescence microendoscopy of the 
gastrointestinal tract, and we demonstrated the ability of our custom algorithm to accurately (up 
to 85% sensitivity) extract colorectal crypt area and circularity data, which could minimize the 
burden of training on clinicians. In addition, we proposed fluorescein as an alternative 
fluorescent dye, providing comparable crypt area and circularity information.    
In order to investigate the morphological changes of crypts via the supporting collagen 
structures, we adapted our quantification algorithm to analyze crypt area, circularity, and an 
additional shape parameter in second harmonic generation images of label-free freshly resected 
murine epithelium. Murine models of colorectal cancer (CRC) were imaged at early and late 
stages of tumor progression, and we noted significant differences between the Control groups 
and the late cancer stages, with some differences between early and late stages of CRC 
progression.  
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Chapter I: Introduction 
1. Background 
1.1 Clinical imaging and diagnosis of oral and colonic epithelial cancer 
Cavities in the gastrointestinal tract, from mouth to rectum, are lined in a layer of 
epithelial cells [1]. The epithelium, the layer of epithelial cells, forms a barrier between outside 
substances and the rest of the body’s organs and bloodstream, as well as often facilitating the 
transfer of necessary solutes and solvents from ingested substances [1]. The mucosa consists of 
the epithelium and an underlying layer of nerves, vessels, and a thin layer of smooth muscle [1]. 
In the mouth, while there are various types of oral mucosa including masticatory mucosa 
(tongue, palate, gums), lining mucosa (cheeks, mouth floor, inside of lips), and specialized 
mucosa (taste buds), the epithelial layer largely consists of squamous epithelial cells [2]. In the 
gut, the mucosal surfaces vary and can include either squamous epithelium (esophagus) or 
columnar epithelium (stomach, intestines) [2]. Figure 1 compares the different types of 
epithelium, including squamous epithelium, which consists of flat cells, and columnar 
epithelium, which consists of tall narrow cells [2].  
 
Figure 1. Types of epithelium. Image sourced from seer.cancer.gov webpage [3].   
 Diagnosis of epithelial dysplasia (abnormal cellular behavior) and cancer is achieved by 
histopathological analysis of a biopsy or resected tissue. White-light wide-field microscopes are 
2 
a clinical standard for imaging and pathological diagnosis of sectioned tissue (such as from 
biopsies) or fluid samples (such as blood or fecal smears) [4]. Contrast agents are of vital 
importance in most pathology applications, as the tissues being imaged typically do not exhibit 
inherent differences in color. Tissue sections are commonly stained with hematoxylin and eosin 
(H&E) in order to differentiate the nuclei (dark purple) from the surrounding tissue (pink) [4]. 
Pathologists are trained to detect abnormalities in H&E stained cells by analyzing nuclei (purple) 
shape and distribution, and cellular (pink) morphology and organization. Examples of oral (Fig. 
2) and colonic (Fig. 3b) H&E stained epithelium are shown below [5, 6].  
 
Figure 2. H&E images of healthy oral mucosa and oral squamous cell carcinoma. Images 
modified; left acquired at x100 magnification, right acquired at x400 magnification [5, 7].  
Healthy oral epithelium (Fig. 2a) has a stratified squamous arrangement of cells, with 
layers of squamous cells (non-proliferating flat cells) laid over basal cells (proliferating cells). 
Healthy colonic epithelium (Fig. 3a-c) has a columnar arrangement, with cells forming tubular 
structures called crypts, which have a collagen sheath that provides structure and different types 
of epithelial cells lining the sheath [8]. En face views of healthy crypts display roughly circular 
crypt openings of homogenous size (Fig. 3c). Basal cells lie at the base of crypts, with 
differentiated non-proliferating epithelial cells migrating toward the top of the crypt, and are 
eventually exfoliated into the colonic cavity.  
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Precursor lesions for oral cancer can take an average of two and a half years to progress 
to cancer [9]. Patients who regularly smoke and/or drink alcohol are at increased risk since 
tobacco and alcohol are the two major etiologic agents in oral cancer [9]. Histological findings 
for white (leukoplakia) or red (erythroplakia) oral lesions can vary, and therefore these lesions 
are simply flagged for further testing, not used as a final diagnosis [9]. There are various 
morphological changes that are used in diagnosing oral squamous cell carcinoma (Fig. 2b), 
including increased nuclear to cytoplasmic ratio, increased number or abnormal mitotic figures, 
cellular and nuclear pleomorphism (heterogeneity of size/shape), and irregular epithelial 
stratification [9].  
Adenomatous polyps, small benign growths, can sometimes progress into colorectal 
cancer (CRC) [10]. While most CRC originate from these polyps, they can take years to develop 
into CRC, with approximately 74% of cases documented in patients over the age of 60 [10]. 
Early stages of CRC, before the development of grossly visible polyps, will typically include 
regions of abnormal cellular organization, for example, aberrant crypt foci (ACF) which are 
enlarged or non-tubular (branching) crypts, and/or multiple layers of cells lining a crypt (Fig. 3d) 
[11, 12].   
 
Figure 3. Examples of colon crypt morphology. (a) Representation of crypts in the epithelium; 
modified figure [13]. (b)Transverse section of colonic murine epithelium; scale bar is 500 µm. 
(c) En face view of epithelial layer; scale bar is 100 µm. (c) En face view of an ACF: center 
crypt is larger and has a higher number of elongated nuclei compressed around the crypt; scale 
bar is approximately 100 µm. Modified figure [14]. 
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Cytology, which specifically studies cellular image features, is a branch of pathology that 
has been clinically applied to diagnosis of cells in cervical, anal, and urine smears, and aspirated 
and exfoliated cells [15-19]. Oral cell cytology, specifically, uses colorimetric stains such as 
H&E and Papanicolaou for white-light wide-field microscope image acquisition [19]. Another 
clinical application of white-light wide-field microscopes are endoscopic systems, e.g. 
colonoscopes. Endoscopic imaging systems usually consist flexible probes that can be inserted 
into the body to inspect organs, such as the esophagus, stomach, and colon. Colonoscopy 
systems, used to screen for abnormalities such as discoloration or polyps, consist of a long 
flexible probe that transmits light from a white-light source to illuminate the colorectal tract as 
well as transmitting an image back into the external system for acquisition with a wide-field 
camera. The images are displayed to the clinician in real-time and can be used to guide 
acquisition of biopsies as needed. While ubiquitous, white-light wide-field imaging systems are 
not the only imaging modalities used in clinical settings; various additional optical imaging 
modalities are described below.  
1.2 Optical imaging modalities 
Microscopes – and microscopy – fall under the category of optical imaging, which 
according to the NIH is an imaging technique that uses wavelengths in the range of visible light 
[20]. Other common clinical imaging modalities include MRI (magnetic resonance imaging), X-
ray, and CT (computed tomography) systems, but these are not optical imaging modalities. 
Contrast in MRI is created by a magnetic field, and relies on the differences in radio frequency 
signals to distinguish between soft tissues (Fig. 2) [21]. Contrast in the X-rays are due to 
differences in tissue density; dark regions in the black and white image represent low-density 
regions where the x-ray emissions passed through, and brighter regions represent high-density 
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regions where calcification (teeth, bone) block the signals from reaching the sensors [22]. CT 
imaging also uses x-ray, but the sensors are set at many different angles around the patient and 
the signals are then computationally restructured into multiple images and/or a 3-dimensional 
model [23].   
Advantages of using optical imaging include reduction of patient exposure to radiation, 
image acquisition of specific or targeted molecules, as well as the option to utilize various 
colors/wavelengths to probe various properties simultaneously [24]. For example, common 
dental x-ray imaging systems produce sufficient x-ray radiation to be regulated and considered 
cause for concern, with CT producing higher doses of radiation [25-27]. While occasional use is 
not considered to be of high risk, it poses an increased risk to patients undergoing continuous 
screening/treatment [25, 27]. While optical imaging could cause local damage within tissue if the 
optical power is high and/or continuous, low level laser therapy has been used clinically and 
optical power dosage guidelines have been published to prevent adverse effects [28]. High 
optical power even has been used in combination with experimental drug delivery carriers, which 
are activated by targeted pulses of high optical power in order to obtain an accurate and 
controlled increase temperature in a region of interest [29, 30]. Another advantage of optical 
imaging is the ability to stain or immunolabel different molecules with different colorimetric 
markers and simultaneously or sequentially acquire images of various molecules in the same 
sample [31, 32]. An example of this are composite fluorescent images of cells that display blue 
nuclei and red actin fibers [33].  
MRI does not carry the risk of radiation, but is also is limited to probing for differences in 
density in soft tissues, whereas optical imaging systems, such as H&E staining of tissue sections 
or multiphoton microscopy, can acquire functional information such as nuclear and cellular 
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morphology [34, 35]. The greatest disadvantage of optical imaging is the scale, or field of view 
and depth, that can be acquired using the visible light spectrum. Wide-field microscopes require 
thin sections of tissue, typically in the range of 5μm-10μm, or equally thin smears of fluid 
samples. Microendoscopes are limited to investigating the topmost layers that the imaging probe 
comes into contact with. Multiphoton imaging is the most capable of imaging deeper into tissue, 
up to several hundred microns into tissue depending on the type of tissue [36].  
Fluorescence and fluorescence microscopy 
Due to the central role of cellular morphology in clinical diagnosis, optical imaging 
alternatives to tissue removal and subsequent H&E staining have been widely investigated. 
Sources of contrast in imaging of epithelium range from colorimetric stains, to fluorescence and 
autofluorescence. Colorimetric stains, such as the previously described H&E (Fig. 2), Giemsa, 
and others, display visibly distinguishable colors when viewed with a white light source [4, 37]. 
Fluorescence, in broad terms, is the result of electrons in susceptible molecules absorbing energy 
when targeted with light (excitation), becoming energized and entering a higher energy state, and 
releasing a reduced amount of the energy (emission) when returning to their original state (Fig. 
4a). As can be seen in Figure 4b, the blue extinction curve displays the efficiency of various 
excitation wavelengths (intensity of the fluorescence when excited at a given wavelength) and 
the orange emission curve represents the intensity of different emitted wavelengths when excited 
with 400nm light. Fluorescent contrast agents can be applied to add contrast to cellular 
structures, or highly sensitive imaging systems can be used to acquire fluorescent signals from 
endogenous fluorophores present in cells [34, 35].  
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Figure 4. Example of fluorescent excitation and emission. (a) Jablonski diagram showing an 
electron being excited by a photon into a higher energy state, then relaxing and releasing 
fluorescent light. (b) Extinction/emission curves for proflavine; adapted from PhotochemCAD 2 
data [38].  
Cells have some measure of endogenous fluorescent molecules, but these fluorescent 
emissions are too dim to image using wide-field microscopy. Confocal imaging systems are 
sensitive enough to capture this endogenous fluorescence, though sometimes confocal systems 
will still be used in conjunction with fluorescent contrast agents. Confocal laser systems rely on a 
small pinhole to eliminate out-of-focus light, and this pinpoint of light is scanned across the field 
of view, acquiring an image pixel by pixel using highly sensitive detectors (photomultiplier 
tubes). Fluorescence imaging, including confocal microscopy systems, have a light source of 
higher-energy/shorter-wavelength which is used to stimulate the emission of lower-
energy/longer-wavelength signals.  
Multiphoton fluorescence microscopy: two photon excitation 
In contrast to confocal systems, multiphoton microscopy takes advantage of a 
phenomenon in which two (or more) photons of light excite a molecule at virtually the same time 
and place (a cross section of 10−50 cm4 s) and the electron absorbs the energy of both and 
therefore releases light of longer wavelength than the combined energy, but shorter than the 
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original light source (Fig. 5) [39]. Practically, this means that a pulsed high-frequency red light 
can be used to excite molecules that typically require blue light excitation. Due to the reduced 
Rayleigh scattering of longer wavelengths, multiphoton microscopy allows for imaging deeper 
into tissue sample, as well as virtually eliminating any shorter wavelength excitation outside of 
the focal plane [39]. This reduction of out-of-focus fluorescence means that multiphoton imaging 
is ideal for label-free imaging of endogenous fluorophores present in tissue.  
 
Figure 5. Example of two-photon fluorescence. Jablonski diagram showing an electron being 
excited by a combination of two photons into a higher energy state, then relaxing and releasing 
fluorescent light. 
Second harmonic generation imaging 
Multiphoton imaging systems have also been used for acquiring second harmonic 
generation (SHG) signals. SHG is a nonlinear optical process in which two equal-energy photons 
interact with a nonlinear medium and produce, without absorption nor energy loss, a single 
photon of half the original wavelength of the excitation [40, 41]. A linear optical process is when 
two waves (sound, light, etc.) combine constructively, where components combine into a single 
wave of greater amplitude, or destructively, where positive and negative components cancel out 
into a lesser amplitude or completely zero [40, 41]. A nonlinear optical process is when two light 
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waves do not combine to produce a greater amplitude, but combine to produce a wavelength of 
equal amplitude but higher frequency [40, 41]. SHG requires a nonlinear medium to mediate this 
production of higher-frequency photons. The refractive index of a nonlinear medium changes 
with light intensity, thereby changing speed/frequency [40, 41]. This process usually occurs at 
high frequencies, such as in pulsed photons emitted by a femtosecond laser (commonly used in 
multiphoton microscopy), and depends on the degree of the polarization of a nonlinear medium 
[40, 41]. This nonlinearity, including the polarization of the medium, leads to the generation of a 
wave at twice the original frequency. This means that certain nonlinear endogenous molecules, 
most relevant for this manuscript being collagen, can be imaged using multiphoton microscopy.  
 The following sections describe different optical imaging modalities, contrast agents, 
and techniques that were applied to investigation of morphological image features in oral and 
colorectal epithelial cancer cells. 
2. Proflavine as a contrast agent for oral cell cytology  
2.1 Oral squamous cell carcinoma 
Oral and pharyngeal cancer is the sixth most common cancer worldwide, with two thirds 
of cases arising in developing countries [42]. In countries with the highest incidence rates, for 
example Sri Lanka and India, oral cancer is the most common cancer in men, contributing up to 
25% of all new cancer cases [42]. Oral squamous cell carcinoma (OSCC), one subtype of oral 
cancer, is the most common malignant tumor of the head and neck [43]. For many populations, 
including Asia, tongue and buccal (cheek) mucosa are the most common incident sites of oral 
cancer [44]. Oral epithelial dysplasia (OED) is the histological marker of premalignancy, and 
carries an increased risk for developing OSCC [45]. Typical histological markers to diagnose 
OED include, but are not limited to, loss of cellular organization, enlargement of nuclei, basilar 
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hyperplasia, mitosis above the basal cell layer, and skip areas of dysplasia [46]. In 16% of cases, 
OSCC developed within 6.5 years after an OED diagnosis [46].  
OSCC is diagnosed either during a routine inspection of the oral cavity by a dentist or 
physician, or due to a patient presenting discomfort or suspicion [47]. In a low-resource location 
in Bangladesh, 85%-95% of cases in a clinical study had a history of irregular (less than yearly) 
dental visits, reducing the likelihood of early detection of OSCC [48]. In order to address this 
lack of medical surveillance in low-resource settings, there have been various attempts made to 
conduct screening initiatives, such as sending health workers and volunteers to rural areas in 
order to conduct routine inspections, specifically looking for white or pink lesions, or visible 
growths [49]. A study by Wesley et.al. compared results from two cancer detection camps versus 
youth volunteers sent to visit households in the area and reported more favorable results from the 
cancer detection camps [50]. Studies reported compliance (accepted invitation for follow-up at a 
clinic) percentages for industrialized countries as high as 100%, while most studies conducted in 
the Indian sub-continent hovered around 50% [50]. While screening initiatives have provided 
many with the opportunity for earlier detection of OSCC, there is still a need for point-of-care 
diagnosis that can more easily reach these high-risk populations.   
In order to increase early diagnosis, and therefore increase survival rates, multiple 
screening tools for oral cancer have been developed to diagnose lesions early, expedite 
treatment, and do not necessitate high levels of training. Alternative oral screening procedures 
are designed to collect exfoliated cells, such as oral rinses and oral brushes to more stringently 
exfoliate cells of a suspicious region, for subsequent histopathological examination [51]. Kujan 
et. al. discussed the difficulty of using cervical cytobrushes for their oral study, due to “their size 
and shape”, since at the time there was no commercially available cytobrush [52]. Currently, the 
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most commercially accepted clinical on-the-market oral screening tool is the OralCDx brush, 
which is marketed for scrubbing of suspicious regions, then sending the brush and exfoliated 
cells to their laboratory for diagnosis [53, 54]. Investigational cytological studies included 
similar procedures, and stained the exfoliated cells with a variety of contrast agents [51].  
2.2 Cytological contrast agents 
Once oral cells have been exfoliated, one of many contrast agents are applied in order to 
highlight the morphological image features used to determine a diagnosis [55]. The most 
common cytological contrast agents in oral cytology are Feulgen, acridine orange, propidium 
iodine, Giemsa, May-Grünwald-Giemsa, and ethidium bromide [55]. These contrast agents fall 
into either the category of a colorimetric contrast agent that requires white light and a color 
camera, or a fluorescent contrast agent that requires a small range of excitation wavelengths (e.g. 
an LED or laser) and a filter set. While colorimetric stains (e.g. Feulgen, Giemsa) are current 
contrast agents used for oral cytology, fluorescent dyes (e.g. acridine orange, propidium iodine, 
ethidium bromide), depending on the stain and the application, have benefits that include higher 
signal to background during imaging, rapid staining, little or no need for fixation, low cost, and 
minimal need for lab tools. Qualitatively, fluorescent imaging is comparable to colorimetric 
methods when considering morphological features, specifically nuclei size and distribution.  
Propidium iodine and ethidium bromide are commonly used in live/dead cell assays, and 
therefore the majority of the studies where they were used as contrast agents, they were used to 
stain the nuclei of dead or fixed cells, or were shown incapable of staining any of the nuclei in 
the live cells of the study [55]. An alternative in the acridine derivative family is acridine orange, 
which is used in many applications requiring different colorimetric features to differentiate cells 
with varying cellular content, such as the acidic vesicles [56, 57]. However, the fluorescence 
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emissions of acridine orange are dependent on concentration, pH and incubation time and it 
requires strict control. For applications where colorimetric-based differentiation between 
multiple cell types is not necessary and morphological features would suffice, proflavine would 
be a more suitable contrast agent for oral cytology. 
Proflavine is a fluorescent DNA-intercalating dye, of the aminoacridine derivative 
family, with amphipathic properties that allow for rapid absorption into the cell cytoplasm and 
nuclei [58]. Proflavine has been used clinically since 1917 [59], but its use as a cytological tool 
is not widespread despite its potential advantages, though there has been renewed interest in its 
use for point-of-care diagnostic applications in low-resource settings due to its physical and 
chemical stability in solution [60]. Proflavine is very stable in solution, up to 12 months if 
refrigerated [60]. Proflavine is useful in applications that require minimal preparation and 
staining steps, as well as high signal to background, as a fluorescent dye that can rapidly stain 
live cells, unlike the previously described contrast agents, and is not pH dependent, unlike other 
dyes in the aminoacridine family.  
2.3 Objective 
Rapid identification of oral cells with large nuclei to cytoplasm ratios using low-cost 
fluorescence imaging systems could serve in further development of point-of-care OSCC 
screening tools. Proflavine, a DNA-intercalating vital dye, could serve as an alternative contrast 
agent for oral cytology screening systems in regions where clinical pathology services are not 
readily available.  
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3. Image feature quantification and alternative contrast agent for a translational 
microendoscopy system 
3.1 Colorectal cancer 
Colorectal cancer (CRC) causes approximately 50,000 deaths per year in the United 
States, with 14.5 deaths per 100,000 men and women [61]. When diagnosed early, the 5 year 
survival rate can be over 90%, but unfortunately over 20% of cases are diagnosed at a late stage 
when the survival rate drops below 14% [61]. There are various types of CRC, including 
familial, familial adenomatous polyposis (FAP), hereditary nonpolyposis (HNPCC), ulcerative 
colitis/Crohn’s disease related, rare syndromes such as Lynch and hamartomatous polyposis 
syndromes, and – the most prevalent – spontaneous adenocarcinoma [62, 63]. Spontaneous 
adenocarcinomas, accounting for 65-85% of CRC cases, commonly arise from adenomatous 
polyps, some of which may progress into invasive adenocarcinomas over time (Fig. 6) [62, 
64].  This progression is thought often take years (up to a decade) and be dependent on the size 
and histology of the polyp [65]. Routine screening can lead to early detection and removal of 
polyps, which can reduce the number of CRC deaths.  
 
Figure 6. Stages of colorectal cancer. Image sourced from www.shsg.com.au.  
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Routine screening of CRC depends on traditional colonoscopy, which utilizes long 
flexible probes attached to a white light illumination source and a wide-field color camera, which 
is then inserted into the colon to screen for any grossly visible polyps [6]. The physician inspects 
for any visible growths or suspicious lesions, such as discolored or inflamed epithelium [2]. 
Small polyps can be removed immediately during the colonoscopy [66], and are sent to the 
pathologist to determine if it was a benign growth or if it requires additional removal of 
surrounding tissue. Any suspicious lesions are biopsied, the recommended number being four-
quadrant biopsies every 10 cm [67]. Due to the increased number of people undergoing routine 
screening, yearly CRC cases for those over 50 years of age have decreased 32% between 2000 
and 2014 [68]. Despite this decrease, CRC remains the second leading cause of death in the US, 
and third leading cause worldwide [61].   
3.2 Recurrence and endoscopic imaging of colorectal cancer 
Once a polyp has progressed into CRC, the curative standard for CRC is excision of the 
tumor, often followed by surveillance for recurrence [69, 70]. Chemotherapy and radiotherapy 
are common treatments designed to reduce the size of the tumor before resection, and/or prevent 
metastasis of cancer cells from the tumor [69, 70]. Despite therapeutic treatment, recurrence is a 
common outcome after resection of the primary tumor. In one randomized study, cancer recurred 
in 44% of patients, leading to further surgery [70]. The majority of these recurrence-related 
surgeries were performed within the first two years following the initial resection [70].  
 There are a number of tools that have been developed to determine recurrence during 
surveillance of patients, including detection of a range of salivary protein markers [71]. An 
alternative technique is the investigation of endoscopic imaging modalities, since operating 
rooms and clinicians are already equipped for these imaging systems due to the widespread use 
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of endoscopic probes, such as during colonoscopies or robotic surgery [72]. Examples of 
imaging modalities that have been developed and tested in colorectal epithelium include 
chromoendoscopy, indigo carmine staining in conjunction with traditional colonoscopy, and 
microendoscopy. There are a variety of sources of contrast used in endoscopic imaging of 
colorectal epithelium, such as colorimetric stains in chromoendoscopy, hemoglobin absorption in 
narrow-band imaging, fluorescence in microendoscopic imaging, and autofluorescence in 
confocal and multiphoton imaging systems. Chromoendoscopy typically uses a colorimetric 
contrast agent, such as indigo carmine, to enhance dysplastic regions under traditional white light 
colonoscopy [73]. Narrow band imaging has been described as label-free chromoendoscopy, as 
optical filters only allow imaging of a small range of wavelengths, which enhance blood vessels 
and contrast in capillary patterns without the need for indigo carmine or another contrast agent 
[74, 75]. Laser endomicroscopy allows for imaging of cellular and subcellular structures, 
providing more detailed imaging of features that relate more closely to histopathological features 
[76].  
One robust imaging modality, fluorescence microendoscopy, combines the untargeted 
staining method of chromoendoscopy with the microstructural detail of microendoscopy. 
Microendocopy is an imaging system that has been investigated due to its robust and relatively 
inexpensive build, and its ability to provide a detailed look at cellular structures that are not 
visible during routine wide-field endoscopy [77-79]. Microendoscopy imaging techniques that 
have been developed to provide complementary information for the clinician during a 
colonoscopy include autofluorescence endoscopy with image processing, narrow band 
reflectance imaging, and combined multimodal methods [66, 80, 81]. Microendoscopic imaging 
using proflavine (the previously described DNA-intercalating fluorescent contrast agent) has 
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been investigated in clinical settings, in conjunction with manual quantification of image features 
[79, 82-86].  Limitations of fluorescence microendoscopic imaging include limited imaging 
depth and small field of view. Advantages of microendoscopic imaging using proflavine include 
rapid staining times, no need for rinsing, high signal to background ratios, and high-resolution of 
cellular structures. Qualitative analysis of morphological structures (such as glandular shape, 
epithelial thickness, and nuclear organization) in images acquired with fluorescence 
microendoscopy by trained observers has been shown to be highly sensitive and specific (over 
90% for both) [86]. Since the use of proflavine has been limited to investigative studies, we have 
also explored the use of fluorescein as an alternative contrast agent to proflavine, due to its FDA-
approved intravenous use for alternate applications [87].  
3.3 Manual and automated quantification of morphological image features 
An additional tool that we investigated was the automated quantification of image 
features, specifically the size and shape of crypt structures. Image feature quantification could be 
defined as numerical measurement of an object or multiple objects in an image, as opposed to 
coming to a conclusion or diagnosis based on observation alone. Counting polyps in the 
colorectal tract during routine colonoscopies is a basic example of image quantification; a 
diagnosis of familial adenomatous polyposis “is made when at least 100 colonic adenomas are 
identified” [88]. This example highlights how thresholds, such as the numerical value of 100 
polyps, can be determined based on clinical studies, and can be used as a suggested value for 
diagnosis.   
Manual quantification exists in varying degrees in cancer research and clinical workflow, 
such as the aforementioned examples of polyp counting during a colonoscopy. Manual 
quantification retains the advantages of observer-based analysis and image quantification by 
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using trained clinicians to accurately select important image features (such as distinguishing 
polyps from surrounding tissue), and adds the advantage of numerical results that can be 
replicated and used to create thresholds and ranges of normalcy (such as selecting 100 polyps as 
a numerical threshold). When comparing diagnoses of dysplasia – presence of abnormal cellular 
morphology and/or organization that are a precursor to cancer – in colorectal microendoscopy 
images by experienced clinicians, inter-observer variability among trained observers was 96% 
[89]. While manual quantification retains the high accuracy feature analysis when using trained 
clinicians, it also retains the disadvantage of requiring an experienced observer, as well as the 
burden of spending increasingly longer periods of time spent analyzing the data especially as 
modern imaging systems increase their capability of acquiring large image data sets.  
Automated quantification uses trained algorithms to select, segment, and quantify image 
features independent of the user. Automation is targeted at the reduction of the burden of time on 
trained clinicians, as well as reducing user-bias and error of minimally trained clinicians or 
researchers. Minimally trained users are more likely to include false positives or a false negative. 
An example of a false positive would be determining that a certain cell is dysplastic when it is 
healthy, while a false negative would be determining that a certain cell is healthy when it is 
dysplastic [89, 90]. A few of the studies that utilize automated quantification include automated 
image segmentation of cells to measure cellular metabolic rates [91], segmentation of renal 
sections to calculate fibrosis [92], and 3-dimensional fiber orientation [93].  
3.4 Objective 
Automated quantitative analysis of morphological features in microendoscopic images 
can provide an objective method of distinguishing between normal and neoplastic regions. 
Complementary microendoscopic-level information can be included into traditional colonoscopy 
18 
workflow, as demonstrated by various studies, and can increase detection of neoplastic lesions at 
an early stage, with automated quantification minimizing user effort and bias. The use of 
fluorescein, currently approved for intravenous use in certain clinical applications, in conjunction 
with these microendoscopic systems could provide investigators an alternative contrast agent 
with similar quantitative results for translation into in vivo study.  
4. Second harmonic generation imaging of murine epithelium for crypt morphology image 
feature analysis of spontaneous and colitis-associated colorectal tumors 
4.1 Ulcerative colitis and colorectal cancer 
Ulcerative colitis (UC) and Crohn’s disease are the two major forms of inflammatory 
bowel disease (IBD), which is characterized by chronic inflammation of the gastrointestinal tract 
[94]. UC is characterized by severe inflammation and extensive ulcers on the epithelial surface 
of the gastrointestinal tract [95]. Crohn’s disease is characterized by lesions over Peyer’s patches 
(lymphatic tissue found in the ileum region), and the inflammation is non-continuous in location 
as well as spanning the entire depth of the intestinal wall [95-97]. There has been progress in 
discovering possible genes that contribute to disease susceptibility, as well as a rise in IBD 
patients in previously low-risk countries showing the likely correlation between environmental 
factors and IBD, but despite these studies there is still much of the pathogenesis of IBD that is 
yet to be understood [95].  
While there is no individual endoscopic or histological result that is specific for UC or 
Crohn’s disease, an important distinction is the distribution pattern of the inflammation. UC is 
diagnosed when examination shows continuous inflammation of the colon beginning at the 
rectum, whereas a diagnosis of Crohn’s disease is determined when there are lesions over 
Peyer’s patches [95-97]. Patients with UC have long been considered at increased risk for 
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colorectal cancer (CRC), though there are less conclusive studies on the risk of CRC in patients 
with Crohn’s disease [98-102]. While both types of IBD are associated with inflammation, in UC 
pro-inflammatory cytokines are believed to directly influence cancer progression [103], and 
patients are commonly provided with anti-inflammatory therapy, such as 5-aminosalicylic acid 
[62]. Unfortunately, even this therapy is only able to achieve remission in 1 of 6 patients [104].  
4.2 Spontaneous and colitis-associated tumor development in ulcerative colitis patients 
Due to the high risk of UC patients developing CRC over time, if malignant lesions are 
discovered the standard of care is curative colectomy (complete removal of the colon) [62, 105]. 
Within 10 years of diagnosis, approximately 29% of UC patients develop CRC compared to 
2.9% of patients with Crohn’s disease [99, 101, 106, 107]. UC patients are more often considered 
candidates for curative colectomy, since they have continuous inflammation of the colon [108]. 
The gold standard for detection and diagnosis of malignant lesions and/or tumors in IBD patients 
is routine surveillance colonoscopy and subsequent endoscopic biopsy. Surveillance procedures 
are designed to detect early dysplasia and neoplasia (pre-cancerous abnormalities), in order to 
prevent CRC progression. Two types of lesions detected during colonoscopy, associated with 
intraepithelial neoplasia, are dysplasia-associated lesion/masses (DALM) and adenoma-like 
masses (ALM) [74, 105]. A DALM is classified when a lesion is flat or raised but does not have 
a sharp contrast against surrounding healthy epithelium, and this type of lesion is frequently 
associated with malignancy [74]. Endoscopically, an ALM lesion has features similar to 
spontaneous protruding adenomas that are observed in non-IBD patients [74].  
 In non-IBD patients, for example those with spontaneous polyp (non-cancerous) growth, 
the standard procedure is a polypectomy which completely resects the mass [74, 105]. Recent 
studies have suggested that polypectomy of an ALM mass in IBD patients is highly successful, 
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and could postpone the need for curative colectomy [74, 105]. In contrast, a retrospective study 
showed that a higher proportion of unresectable lesions harbored cancer [109]. The 
histopathological differences between ALMs and DALMs are subtle and varied, and an accurate 
diagnosis determines if the patient will undergo endoscopic polypectomy or surgical colectomy 
[74]. The diagnosis must also take into account additional factors such as patient age, duration of 
disease, and if the lesion is within the region affected by colitis [62]. The recommendation of an 
international consensus in 2005 was to perform four-quadrant biopsies every 10cm, with a 
minimum total of 32 biopsies during surveillance [67]. Despite surveillance, between 50% and 
80% of DALM lesions are not visible during traditional endoscopy [110].  
4.3 Endoscopic imaging of UC patients 
In order to improve detection of easily missed lesion, various endoscopic imaging 
modalities have emerged to provide additional information during the surveillance of IBD 
patients, including chromoendoscopy, narrow band imaging, and laser endomicroscopy [73]. The 
first study of chromoendoscopy in IBD patients was published in 2003, in which the colonic 
epithelium was sprayed with 0.1% indigo carmine (a colorimetric contrast agent), and the results 
showed that three times as many neoplastic lesions were detected via chromoendoscopy than 
with traditional colonoscopy [73]. Magnification chromoendoscopy detection of intraepithelial 
neoplasia was four times as high as traditional colonoscopy [111]. Narrow band imaging, as 
previously described, can image blood vessels and capillary patterns without the need for indigo 
carmine or another contrast agent [74, 75]. While these imaging modalities have increased 
detection of lesions, they cannot distinguish between ALMs and DALMs, as the image features 
are similar [74]. Laser endomicroscopy allows for imaging of cellular and subcellular structures, 
providing more detailed imaging of features that relate more closely to histopathological features 
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[76]. A combined study of chromoendoscopy and endomicroscopy showed a 4.75-fold increase 
in detection of lesions, as well as a 50% reduction in the number of required biopsies [73].  
Laser endomicroscopy could describe either confocal or multiphoton laser 
endomicroscopy systems, both of which can provide high-resolution depth-sectioned information 
on changes in cellular and even subcellular structures. Confocal laser endomicroscopy systems in 
studies were dependent on contrast agents, such as the contrast provided by intravenous 
fluorescein (a fluorescent contrast agent), and therefore provided images of structure and 
morphology based on blood flow patterns [76]. Neoplastic regions predicted by the system were 
compared to histopathology and found to be highly accurate (97% sensitivity, 99% specificity) 
[76]. In patients with UC, a study showed that the combination of chromoendoscopy and 
endomicroscopy increased the discovery of neoplastic regions 4.75-fold [76]. An in vivo case 
studied a DALM lesion and adjacent colorectal epithelium, using the Cellvizio ® 
Endomicroscopy System (Mauna Kea Technologies, Paris, France), a 2.5mm catheter imaging 
probe inserted into an existing working channel during colonoscopy, and 5mL of 10% sodium 
fluorescein injected intravenously [112]. Acquired confocal images showed enlarged crypts, 
increased irregularity in the distribution of crypts, increased space between crypts, as well as 
crypt destruction or fusion [112]. They also showed the transition from inflamed mucosa (due to 
ulcerative colitis) to dysplastic mucosa [112]. Inflammation was characterized by enlarged crypt 
openings, with leaking of fluorescein into the crypt lumen that appeared as bright regions in the 
crypt center, while low-grade dysplastic regions were characterized by dark centers with 
irregular structural patterns [112].  
Previously mentioned imaging methods, such as chromoendoscopy and confocal imaging 
with intravenous fluorescein, require a contrast agent which can have various disadvantages. 
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Chromoendoscopy requires topical application of the contrast agent, followed by rinsing, and 
there are reports of the contrast agent not homogenously covering all the epithelial surfaces of 
interest in addition to the amount of time each of these application and rinse cycles can take 
(after applying the contrast agent, there is a 5 minute wait before rinsing) [73]. In addition, these 
contrast agents are not targeted to a specific protein or molecule, therefore the images provide 
important information on vasculature patterns and morphological structure, but do not provide 
more specific cellular information. Narrowband imaging does not require an external contrast 
agent, but it also predominately images vasculature patterns. Multiphoton microscopy is capable 
of acquiring label-free images of bulk tissue without need for fixation, and rapid 3-dimensional 
image acquisition up to several hundred microns [40]. Contrast for fluorescence imaging using 
multiphoton microscopy comes from the endogenous fluorescence of cellular molecules such as 
NADH and FAD, which have been investigated as providing insight into metabolic information 
[34, 35]. Miniaturization of multiphoton laser microscopy systems allows for in vivo imaging, 
utilizing the advantages of multiphoton acquisition of functional data without need for a contrast 
agent, in combination with using near infrared wavelengths to image tissue at increased depth 
[113, 114]. 
4.4 Second harmonic generation imaging applications 
Second harmonic generation (SHG) imaging is an alternative imaging method accessible 
when using multiphoton microscopy. The first biological application of SHG imaging was in 
1986, investigating the polarity of collagen fibers in rat tail tendons [115]. Collagen type I makes 
up much of extracellular matrix (ECM) and connective tissue, and has a history of being 
investigated via SHG imaging [113, 116]. Collagen fibers are a nonlinear medium due to their 
non-centrosymmetric nature (their crystal structure cannot be inverted without change since it 
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does not have a point of symmetry), and the polarization of the fibers can be studied using SHG 
imaging [117]. SHG imaging in healthy colorectal epithelium highlights crypt shape, as the 
collagen fibers provide structure surrounding the cellular arrangement [118, 119]. Miniaturized 
multiphoton microendoscopes have been shown to be capable of SHG imaging of bulk tissue. 
Miniaturized multiphoton label-free fluorescence imaging of intact rat tissue has been reported as 
early as 2001 [120], with endogenous fluorescence and SHG images of fixed murine tail tendons 
acquired in 2009 [121], and in 2011 a 3mm-diameter multiphoton endoscopic probe was shown 
to acquire both endogenous fluorescence and SHG images of ex vivo murine tissue (tail, lung, 
and colon) [114]. The addition of a SHG imaging channel to multiphoton microendoscopes 
would provide supplemental structural information about connective tissue, such as collagen, 
tendon, and muscle without the need for contrast agents [122]. Preliminary work on SHG 
imaging in a murine CRC model has shown SHG imaging of epithelium as providing data on 
collagen structural changes that could be used as early indicators of disease [123].  
4.5 Objective 
Increasing the ability to distinguish between spontaneous (ALM) and colitis-associated 
(DALM) tumors in UC patients could guide clinicians in appropriate treatment. Emergence of 
multiphoton endoscopic systems allow for combination of functional and structural data to 
improve detection and diagnosis of ALM and DALM regions in UC patients, and a quantitative 
study of structural/morphological SHG data in these tumor models had not been documented. 
SHG image features could serve as complementary data during multiphoton microendoscopic 
imaging, and provide insight on collagen changes during crypt deformation, which could serve a 
translatable measure towards detection and distinction of lesions in UC patients.  
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5. Specific Aims 
Introduction 
Early detection of oral and gastrointestinal cancer is crucial in decreasing the risk of 
morbidity; if detected early, the 5-year survival rate for oral cancer and colorectal cancer is on 
average 82% and 92% respectively [61]. For oral cancer, cellular morphological markers of 
cancerous cells include large nuclei and large nucleus to cytoplasm ratio [46]. For colorectal 
cancer, there are known changes in morphological structure of crypts – cells organized into 
cylindrical structures – such as enlarged crypts and loss of cylindricity [11, 12, 124]. Analysis of 
morphological markers, such as nuclear size and crypt cylindricity, is typically performed via 
histopathology [9, 12].  Since histopathology requires tissue biopsy or resection, often followed 
by sectioning, then staining, one area of investigation has been rapid or in vivo imaging of 
morphological markers.  
Optical imaging of cellular structures makes use of wavelengths of visible light, distinct 
from magnetic resonance (MRI) or high frequency wavelengths (x-ray, CT) [21-23]. Optical 
imaging modalities range from inexpensive portable devices to expensive investigational 
systems. Many of these systems, both expensive and inexpensive, are being adapted for 
integration into existing clinical workflow. Low-cost fluorescent systems can be used to analyze 
cell morphology in conjunction with fluorescent contrast agents, while expensive devices are 
capable of acquiring contrast from endogenous optical signals in unstained tissue. Analysis of 
cellular morphology has the potential of detecting abnormal changes in tissue, such as dysplasia 
or cancer, before they are grossly visible. The following aims were designed to address the 
investigation and optimization of morphological imaging of epithelial cancers, specifically oral 
and colon cancer, for early detection.   
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Specific Aim 1: Proflavine as a Contrast Agent for Oral Cell Cytology1 
Background: Oral and pharyngeal cancer is the sixth most common cancer worldwide, with two 
thirds of cases arising in developing countries [42]. While oral squamous cell carcinoma (OSCC) 
is commonly detected during regular physician or dentist visits, as high as 95% of populations in 
low-resource settings declare a history of irregular dental visits, increasing the risk for OSCC to 
develop to late stages without detection [48].Conventional clinical cytology requires biopsies, 
fixing, and staining, and investigators have designed alternative protocols, such as oral rinses and 
brushes, which can collect exfoliated oral cells for cytological analysis. For both conventional 
and investigational oral cytology, morphological image features guide diagnosis of epithelial 
cells, where healthy cells are relatively large with small nuclei while oral cancer cells have a 
large nucleus to cytoplasm ratio [46].  
Low-cost translational devices for cell cytology have used a variety of contrast agents in 
order to analyze morphological markers, including fluorescent contrast agents that have 
advantages that include high signal to background, rapid staining, and low cost. The use of 
proflavine, a rapid fluorescent vital dye, in cytology of OSCC has not been studied. Proflavine 
could serve as an alternative contrast agent for future translational cytological devices.  
Objective: Rapid identification of oral cells with large nuclei to cytoplasm ratios using low-cost 
fluorescence imaging systems could serve in further development of point-of-care OSCC 
screening tools. Proflavine, a DNA-intercalating vital dye, could serve as an alternative contrast 
agent for oral cytology screening systems in regions where traditional pathology services are not 
readily available. 
                                                          
1 Full manuscript available as Chapter II 
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Aim 1: Determine the viability of proflavine as an alternative contrast agent for oral cytology. 
Our study qualitatively and quantitatively investigated the utility of proflavine solution in 
imaging of exfoliated oral cells for OSCC screening. We examined the potential of proflavine as 
a contrast agent for oral cell cytology, using a portable (POC capable) microscope in order to 
qualitatively distinguish differences between healthy and cancerous cells, and quantitatively 
distinguish morphological differences (specifically nuclear to cytoplasm ratio).  
Results: Images of proflavine-stained cells show morphological detail similar to traditional 
staining, with bright distinguishable nuclei and granulation (keratohyalin). Quantification of 
nuclear to cytoplasmic ratio in the images showed significantly (p < 0.001) larger ratios in OSCC 
cells compared to normal cells, where OSCC cell ratios averaged above 0.8 compared to normal 
cell ratios averaging below 0.1.  
Significance: Our comparison of nuclear to cytoplasmic ratios could help guide future POC 
imaging system design for low-resource oral cytology screening. Quantitative analysis of image 
features in oral cell cytology using proflavine had not been investigated. Future studies could use 
one-step proflavine staining to qualitatively inspect cells, or computer-aided image segmentation 
could be implemented to measure nuclear size and create rapid analysis of exfoliated oral cells.  
Specific Aim 2: Image feature quantification and alternative contrast agent for a 
translational microendoscopy system2 
Background: Colorectal cancer (CRC) is the second leading cause of cancer death in the United 
-States [61]. After resection of the primary tumor, recurrence remains a common outcome; 
cancer recurred in 44% of patients, requiring further surgery [70]. Increased screening using 
traditional white-light wide-field colonoscopy has led to a decrease in morbidity in the past few 
                                                          
2 Full manuscripts available as Chapters III and IV 
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decades, but it is not an ideal imaging modality for detection of sessile or flat lesions [77-79]. 
Various techniques have been investigated for surveillance of at-risk patients, including salivary 
protein markers, but endoscopic imaging systems have several advantages [71]. Endoscopic 
imaging systems analyze cellular and crypt morphology, which pathologists are trained in 
identifying. In addition, conventional colonoscopy already has clinical protocols and physical 
tools in place for endoscopic imaging, thereby facilitating translation of these imaging systems 
into in vivo clinical settings [72].  
Microendoscopic imaging systems have been studied in CRC patients and quantitative 
analysis of a clinical fluorescence microendoscopy images using proflavine as a contrast agent 
has shown up to 98% specificity in diagnosis of neoplastic polyps [86]. In vivo clinical diagnosis 
was made on morphological image features based on crypt morphology, including nuclear 
organization and epithelial thickness [86]. Viability of automated quantification of these image 
features, specifically crypt size and circularity, in microendoscopic images has not been studied.  
Objective: Automated quantitative analysis of morphological features in microendoscopic 
images can provide an objective method of distinguishing between normal and neoplastic 
regions. Complementary microendoscopic-level information can be included into traditional 
colonoscopy workflow, as demonstrated by various studies, and can increase detection of 
neoplastic lesions at an early stage, with automated quantification minimizing user effort and 
bias. The use of fluorescein, currently approved for intravenous use in certain clinical 
applications, in conjunction with these microendoscopic systems could provide investigators an 
alternative contrast agent with similar quantitative results for translation into in vivo study. 
Aim 2: Quantification of microendoscopy images toward computer-aided analysis of crypt 
morphology in colorectal cancer. Our study investigated the potential of automated 
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quantification of crypt size and circularity in microendoscopic images using a custom algorithm. 
We tested the algorithm’s ability to quantify images of normal and abnormal colorectal 
epithelium, using both proflavine and fluorescein as contrast agents.  
Sub-aim 1: Development of a custom algorithm for automated analysis of microendoscopic 
image features. Acquired images of ex vivo porcine colorectal epithelium stained with 
proflavine, a contrast agent used in clinical studies, for development of a custom algorithm for 
automated image segmentation and quantification of crypt size and circularity. Quantitatively 
compared preliminary data from freshly resected clinical colorectal tissue.  
Sub-aim 2: Determine the viability of fluorescein as an alternative contrast agent for 
microendoscopic imaging. We tested our previously developed algorithm on images of 
fluorescein-stained ex vivo human and animal epithelium, to determine the feasibility of using 
fluorescein as an alternative contrast agent in microendoscopic imaging. We compared crypt 
detection sensitivity of the automated algorithm in proflavine versus fluorescein stained normal 
and abnormal colonic epithelium.   
Results: Our custom algorithm showed above 80% crypt detection sensitivity using images of 
proflavine-stained freshly resected porcine and human epithelium. Preliminary comparison of 
normal and adenomatous diagnoses in human epithelium showed increased crypt area and 
circularity in adenoma-adjacent regions. The custom algorithm yielded better crypt detection 
sensitivity (>90%) using fluorescein, an alternative contrast agent for microendoscopic imaging. 
Preliminary results using fluorescein in ex vivo clinical specimens showed a decrease in average 
crypt size in regions of adenocarcinoma when compared to normal regions.  
Significance: Microendoscopic imaging has been qualitatively investigated as a potential 
intraoperative aid during surveillance colonoscopy, but quantitative analysis of crypt 
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morphology as biomarkers of carcinoma had not been documented for this system. Our results 
could guide implementation of automated quantification in microendoscopic system design, 
including image features such as area and circularity which resulted in significant differences 
between normal and cancerous regions. The use of in vivo automated quantification could be 
further studied for future translation into clinical settings during CRC surveillance. In addition, 
the use of intravenous fluorescein as an alternative contrast agent for confocal endomicroscopy 
imaging systems has been studied, but our results show that topical application is a viable 
alternative for microendoscopic imaging [112, 124]. 
Specific Aim 3: Second harmonic generation imaging of murine epithelium for crypt 
morphology image feature analysis of spontaneous and colitis-associated colorectal tumors3  
Background: Spontaneous polyp, and subsequent tumor, formation accounts for a majority of 
CRC cases, with polypectomy (local resection of polyps) a standard treatment [74, 105]. A 
smaller percentage of CRC cases have a history of ulcerative colitis (UC), one of two major 
types of inflammatory bowel disease, which is linked to increased risk for CRC [94, 98]. Often, 
the end-treatment for UC patients is curative colectomy, yet this treatment is deferred until 
deemed necessary due to the presence of malignancy [62, 105]. Studies have shown that in UC 
patients there is still a distinction between spontaneous tumors, which can be resected via 
polypectomy with limited risk of recurrence, and colitis-associated tumors require curative 
colectomy [74, 105].  
Various translational imaging modalities have been applied to the task of distinguishing 
between spontaneous tumors (adenoma-like mass or ALM) and colitis-associated tumors 
(dysplasia-associated lesion/mass or DALM) [74]. Endoscopic systems capable of in vivo 
                                                          
3 Full manuscript available as Chapter V 
30 
imaging of colorectal epithelium include miniaturized confocal systems, such as the Cellvizio ® 
Endomicroscopy System [112], and investigational multiphoton systems. Benefits of 
multiphoton imaging, miniaturized for endoscopic applications, include label-free imaging (no 
need for contrast agents) and the ability of acquiring data of both functional (autofluorescence) 
and structural (second harmonic generation) biomarkers [113, 114]. As previously described, in 
early cancer development, crypt structures become non-homogenous in size and shape, but the 
use of second harmonic generation (SHG) imaging of crypt morphology, via collagen structures, 
has not been quantitatively investigated.  
Objective: Increasing the ability to distinguish between spontaneous (ALM) and colitis-
associated (DALM) tumors in UC patients could guide clinicians in appropriate treatment. 
Emergence of multiphoton endoscopic systems allow for combination of functional and 
structural data to improve detection and diagnosis of ALM and DALM regions in UC patients, 
and a quantitative study of structural/morphological SHG data in these tumor models had not 
been documented. SHG image features could serve as complementary data during multiphoton 
microendoscopic imaging, and provide insight on collagen changes during crypt deformation, 
which could serve a translatable measure towards detection and distinction of lesions in UC 
patients. 
Aim 3: Determine utility of SHG imaging in investigation of morphological changes in murine 
colonic crypt structure in spontaneous and colitis-associated tumor progression. We used SHG 
imaging in murine CRC models to analyze data on structural changes in cryptal collagen that 
could be used as indicators of disease. 
Sub-aim 1: Quantitative comparison of morphological image features in ALM and DALM 
murine models. We used SHG imaging to acquire and quantify data on crypt size, shape, and 
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distribution in ALM and DALM murine models, to determine feasibility of using SHG imaging 
as a complementary source of data using miniaturized multiphoton systems. We sought to 
determine which image features held the most potential for distinguishing between ALM and 
DALM regions. 
Sub-aim 2: Quantitative comparison of morphological image features in early and late time 
points of tumor development. We compared SHG image features in early and late time points in both 
ALM and DALM murine tumor development, to determine the potential of SHG imaging in assisting 
early detection of CRC.  
Results: Our results showed that mean and variance of nearest neighbor (distance between 
crypts) and circularity were potential image features for SHG modalities in distinguishing 
between Control, ALM, and DALM regions in murine models. Control crypts had smaller 
average distance to the nearest neighbor compared to late-stage ALM and early-stage DALM 
development, as well as more homogeneous distances between crypts (variance). Preliminary 
results showed promise in the nearest neighbor image feature (mean and variance) serving as a 
morphological marker for distinguishing between early and late-stage DALM time points in our 
murine tumor models. Images of late-stage DALM crypts had lower average nearest neighbors 
compared to early-stage DALM.  
Significance: Miniaturized multiphoton imaging systems have been used to qualitatively and 
quantitatively study functional data acquired via fluorescence channels (e.g. redox ratios and 
cellular metabolic response), and studies on collagen fiber density and pattern using SHG 
channels in various cancers have been documented [113, 114, 123]. Our quantified SHG image 
features, specifically nearest neighbor, showed differences in crypt distribution in ALM and 
DALM murine models. This could guide future multiphoton studies of these murine models, 
such as in vivo studies to acquire both autofluorescence and SHG data to more thoroughly 
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understand crypt morphological changes in spontaneous versus colitis-associated tumors. 
Automated quantification of SHG image features, as a complementary modality during 
endoscopic multiphoton imaging, could potentially contribute to more accurate screening and 
diagnosis of suspicious lesions and polyps during surveillance of high-risk UC patients. 
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Chapter II: Proflavine Hemisulfate as a Fluorescent Contrast Agent for Point-of-Care 
Cytology [1] 
1. Introduction 
Cytology is defined as the study of cells on a microscopic scale with a focus on 
morphology and structural distinctions [2]. Considering the many cytological procedures that 
depend on visual diagnosis, and distinguishing of structural features such as nuclear size, nuclear 
to cytoplasmic ratios, and cytoplasmic features, the field depends significantly on contrast-
enhancing agents. Clinical cytology is typically performed by sample collection, fixation, 
staining, and visual inspection by a trained pathologist. Cytology specimens may include 
peripheral blood smears, fine needle aspirations (FNA), bronchial alveolar lavages (BAL), and 
oral as well as vaginal/cervical exfoliated cells. Clinical cytology provides complementary 
information to more conventional histopathology examination of thin tissue sections made from 
solid tissue, particularly when screening for cellular atypia and dysplasia [3]. 
Common contrast agents used for cytology include conventional hematoxylin and eosin 
(H&E), Giemsa, and Papanicolaou (PAP) staining [4, 5]. Fluorescent dyes are also popular 
contrast agents due to their high signal-to-background ratios, as well as offering the option for 
varying levels of specificity in targeting of molecules and/or structures. Fluorescent contrast 
agents do not necessarily need to be as target-specific as immunofluorescent staining. Common 
untargeted exogenous fluorescent stains include ethidium bromide, acridine orange, propidium 
iodide, and acriflavine hydrochloride / proflavine hemisulfate. Popular stains such as the 
fluorescent dye acridine orange are widely used in flow cytometry and cytochemistry 
applications which do not require the selectivity of immunofluorescence, such as the lysosome 
staining of living blood cells, and in distinguishing between different types of lung cells [6]. 
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Nucleic acid probes, which do not fall under the category of target-specific dyes, despite their 
preferential binding to nucleic acids, are used routinely to determine the ploidy or phase of a cell, 
but usually require fixation and permeabilization [7-9]. A common benefit of untargeted 
fluorescent stains is the simplicity of the staining process, compared to the hybridization time 
and environmental factors, such as temperature and media, required for immunolabeling. 
Proflavine, an aminoacridine-derived dye similar to acridine orange, non-specifically stains 
cellular structures, as well as preferentially stains cell nuclei. It exhibits fluorescence with a peak 
excitation around 460nm and emission around 515nm, with a quantum efficiency of 0.5 [10, 11]. 
Proflavine can be used to rapidly stain fresh cells due to its small molecular size and amphipathic 
chemistry, enabling the molecule to easily pass through the lipid bilayer of the cell and nuclear 
membrane [12]. It has been shown to intercalate double stranded DNA, providing strong nuclear 
contrast [13, 14]. In addition, proflavine exhibits less prominent staining of cytoplasmic 
structures, which can be beneficial for cell classification, allowing for applications in cytological 
analysis. 
Proflavine has been used clinically since 1917 [15], but its use as a cytological tool isn’t 
widespread despite its numerous advantages. Its ability to intercalate DNA has provided many 
applications including anti-cancer, anti-bacterial, and anti-viral drugs [16-18]. Common research 
applications include endoscopy and microendoscopy imaging, modalities that benefit from 
contrast agents that allow for rapid topical staining of intact epithelium, where proflavine is used 
as a topical contrast agent for histological analysis [15, 19, 20]. There has also recently been 
renewed interest in proflavine for point-of-care diagnostic applications in low-resource settings 
due to its physical and chemical stability in solution, lasting at least 12 months under 
refrigeration [21]. 
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In this paper we will demonstrate the benefits of proflavine staining in cytological 
samples, including rapid and preferential staining of nucleic structures such as cytosol, 
membrane, granules and nuclei. Proflavine’s rapid staining eliminates time-consuming 
procedures while retaining the benefits of fluorescence imaging. We have demonstrated 
proflavine staining in a variety of cell types, including normal exfoliated oral squamous cells, an 
in vitro cultured oral squamous carcinoma cell line (Cal 27), and normal human leukocytes from 
whole blood. All proflavine fluorescence images were acquired using a custom-built, cost-
effective and portable fluorescence microscopy platform. Automated image analysis tools were 
used to demonstrate the feasibility of using computer aided diagnostic approaches on proflavine-
stained cytology specimens. 
2. Materials and Methods 
Mammalian Cell Culture 
CAL 27, a squamous cell carcinoma cell line (ATCC CRL-2095, ATCC, Manassas, VA), 
was cultured in Dulbecco’s Modified Eagle Medium (DMEM) media supplemented with 10% 
fetal bovine serum (ATCC, Manassas, VA) and 1% Penicillin-Streptomycin (Life Technologies, 
Grand Island, NY) and incubated at 37°C in 5% CO2. The cells were utilized up to passage 
number four. Before staining, the cells were trypsinized with 0.25% Trypsin-EDTA (Life 
Technologies, Grand Island, NY). 
Human Cell Collection 
All human cells used in this study were collected following written informed consent 
from healthy volunteers as part of a protocol (IRB#13-06-759) approved by the University of 
Arkansas Institutional Review Board. 
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Exfoliated oral epithelial cells were collected through an oral rinse consisting of a 30 sec 
rinse to remove food particles and bacteria that were discarded followed by a 90 sec collected 
rinse. The cell suspension was filtered through a 100μm cell strainer (Falcon, Bedford, MA) to 
remove mucus and washed three times by centrifuging at 200g for 5 min, decanting the 
supernatant, and resuspending in phosphate buffered saline (1x PBS, Sigma-Aldrich, St. Louis, 
MO). Whole blood was collected using a fingerstick lancet (30 Gauge Ultra-Thin Lancets, 
ReliOn, Bentonville, AR). The first drop was discarded [22], and approximately 20μl of blood 
was collected using a micropipette. 
Papanicolaou Staining of Oral Epithelial Cells 
A cotton swab was used to transfer exfoliated oral epithelial cells from the oral cavity to a 
clean slide, where it was left to dry completely. Following a conventional Papanicolaou staining 
procedure [23], the cells were fixed with 95% ethanol, chromatin stained using Gill Hematoxylin 
#1 (Millipore, Billerica, MA), blued with Scott’s tap water substitute (Millipore, Billerica, MA), 
cytoplasmic counterstained using Modified OG-6 and Modified EA (Millipore, Billerica, MA), 
and cleaned with Xylene. After mounting a no.1 coverslip, the slides were imaged in brightfield 
using a Nikon Eclipse Ci microscope (Nikon Instruments Inc., Melville, NY) and a 60x Nikon 
Plan Apo VC oil immersion objective (N.A. = 1.40, Nikon Instruments Inc., Melville, NY). 
Papanicolaou Staining of CAL 27 Cells 
After passaging the CAL 27 cells, the cell suspension, ranging from 600,000–800,000 
cells, was centrifuged at 200g for 5 min and the media removed. The cells were resuspended in 
1X PBS and washed once by centrifuging at 200g for 5 min, decanting the supernatant, and 
resuspending in PBS. A glass slide was prepared by pipetting 10μl of the cell suspension and 
using the pipette tip to spread the droplet into a monolayer. The slide was dried completely and 
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stained following the same modified Papanicolaou staining procedure described previously. The 
slide was imaged in brightfield using the same Nikon microscope and 60x oil immersion 
objective. 
Giemsa Staining of Blood Smears 
A peripheral blood smear was Giemsa stained following standard methods [22]. The 
smear was allowed to completely dry before being fixed with methanol for a few seconds. The 
slide was then stained with a 10% Giemsa (Alfa Aesar, Ward Hill, MA) solution for 5–10 min. 
The slide was rinsed with clean water and allowed to dry before mounting a coverslip. The slides 
were imaged with a brightfield microscope (Nikon Eclipse Ci, Nikon Instruments Inc., Melville, 
NY) using a 60x oil immersion objective (60x Nikon Plan Apo VC, Nikon Instruments Inc., 
Melville, NY). 
Proflavine Staining of Oral Epithelial Cells 
The samples of exfoliated cells were washed in PBS three times and incubated in 1% 
albumin from bovine serum (BSA, Sigma-Aldrich, St. Louis, MO) for 5 min. The BSA was 
removed and the cells were stained with a solution of 0.01% (w/v) proflavine in PBS. 
Additionally, to collect immature oral epithelial cells, a cotton swab was used to collect normal 
oral cells from a volunteer. The swab was mixed in a 0.01% (w/v) proflavine solution to suspend 
and stain the cells. A 10μl sample of stained cells from each collection method was added to a 
slide and (no.1) coverslipped. The slide was imaged with our epi-illuminated fluorescence 
system using a 40x Nikon Plan Achromat air objective (N.A. = 0.65, Nikon Instruments Inc., 
Melville, NY). 
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Proflavine Staining of CAL 27 
Passaged CAL 27 cells (up to passage number four) were centrifuged at 200g for 5 min 
and the media removed. The cells were washed once with PBS by centrifuging at 200g for 5 min, 
decanting the supernatant, and resuspending in 1% BSA for 5 min. The BSA was removed and 
the cells were stained with the 0.01% (w/v) proflavine solution. The slide preparation and 
imaging was conducted the same as previously described. 
Proflavine Staining of Leukocytes 
The samples of whole blood were stained at a final concentration of 0.01% (w/v) 
proflavine solution. The slide preparation and imaging was conducted the same as previously 
described. 
Custom Fluorescence Imaging System 
Image acquisition was also performed using a custom epi-fluorescence microscope (see 
Fig 1) based on a microendoscopy platform previously demonstrated [24]. This system 
comprises an LED illumination source at a center wavelength of 455nm (Philips, San Jose, 
California) providing approximately 8mW at the sample, a 475nm dichroic filter set (Chroma 
Technologies, Bellows Falls, VT) and a 525/40nm bandpass emission filter. The imaging system 
used a 40x Nikon Plan Achromat air objective (N.A. = 0.65, Nikon Instruments Inc., Melville, 
NY) and a 150mm achromatic doublet tube lens (Thorlabs, Newton, NJ). A Flea 3 USB camera 
(Point Grey Research, BC, CA) was used for imaging. The samples were placed on a set of linear 
translation stages (Thorlabs, Newton, NJ) for x and y axis translation. This system performs 
comparably to any conventional epi-fluorescence microscope equipped with a fluorescein or 
green fluorescent protein (GFP) filter set and monochrome camera. Images were taken with no 
gain, and with exposure times in the range of 100 to 150 msec. Fluorescence images were 
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normalized to ensure equal pixel intensity maxima in all images, in order to compensate for 
photobleaching and other uneven illumination artefacts. The histograms were stretched, 
assigning the highest pixel value to be at maximum intensity (255 for an 8-bit image) and the 
other pixel values were scaled accordingly to conserve the ratios. 
 
Figure 1. Custom epi-fluorescence microscopy system. Comprises a Flea 3 USB camera, 
525/40nm bandpass emission filter, 475nm dichroic filter set, 455nm LED light source, 40x 
Nikon Plan Achromat air objective and two linear translation stages. 
Manual Segmentation for Nuclear to Cytoplasmic Ratio 
Images were semi-quantitatively analyzed using ImageJ [25]. Digital images acquired 
using our custom microscopy system were hand-segmented using ImageJ to isolate the nucleus 
from the cytoplasm. The boundary around the nucleus was traced using the free-hand tool, 
measuring the area, and repeating the process for the boundary around the entire cell (see Fig 2). 
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The number of pixels within each measured area (nuclear, whole cell) was tabulated. The 
cytoplasmic area was then calculated by subtracting the nuclear area from the whole cell. The 
nuclear to cytoplasmic ratios were then calculated for each cell. The mean and standard deviation 
values of these ratios were computed for both normal oral and Cal 27 cells. 
 
Figure 2. Illustration of manually-segmented oral epithelial cells stained with proflavine. Top 
row: Normal exfoliated oral epithelial cells. Bottom row: CAL 27 oral squamous carcinoma 
cells. Scale bars = 10μm. 
Image texture features used to analyze the images included the calculated standard 
deviation of the pixel intensity across the entire image, as well as entropy values. Entropy is an 
image texture function in the MATLAB toolbox which examines the entire image for pixel 
intensity variation, as a measurement of heterogeneity in an image. Standard deviation and 
entropy of one hundred images of each type, normal exfoliated oral squamous epithelial cells and 
cultured Cal 27 oral squamous carcinoma cells, were computed, averaged, and tabulated. The 
statistical significance for each group (p values) were computed using a two tailed Student’s t 
test. 
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3. Results 
Comparison of Cytologic Features Seen in Papanicolaou and Proflavine Stained Oral Cells 
Proflavine stains both cytosol and nuclei in oral cells, yet the two regions are still 
distinguishable. As seen in Fig 3, Papanicolaou stained cells are compared with similar cell types 
stained with proflavine. Nuclear as well as cytoplasmic shape, size, granulation (keratohyalin) 
and the golgi zone are distinguishable in both the colorimetric and fluorescently stained cell 
types (Fig 4). Note the small, well-defined nuclei in normal oral cells, which exhibit significantly 
brighter fluorescence than the surrounding cytoplasm. Cytoplasmic detail, such as keratohyalin 
granules, is also apparent. Cal 27 oral squamous carcinoma cells, by comparison exhibit very 
large and somewhat undefined nuclear envelopes and prominent Golgi zones. In both cases, 
proflavine fluorescence and Papanicolaou staining patterns are similar. 
 
Figure 3. Visual diagnosis comparison of Papanicolaou and proflavine-stained normal oral cells 
and CAL 27 cell line. First row: Papanicolaou stained normal oral cells. Second row: 
Papanicolaou stained CAL 27 cells. Third row: Fluorescent images of proflavine stained normal 
oral cells. Fourth row: Fluorescent images of proflavine stained CAL 27 cells. Scale bars = 
10μm. 
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Figure 4. Comparison of cellular features seen in Papanicolaou (top row) and proflavine (bottom 
row) stained cells. Left column, oral squamous epithelial cells. Right column, Cal 27 squamous 
carcinoma cells. NU: Nucleus, NO: Nucleolus, KH: Keratohyalin granule, GZ: Golgi zone. Scale 
bars = 10μm. 
Comparison of Cytologic Features Seen in Giemsa and Proflavine Stained Human 
Leukocytes 
As seen in Fig 5, while Giemsa stains both erythrocytes and leukocytes, proflavine 
preferentially stains the nuclei-containing leukocytes. Proflavine, given its ability to intercalate 
DNA, prominently highlights nuclear structures within cells. Since human erythrocytes have 
little DNA content, there is very little proflavine signal present from these cells. While the 
erythrocytes are not visible with proflavine staining, the monolobar and multilobar structures 
within leukocytes are clearly distinguishable. Proflavine stained neutrophils exhibit classic 
multilobar architecture, with detectable granulation in the cytoplasm. Proflavine stained 
monocytes display a smooth, convoluted nuclear envelope and relatively homogeneous 
cytoplasm. Proflavine stained lymphocytes are easily distinguished by their characteristically 
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smaller size, and display a relatively heterogeneous chromatin staining pattern and scant 
cytoplasmic labeling. 
 
Figure 5. Giemsa (top row) and proflavine (bottom row) stained leukocytes. First row, Giemsa 
stained neutrophil (A), monocyte (B), lymphocyte (C). Second row, proflavine stained neutrophil 
(D), monocyte (E), lymphocyte (F). Images were captured at 60X. Fluorescence images were 
normalized as described in the Methods section. Scale bars = 10μm. 
Morphology and Quantitative Image Analysis of Oral Cells 
Cytology images were analyzed quantitatively to extract important metrics indicative of 
cellular morphology. Both manual image metrics and automatic image texture analysis were 
used. Using ImageJ, the ratio between nuclear and cytoplasmic area was computed for 
comparison between normal human oral squamous cells and cultured Cal 27 oral squamous 
carcinoma cells. Using automated image texture analysis, we also report the use of entropy- a 
statistical measure of the randomness of pixel intensity within an image- to characterize images 
of proflavine-stained oral cells. 
Manual Segmentation for Nuclear to Cytoplasmic Ratio 
The nuclei and cytoplasm of 100 normal cells and 100 CAL 27 cells were manually 
segmented and measured in ImageJ. Mean and standard deviation values for nuclear to 
cytoplasmic ratio were computed as described in the methods section. These results can be seen 
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in Fig 6. Note that the nuclear to cytoplasmic ratio of normal oral cells was significantly smaller 
than the ratio of Cal 27 oral squamous carcinoma cells. This is expected when comparing 
normal, mature exfoliated oral squamous cells to in vitro cultured oral squamous carcinoma 
cells. 
 
Figure 6. Bar plot comparing nuclear to cytoplasmic ratios for normal and CAL 27 cells. P value 
<< 0.001 with Student T test. Error bars denote standard deviation. 
Image Texture Analysis 
The same 200 images used to calculate nuclear to cytoplasmic ratios were analyzed using 
automated image texture analysis. The texture of each image was quantified individually using 
standard deviation and entropy. The difference in mean standard deviation and mean entropy 
values for each cell type were statistically significant (Fig 7). The average entropy (measure of 
pixel intensity randomness) values for the cultured CAL 27 carcinoma cells were significantly 
larger than the normal exfoliated oral cells. Similarly, the standard deviation of pixel values in 
the CAL 27 images were significantly larger than the normal exfoliated oral cells. These results 
imply that the internal texture, or variation in pixel intensity values within the image of each type 
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of cell, is significantly greater in the Cal 27 cells when compared to the normal oral squamous 
cells. 
 
Figure 7. Bar plot comparing features between normal and CAL 27 cells. For both plots, p value 
<< 0.001 with Student t-test. 100 cells per group. Error bars denote standard deviation. 
4. Discussion 
In this manuscript, we have demonstrated that proflavine can be used to rapidly stain 
fresh cells for cytologic analysis. Proflavine is an effective fluorescent contrast agent for 
exfoliated oral squamous cells, highlighting nuclear and cytoplasmic structures, including 
keratohyalin granules in mature cells. Structural definition in proflavine-stained cells is 
comparable to Giemsa or Papanicolaou staining. As opposed to the multi-step procedure of 
Papanicolaou staining, proflavine staining requires only the addition of the dye to the cell 
medium before mounting on a slide, eschewing the need for fixation. Giemsa is also a 
conveniently applied cytologic stain for hematology specimens, but lacks the benefit of the high 
signal to background ratios that fluorescence imaging provides. Compared to traditional 
pathology stains, proflavine is cost-effective, requires little setup and materials, and does not 
require lengthy staining time (see Table 1). Additionally, proflavine can rapidly stain freshly 
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collected leukocytes, clearly showing the multilobar structure of granulocytes in contrast to other 
cellular components. Finally, fluorescence images of proflavine stained cells can be analyzed 
quantitatively to highlight statistically significant differences in cell types based on morphologic 
features. 
Table 2. Comparison of proflavine and PAP stained oral cells. 
 Proflavine Giemsa Diff-Quik H&E 
Cost/Slide (materials only) Estimated $0.50 Estimated $1.00† $1.50 [26] $3.39 [27] 
Time/Slide Unit Value* Estimated 1 min 14 min [28] 10-30 min [26]  1.5 min‡ [28] 
*Not including time required to examine a slide to reach a diagnosis. 
†Based on an average yield of 1000 slides/L. 
‡H&E performed with an autostainer. 
Normal oral epithelial cells can be classified as basal, parabasal, intermediate, and 
superficial. Using our system we have collected mostly intermediate and superficial cells. 
Normal superficial cells have a large cytoplasm, with small, well defined nuclei, and small 
granules [5]. Cancer cells, due to their high mitotic activity, tend to have enlarged nuclei with 
diminished cytoplasm, to the point that the cytoplasm might visibly be a narrow region around 
the nucleus, or the nuclei aren’t clearly visible [5]. Of the 100 normal oral epithelial cells stained 
with proflavine, all exhibited clearly defined nuclei, while of the 100 cancer cells imaged, 
slightly more than half displayed clearly defined nuclei. Proflavine stained cells displayed 
comparable cytologic features to PAP stained cells, such as well-defined membranes, nuclei, 
granules, and bacteria. Tables 2 and 3 qualitatively compare key image features of proflavine 
stained cells with conventionally (PAP or Giemsa) stained cells. Twenty randomly selected 
images from each set were visually inspected and evaluated for contrast between features—
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membranes, nuclei, and keratohyalin granules—and the surrounding structures, and each set was 
given an overall rating of distinct / strong contrast (++), visible but moderate contrast (+), or 
poor contrast / not visible (-), with one feature (the presence of bacteria) classified as N/A for 
cultured CAL 27 cells which were intentionally kept free of bacteria (see Table 2). 
Table 3. Comparison of proflavine and Giemsa stained leukocytes. 
 
Clearly defined cell membranes (++) were defined as showing a sharp contrast between 
the edge of the membrane and the dark background surrounding the cell, while visible 
membranes that had indistinct borders were defined as visible but moderate contrast (+). PAP 
stained cells were designated as having clearly defined membranes (++) if they showed a sharp 
contrast between the bluish-purple edge of the membrane and the white-beige background 
surrounding the cell, while membranes that had a color difference but did not have a clearly 
defined boundary were defined as (+). As seen in Table 2, PAP stained cells have clearly defined 
cell membranes, and proflavine stained CAL 27 cells also had pronounced definition. Proflavine 
stained normal cells were labelled with visible with moderate contrast (+) due to some of the 
assessed cell membranes having low membrane to background contrast, or having a small gap in 
the perimeter, where the membrane was left unstained and the cytoplasm seems to merge with 
the background and surroundings. The nuclei, nucleoli, and bacteria were similarly assessed, 
with their outer boundary compared against its surroundings (cytoplasm, nucleus, or cytoplasm, 
respectively) for strong contrast (fluorescent or colorimetric). CAL 27 cells have large nuclei that 
can be difficult to distinguish due to their size and lack of sharp boundaries in both PAP and 
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proflavine stained images, whereas their normal counterparts demonstrate high contrast with 
both methods of staining. Nucleoli, when visible, appeared with high contrast (++). The Golgi 
zone lacked the sharp boundaries of other features, and was defined as clear (++) when the area 
was a different intensity or color from the rest of the cytoplasm, visible but unclear (+) when 
there was a difference in the area surrounding the nucleus but difficult to tell where the Golgi 
zone ended and the cytoplasm began, and unclear (-) if the Golgi zone was not apparent, with 
proflavine showing a greater contrast in CAL 27 cells, but not distinguishable in either stain in 
normal oral cells. 
Whole blood from healthy volunteers was also imaged, and classified by an expert 
pathologist (SGS). Features highlighted by proflavine staining, specifically the shape and 
number of lobar structures in the nuclei of neutrophils, could be used to classify leukocyte types 
[29]. Features such as lobar structure and membrane definition were comparable to Giemsa 
stained whole blood, with the primary difference being that erythrocytes are nearly invisible in 
proflavine fluorescence images. Randomly selected images from each set were assessed for 
features such as lobar structure, membrane definition, and lobar texture (see Table 3). Lobar 
structure and membrane was defined as high contrast (++) when the outer boundary was in sharp 
contrast with its surroundings, and the shape of the lobes or membrane were easy to identify. 
Both Giemsa and proflavine stained leukocytes showed clearly defined lobes, and did not require 
use of the visible but moderate contrast (+) label. Proflavine stained leukocytes had a higher 
tendency to have diffuse membrane boundaries (-), though they were clearly different from their 
surroundings. Lobar texture was assessed by looking at contrasting regions within the lobes 
themselves; areas within the same lobes can be in contrast (fluorescent or colorimetric) with 
neighboring regions. High contrast lobar texture (++) was defined as distinct patchy contrasting 
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regions within lobes, while the lobe texture was deemed to have moderate contrast (+) if there 
was little diffuse contrast within. Lobes without internal contrast (-) were commonly due to stain 
saturation and were rare in both Giemsa and proflavine stained leukocytes. In summary, 
proflavine stained cells displayed comparable cellular features to PAP and Giemsa stained cells, 
with less membrane definition overall due to the preferentially nuclei staining nature of 
proflavine, but no significant loss of features that would limit cytological classification. 
Our study included only a select set of examples of quantitative image analysis of 
proflavine stained cells. We have shown that quantification of morphological features of normal 
oral, abnormal oral, and leukocytes is achievable using proflavine-staining cytology. 
Computational classification algorithms have been previously used in conjunction with imaging 
to provide additional tools for the pathologist [30]. Such algorithms could be implemented in 
cytological analysis of proflavine-stained leukocytes, using a combination of image texture and 
automatically-segmented structural features. Quantitative image analysis could be useful as an 
adjunctive tool when analyzing cytology specimens which are ambiguous. Additionally, 
computer-aided analysis could allow for diagnosis in the absence of an expertly trained 
pathologist. Computer-aided diagnostic platforms are currently in use, including image 
segmentation and analysis systems like the CytoSavant and the CellSearch system (specifically, 
CellTracks Analyzer) [31, 32]. Additional image analysis platforms and systems have been either 
implemented, or heavily researched, such as image analysis of ultrasound data [33-35]. 
As a research tool, proflavine staining could enable quantitative morphologic 
comparisons between many different cell types, while simplifying current imaging lab 
procedures. Proflavine fluorescence is compatible with conventional fluorescein isothiocyanate 
(FITC)-equipped microscopy tools, and could potentially be introduced as a label in flow 
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cytometry. Other methods of flow cytometry / image cytometry include classification of 
lymphoblastic leukemia using specific cell surface markers through immunofluorescent labeling 
[36]. Non-specific dyes such as propidum iodide and FITC have been used in combination to 
distinguish contours, such as the nuclei, and can approximate the accuracy and sensitivity of 
“advanced flow cytometers” [37]. 
Proflavine, as an aminoacridine derivative, is a promising contrast agent for point-of-care 
cytology due to its rapid uptake, highly simplified staining procedure, and robust and consistent 
staining of cellular structures. Other aminoacridine derivatives, such as acridine orange- with a 
peak excitation wavelength of 450 and emission of 650- have also been widely studied as a 
nucleic acid stain [38]. Acridine orange has also been studied for point-of-care diagnostics, such 
as malaria, due to its rapid and selective staining and high contrast images of intracellular 
plamsmodium parasites [39, 40]. Cost-effective point-of-care cytology is currently of high 
interest to the biomedical research community, especially for applications in rural or developing 
regions. Cell phone imaging technology has been developed and is still being investigated. For 
example, an inexpensive white blood cell density counter prototype measured fluorescence in 
leukocytes stained with Syto16, a fluorescent nucleic acid stain that required a 30 minute 
incubation period [41]. We propose that proflavine can be used as a fluorescent structural dye 
across a wide range of unfixed cytology and solid tissue specimens. Using proflavine in 
combination with current point-of-care diagnostics, including portable microscopy platforms, 
microendoscopy devices and lab-on-chip technology, could prove beneficial in reducing time, 
procedure, and cost of screening diseases such as cervical cancer [24, 42-44]. 
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Chapter III: Quantitative analysis of ex vivo colorectal epithelium using an automated 
feature extraction algorithm for microendoscopy image data [1] 
1. Introduction 
Colorectal cancer (CRC) is currently the third leading cause of cancer death in the United 
States, despite increased screening rates and a concomitant decline in incidence and mortality [2, 
3]. CRC commonly arises from adenomatous polyps, some of which may progress into invasive 
adenocarcinomas over time [4]. This progression is thought to be slow and is dependent on the 
size and histology of the polyp [5]. Screening for colorectal polyps via conventional white light 
colonoscopy has had a dramatic effect on reducing the overall morbidity and mortality due to 
CRC, as visible polyps can be safely removed during this procedure [6]. However, small lesions, 
sessile (i.e., flat) lesions, or regions of occult dysplasia can be occasionally missed. A broad 
range of alternative strategies have been recently employed to improve endoscopic screening 
methods, including autofluorescence endoscopy with real-time image processing, narrow band 
reflectance imaging, and combined multimodal methods [7-9]. While these approaches have 
demonstrated improved sensitivity for early detection of neoplasia, false positive rates remain 
elevated, limiting widespread adoption of these methods for screening purposes [10]. 
High-resolution endoscopic imaging modalities have been widely explored to improve 
detection of these focal regions of early dysplasia in gastrointestinal epithelium [11-14]. Laser 
scanning confocal imaging methods employing novel miniaturized distal scanning mechanisms 
based on microelectromechanical systems have been demonstrated to yield excellent lateral and 
axial spatial resolution [15-17]. Clinical trials of a hybrid endoscope/miniaturized laser scanning 
confocal microscope system have demonstrated utility in diagnosing focal regions of dysplasia in 
the setting of Barrett’s esophagus and during colonoscopy [18]. These systems offer real-time, 
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histology-level information to be displayed to the clinician at the time of endoscopy, potentially 
greatly improving biopsy targeting to locations most likely to show evidence of dysplasia [19, 
20]. Nonscanning, wide-field fiber bundle microendoscopy methods have also been 
demonstrated to yield high-resolution image data from the superficial epithelium with promising 
diagnostic accuracy despite the limited field of view [21], restricted by the biopsy port 
(∼2mm∼2  mm) through which these devices are deployed in vivo. While certain technical 
challenges that remain before microendoscopy methods may be widely disseminated in clinical 
applications, the combination of improved wide-field endoscopic methods and high-resolution 
microendoscopy methods may greatly improve upon currently achieved accuracy [21, 22]. 
Furthermore, although several clinical trials of a high-resolution fiber bundle 
microendoscopy device have demonstrated excellent interobserver agreement in interpretation 
and classification of fiber bundle microendoscopy images of colorectal polyps [21], there is 
currently no widely accepted, quantitative image analysis criteria that can be used to objectively 
classify fluorescence image data of colorectal polyps without human intervention. Previously 
demonstrated interobserver agreement of microendoscopic image interpretation is dependent on 
highly trained staff and physicians. This need for high levels of training can be limiting to the 
dissemination of microendoscopic screening devices, and quantifiable image analysis criteria is 
an option to grant unspecialized practitioners the tools for consistent diagnosis at a reduced 
burden of training. 
Quantitative image analysis applied in other microendoscopy studies include texture 
features of ovarian cancer confocal microendoscopy, cell density in mouse model sarcomas 
using wide-field structured illumination, and wavelet decomposition in color colonoscopic video 
frames [23-25]. These algorithms quantify a range of image features, such as texture (including 
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spatial-frequency content), cell nuclei image segmentation and counting, and discrete wavelet 
transform and covariance [23-25]. There are numerous image features that could be extracted for 
quantification, depending on the data acquired by the imaging modality, but for the 
quantification of image features in fluorescence microendoscopy of nonspecific staining of bulk 
tissue, we chose image features that trained clinicians would typically consider in their analysis, 
namely crypt shape, size, and homogeneity. Pathologists who study en face histopathology of 
colorectal tissue for signs of dysplasia take into account image features such as elongated or 
branched crypts, clusters of crypts or crypts of abnormal size, irregular contours, and 
stratification of the nuclei surrounding the crypt. While pathologists commonly use nucleic 
patterns as a marker for abnormality, due to the length of the colorectal tract, it is of greater 
relevance during microendoscopic screening to use a fiber bundle with a larger field of view than 
to acquire images that resolve individual nuclei. Therefore, the algorithm we developed focuses 
on quantifying the larger structures of epithelial morphology such as crypt area and circularity. 
Additionally, the extent to which image morphology varies in clinically normal colorectal tissue 
in patients with different clinical histories, such as diagnosis, chemotherapy, radiation, prior 
surgeries, or other therapy, has not been described or quantified. There is a significant need for a 
quantitative benchmark for future detection of occult dysplasia in patients who have a range of 
diagnoses and/or prior treatment, and a need for generalized image analysis tools for advanced 
microendoscopy imaging modalities within the gastrointestinal tract. 
Any quantitative image analysis algorithm must be able to exclude motion-blurred or 
other low-quality images; this is of particular concern in the demanding environment of an in 
vivo endoscopy procedure. Approaches such as microarray image processors have demonstrated 
that the inherent variability in signal-to-background ratios is correlated with image quality [26]. 
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Low signal-to-background intensity ratios can affect the ability of an algorithm to accurately 
detect image features, and qualitative image exclusion via manual inspection may introduce 
human bias and additional error. While some microendoscopy images may be significantly 
distorted, the parameters for excluding low-quality images for machine detection by observation 
alone may vary in accuracy when compared to a quantitative threshold based on a standardized 
metric. 
The objective of the study presented in this paper is to explore the quantification of 
microendoscopy images in the clinically normal appearing tissue surrounding grossly visible 
lesions in recently resected colorectal specimens, in order to extract key differences that may be 
used to classify benign epithelial tissue from dysplastic tissue in future computer-aided 
diagnostic algorithms. We present both a quantitative image quality control algorithm to exclude 
low-quality images, as well as an intensity-adaptive quantitative image feature extraction 
algorithm (QFEA) to segment and quantify crypt morphology in images of superficial colorectal 
epithelium acquired via fiber bundle microendoscopy. Both algorithms were first validated using 
an extensive training library constructed from image data acquired from fresh porcine colorectal 
epithelium, a tissue histologically similar to human colorectal epithelium. In addition to 
individual image acquisition, consecutive images were acquired for mosaicking, to demonstrate 
the ability to improve the inherently small field of view in fiber bundle microendoscopy images, 
one prominent disadvantage of microendoscopic systems, using image registration of 
consecutive fields of view [27]. All individual images, and several mosaics, collected from 
human specimens were then analyzed for quality and subsequently quantified using QFEA. 
Images were analyzed to segment crypts within the superficial epithelium, and a centroid map 
was created for identified crypts. From each of these maps, quantitative features were calculated, 
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focused on crypt-specific properties such as crypt area and circularity. While these metrics were 
calculated for proflavine fluorescence fiber bundle microendoscopy, this method could be 
broadly applied over a range of high-resolution microendoscopy imaging modalities. 
2. Materials and Methods 
2.1. Fiber Bundle Microendoscopy System 
The microscopy system used has been described previously [1, 28] and comprises a blue 
light-emitting diode light source (455 nm, Philips) producing 0.5 mW at the sample, a filter set 
(Chroma Tech) with a 525/40nm emission bandpass filter, a 460 nm shortpass filter, and a 
dichroic mirror with a cutoff wavelength of 475 nm, a camera [Flea 3 (USB 3.0), Point Grey 
Research Inc., California], a 10x objective (NA 0.25, Olympus, Japan), and a customized fiber 
bundle image guide with a 1 mm active area diameter (FIGH-50-1100N fiber, Myriad Fiber 
Imaging Tech. Inc.). The fiber bundle image guide has custom SMA connectors on both ends; on 
the distal end, a modified SMA connector’s rounded edges reduce the friction between the fiber 
bundle and the epithelial tissue for smoother continuous image acquisition, as well as protecting 
the glass surface from chipping. 
2.2. Porcine Tissue 
Microendoscopic images of freshly resected colonic porcine tissue were acquired, in 
collaboration with Siloam Springs Processing (Siloam Springs, Arkansas), a local 
slaughterhouse. One hundred images were acquired from four healthy animals for training 
validation of both the quality control and quantitative feature extraction algorithms. These 
images were acquired from regions ∼5cm in length, with an average of 30 images acquired per 
region. Porcine colorectal epithelium, histologically similar in structure and scale to human 
colorectal epithelium, has been previously used as a human analog in myriad imaging studies 
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[29, 30]. Figure 1 shows a comparison of normal porcine and normal human colorectal tissue 
using microendoscopic and histopathology images. 
 
Figure 1. Normal human versus normal porcine colorectal epithelial tissue. (a) and 
(b) Microendoscopy images; scale bar is 100μm. (c) and (d) Histopathology images; scale bar 
is 100μm. (a) and (c) Normal human colorectal epithelium. (b) and (d) Normal porcine colorectal 
epithelium. 
2.3. Human Subjects 
Microendoscopic images of freshly resected human colorectal tissue were acquired in 
collaboration with the University of Arkansas for Medical Sciences (UAMS) in Little Rock, 
Arkansas, following informed consent of each subject per Institutional Review Board standards 
at both institutions (IRB #13-06-759 University of Arkansas, Fayetteville, IRB #202224 UAMS). 
A total of 10 subjects were recruited for this study, with two subjects excluded due to lack of 
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images of clinically normal regions. Thirty-nine microendoscopic images were used to quantify 
the image segmentation algorithm’s crypt detection sensitivity. Twenty-eight of these images 
were used for quantification (after exclusion due to image quality, as described in Sec. 2.5). For 
each human specimen, all microendoscopy images were acquired from a region ∼2cm in length, 
with an average of 15 images acquired per region. Participation was limited to both male and 
female subjects over the age of 18 with known or suspected colorectal dysplasia or cancer, and 
were scheduled for either endoscopic or surgical resection of abnormal tissue. Informed consent 
was performed on each subject prior to scheduled surgery. 
2.4. Microendoscopy Image Acquisition 
Upon receipt of the freshly resected porcine tissue, the colon specimen was longitudinally 
sectioned and cleaned using cold saline. Microendoscopy images were acquired immediately 
following topical application of proflavine (0.01% w/v in 1x phosphate buffered saline) with a 
cotton swab to epithelial surface, with occasional reapplication of dye after several minutes as 
needed. Individual images were acquired by manually placing the distal end of the fiber bundle 
in contact with the epithelial surface of the tissue; consecutive images were acquired by slowly 
dragging the distal end over the epithelial surface for subsequent processing into mosaics. 
Sequential image stacks were acquired over 10 to 20 s (covering ∼1 to 2 cm of epithelium), and 
all images were acquired in the range of 100 to 150 ms exposure and 0 to 5 dB gain. At the 
conclusion of the imaging study, porcine tissue was placed in 10% formalin for fixation 
overnight, prior to paraffin embedding, sectioning, and hematoxylin and eosin staining. 
For human subject imaging, the resected colorectal tissue was first longitudinally sectioned and 
then pinned onto a paraffin block. Additional pins were placed 2 cm apart at regions of interest, 
and images were acquired along a linear path between the pins. Microendoscopy images were 
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acquired immediately following topical application of proflavine (0.01% w/v in 1x phosphate 
buffered saline) with a cotton swab to epithelial surface, with occasional reapplication of dye 
after several minutes as needed. Individual images were acquired by manually placing the distal 
end of the fiber bundle in contact with the epithelial surface of the tissue; consecutive images 
were acquired by slowly dragging the distal end over the epithelial surface for subsequent 
processing into mosaics. Sequential image stacks were acquired over 10 to 20 s (covering ~1 to 
2 cm of epithelium), and all images were acquired in the range of 100 to 150 ms exposure and 0 
to 5 dB gain. For each specimen, typically one to two regions were imaged and sectioned for 
histopathology confirmation. After imaging, the study pathologist (K.L.) sectioned the tissue 
along the path marked by the pins, which facilitated the correlation of histopathology to 
microendoscopy (Fig. 2). 
 
Figure 2. Examples of tissue preparation, microendoscopic image, and histopathology. 
(a) Freshly resected gross tissue, pinned to paraffin block; white arrows point to pins delineating 
imaging location. Scale bar is ∼2cm. (b) Microendoscopic image of untreated normal colon 
epithelium. Scale bar is 100μm. (c) Histopathology image of untreated normal colon epithelium. 
Scale bar is 100μm. Images have enhanced contrast and brightness for publishing. 
Two-centimeter sections of transversely sliced tissue were taken from imaging sites, and 
diagnoses provided by a clinically trained gastrointestinal pathologist (K.L.). Tissue was 
classified as clinically normal, normal with underlying invasive adenocarcinoma, invasive 
adenocarcinoma, or tubular adenoma at each of the imaged sites. 
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2.5. Quantitative Image Quality Control 
We developed a quantitative image quality control algorithm to exclude low-quality 
images prior to image quantification, based on crypt-specific signal-to-background ratio. This 
signal-to-background is based on the contrast between the signal intensity within each crypt and 
the surrounding region; the crypt should be darker than the DNA-containing cell nuclei around it. 
If the ratio between the intensity values in the surrounding region and the intensity values in the 
crypt was too low, the algorithm lost sensitivity in image segmentation and quantification 
(Fig. 3). The image segmentation and quantification algorithm was applied to images of both low 
and high quality (contrast); specifically, the sensitivity and positive predictive value (PPV) of 
crypt identification was calculated. Images with low contrast were excluded from pilot study 
quantification of crypt image features. 
 
Figure 3. Example of image quality based on signal-to-background contrast. Top row: 
microendoscopy image of human epithelium, with superimposed yellow stars marking centroids, 
and yellow box labelling the selected crypt; scale bar is 250µm. Bottom row: surface maps of 
pixel intensity in region marked by yellow box (top row). Unlabeled axes are in pixels; 100 
pixels are approximately 75µm. The respective lowest intensity of each selection was subtracted 
from the image arrays, so that the lowest pixel value is zero without altering the differences in 
intensity. The same smoothing function applied to the line profiles for quality ratio (QR) 
calculation was applied to these image arrays. 
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Prior to calculating the contrast (signal-to-background) ratio, which we have termed the 
QR, all images were preprocessed to reduce common intrascene variation, which can result from, 
e.g., varying amounts of mucosa or variations in staining due to the topography of the tissue. The 
algorithm first masked the original images to restrict analysis and image segmentation to only the 
active area of the fiber bundle, and then contrast the enhanced images, whereby intensity values 
in the image are mapped to new values so that 1% of the image pixels are saturated at the lower 
and upper contrast limits (in this preprocessing step, 1% was saturated at zero intensity and 1% 
was saturated at 255), serving to standardize the images by utilizing the full range of the intensity 
values, before calculating the QR. Images were masked, excluding any values outside a circle 
1000 pixels (750μm) in diameter, ensuring only the uniformly illuminated region of the active 
area is analyzed. A microendoscopy image collected from a uniformly fluorescent agarose 
phantom (2% w/v agarose, mixed with 0.01% w/v proflavine, in distilled water) displayed in the 
full range of colors in the colormap demonstrates this process (Fig. 4). 
 
Figure 4. Example of unmasked microendoscopy image. Arrow points to unwanted light from 
outside the fiber bundle. The circle is 1000 pixels in diameter and represents the image area after 
masking. Image taken of agarose phantom mixed with 0.01% (w/v) proflavine. Scale bar 
is 250μm. 
To calculate the QR, the image quality control algorithm extracted vertical and horizontal 
line profiles (90 total) from the image, at intervals of 40 pixels (Fig. 5). This was done to ensure 
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that line profiles would cross the majority of crypts at least once, accounting for the physical 
scale of crypts (ranging 75 to 250μm in diameter) and the scale of the pixels at the image plane 
(Fig. 5). Each line profile was smoothed to eliminate small intensity variations due to the fiber 
bundle pattern itself. This fiber pattern exhibits a spatial frequency of ∼10 pixels; smoothing 
eliminates this periodic variation [Figs. 6(a)–6(d)]. Then, local regional minima and maxima 
were determined for each line profile, and the ratio between each minimum and its adjacent 
maximum was calculated [Fig. 6(e)]. The regional minima and maxima were determined by 
comparing regions of eight values (eight-connected neighborhoods) to surrounding values and 
outputting a binary map of the values of the local minima or maxima. All ratios within each 
image were then averaged to output a single global average QR metric for the 
image. Figure 7 shows the flow diagram of steps for preprocessing (image masking and contrast 
enhancement) and QR calculation. 
 
Figure 5. Example of typical crypt sizes and chosen grid line spacing. (a) Microendoscopic 
image of healthy porcine colorectal tissue. Inset shows a normal crypt with a width of 80 pixels. 
Vertical yellow lines represent the grid lines, with spacing of 40 pixels (yellow double-headed 
arrow), that are used to calculate QR in the image quality control algorithm. Scale bar is 250μm. 
(b) Example of grid structure and spacing used to extract line profiles for QR calculation. 
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Figure 6. Smoothing and QR calculation. (a) and (b) Microendoscopy images of flat-field 
illumination showing individual fiber artifacts, before and after smoothing is applied. Axes 
display distance in pixels; scale bar is 6μm. (a) Prior to smoothing, gaps between individual 
fibers (red arrow) display a significantly lower intensity than the fiber active area. Periodic 
variation in contrast is more clearly visible in the line plot in (c). (b) After smoothing, the 
intensity difference between individual fiber areas and gaps is reduced, visible in the line plot in 
(d). (e) Microendoscopy image of normal epithelium and resulting line plot of image intensity; 
scale bar is 250μm. Line plot was smoothed and plotted against distance in pixels. Black arrows 
point to first set of minimum (trough) and maxima (peaks). All peak-to-trough values in the 
image are averaged to yield a global QR value. 
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Figure 7. Flow diagram of image preprocessing and quantitative image quality control. The 
original image was masked and contrast enhanced; then line profiles were extracted every 
40 pixels, in a grid-like pattern. Scale bar is 250μm. The local minima and maxima of each line 
profile was extracted, and the algorithm calculated the ratio between each minima and its 
adjacent maxima. The global average of the ratios calculated across the image was termed as the 
image’s QR. 
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In order to demonstrate the effect of QR on image quality and overall automated crypt 
segmentation, we performed the automated QR calculation on the entire porcine image data set 
(100 images) and human data set (39 images). For each image, in both data sets, the number of 
crypts was determined via manual inspection to determine a ground truth value. The average QR 
was tabulated against crypt detection sensitivity (see Secs. 2.6.1 and 3.1) to compute the 
optimum image exclusion threshold value. The aggregate average sensitivity was calculated by 
averaging the sensitivity of all images with a QR greater than, or equal to, the respective QR 
value on the xx-axis, further described in Sec. 3.2. 
2.6. Automated Segmentation of Crypt Features 
QFEA (Fig. 8) was developed to automatically identify and segment each crypt present 
within microendoscopic images, and use this segmented map of crypt location to compute 
morphologic parameters such as area and circularity (Sec. 2.6.2). The accuracy of the QFEA’s 
image segmentation and crypt identification was greatly influenced by the contrast enhancement 
applied prior to conversion into a binary image (further explained in Sec. 2.6.1). To increase 
sensitivity of image segmentation, fivefold cross-validation was performed using the porcine 
(training) data set in order to compute the average detection sensitivity for different contrast 
enhancement parameters (Sec. 2.6.2). The selected contrast enhancement contrast limits were 
then applied to both porcine and human images for calculation of sensitivity and PPV of images 
with various QR values (results in Sec. 3.2). 
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Figure 8. Quantification algorithm flowchart. x is the quantified area of each crypt in pixels. 
Circularity is defined in Eq. (3). Multiple contrast limits were applied to increase sensitivity. 
Scale bar is 250μm 
2.6.1. Selection of optimal contrast limits for image segmentation, using porcine image test 
data set 
As previously stated, all images were preprocessed to reduce common intrascene 
variation, by masking and contrast enhancement. Section 2.5 describes the preprocessing contrast 
enhancement, which used a lower contrast limit value of 0 and upper contrast limit value of 1, 
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hereafter referred as the [0 1] contrast limits. Due to contrast intensity variations in images, 
further contrast enhancement is necessary to create a binary image of crypts with acceptable 
crypt detection sensitivity. As seen in Fig. 9, intensity-adaptive contrast enhancement was used 
to improve overall crypt detection accuracy. Contrast enhancement, which requires selection of 
lower and upper contrast limits, scales image intensity values (0 to 255, for our images) between 
0 and 1, whereby intensity values in the image are mapped to new values so that 1% of the image 
pixels are saturated at the lower and upper contrast limits, as described in 
Sec. 2.5. Figure 9 shows the histograms of an original image and images after contrast 
enhancement with different contrast limit pairs. Crypt detection is not shown for the original 
image, and the image with [0 1] contrast limits, because the image segmentation algorithm 
(QFEA) did not detect any crypts (neither true positive nor false positive) for either of these 
images. Note that the QFEA detected crypts in the image that was contrast enhanced using the 
[0.4 0.9] contrast limits, which were missed by the [0.5 0.9] contrast limits. Contrast limits affect 
the ability of the QFEA to recognize and segment crypts in different regions of the image; 
therefore, the overall crypt detection sensitivity of the algorithm was increased with the 
combination of multiple contrast limit pairs. 
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Figure 9. Comparison of image histograms and crypt detection using different contrast limit 
pairs. Contrast enhancement requires a lower and an upper contrast limit; three contrast limit 
pairs are shown here [0 1], [0.4 0.9], and [0.5 0.9]. The algorithm did not detect any crypts when 
using the original image, nor the preprocessed image. Note that the image that was contrast 
enhanced using the [0.4 0.9] contrast limits detects crypts missed by the [0.5 0.9] contrast limits, 
thereby increasing the sensitivity of the algorithm with the combination of multiple contrast limit 
pairs. Scale bar is 250μm. 
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To determine the optimal combination of contrast limit pairs for image segmentation, we 
iteratively increased the values of the lower and upper contrast limits by 10% (Fig. 10). There 
were 36 contrast limit pairs in the range from [0.1 0.2] to [0.8 0.9]. Due to extremely low crypt 
detection sensitivity in images with [0 1] contrast limits, the lower contrast limit 0 and the upper 
contrast limit 1 were excluded from testing. 
 
Figure 10. Schematic of intensity contrast limit combinations tested for crypt segmentation. 
Contrast enhancement scales image intensity values (0 to 255) between 0 and 1, scale bar is 
250 µm. Both upper and lower contrast limits were iteratively increased by 10% to cover a range 
from [0.1 0.2] to [0.8 0.9]. Gray region depicts unusable contrast limit pairs. 
A training data set comprising 100 images, acquired from porcine colorectal mucosa, was 
used to assess the ideal intensity contrast limit pairs to optimize crypt segmentation sensitivity. 
All 36 upper / lower contrast limit combinations were applied to each image, and the sensitivity 
and PPV of each contrast limit pair was calculated using the number of true positive, false 
positive, and false negative crypts detected, as compared to manual inspection of the image. 
Fivefold cross-validation was used to define test and training sets; one fifth of the data was set 
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aside as the test set, and the remaining four fifths were used to train the algorithm. The algorithm 
selected the best contrast limits using the training set, and then those contrast limits were applied 
to the test set to calculate crypt detection sensitivity. This was repeated four additional times, so 
that each of the five groups served as a test set, and resulting output displayed the selected 
contrast limits and the average sensitivity of the five test sets. The fivefold cross-validation 
algorithm was repeated 10 times, with the random assignment of images yielding slightly 
varying sensitivity averages. Sensitivities of several combinations of contrast limit pairs were 
also calculated using the fivefold cross-validation algorithm; selection of these combinations is 
described in Sec. 3.1. The average sensitivity, and standard deviation, of each selected contrast 
limit pair and combination was tabulated. 
2.6.2. Iterative contrast limits and automated crypt identification, segmentation, and 
morphology quantification 
Using the optimal contrast limit pair combinations (determined using the previously 
described process), porcine and human preprocessed (masked and contrast-enhanced as 
previously described) individual images and human image mosaics were quantified with QFEA. 
The quality control step was not used for the initial analysis, of all porcine and human images, in 
order to determine the optimal QR exclusion value. The QFEA contained the list of selected 
contrast limit pairs, and passed an image and first set of contrast limits to a quantification 
subroutine that returned the coordinates of centroids located, and calculated crypt area and 
circularity. These steps were repeated iteratively (see loop in Fig. 8) with five different pairs of 
contrast limits, to increase the sensitivity of QFEA. The last step was to save the quantified data 
and display the centroids (last step in Fig. 8). 
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Using the optimal contrast limit pair combinations selected after fivefold cross-validation 
of the crypt segmentation algorithm, as described in Sec. 2.6.1, each of the porcine (100) and 
human (39) preprocessed images were converted into a binary image, using a variable threshold 
determined by Otsu’s method [31], choosing a threshold that minimizes the variance of black 
(value 0) and white (value 1) pixels. The binary image was then eroded, with a disk structuring 
element of 5 pixels radius. Erosion, in short, changes binary values to 0 unless the structuring 
element, in this case the disk, overlaps only with binary values of 1 when translated to different 
positions [32]. Since we are quantifying circularity of relatively circular crypts, our structuring 
element is necessarily round and of a radius of 5 pixels since our individual fibers are ∼5 pixels 
in diameter. 
The resulting binary image was then inverted, with all 1 values converted to 0, and all 0 
values converted to 1, and remasked using the field-of-view (FOV) binary image, to ensure that 
the crypts are the value-1 binary shapes. Holes were then closed, where if a region of value 0 is 
completely enclosed by value-1 pixel, the region is converted into value-1s as well. The resulting 
shapes were once more eroded with a disk (5 pixels radius), and the coordinates of centroids of 
detected shapes were extracted, hereafter referred to as crypts, as well as each crypt’s area and 
circularity. The centroid for each crypt is the coordinates for the center of mass of each shape. In 
the eroded binary image, each crypt is defined as a group of continuous value-1 pixel, and the 
centroid is determined as the average of those pixel positions based on the equations 
(1)      𝐶𝑥 = ∑ 𝑋𝑖,
𝑛
𝑖=1  
(2)      𝐶𝑦 = ∑ 𝑌𝑖,
𝑛
𝑖=1  
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where C is the centroid coordinate, (x,y) is the position of a value-1 pixel, and n is the number of 
value-1 pixels in the crypt [33]. Crypt area was quantified as the actual number of pixels in the 
shape (binary value of 1, in this case). The circularity was calculated using 
(3)     𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =
4𝜋𝐴
𝑃2
, 
where A is the area in pixels and P is the perimeter, and a perfect circle has a circularity of 1. 
After extracting crypt area, crypt circularity, each crypt was quality controlled to exclude those 
larger than 100,000 pixels in area or smaller than 500 pixels in area (areas outside the range of 
crypt sizes based on trained observer quantification), or if the circularity was <0.5. This 
exclusion eliminated many shapes that were incorrectly labeled as crypts by the iterative contrast 
enhancement and erosion steps. Finally, each coordinate was compared against the array of the 
previous contrast limit pairs’ centroid coordinates (if applicable), and if any two coordinates 
were at a distance closer than 50 pixels, they were considered duplicates and the duplicate 
centroid data were not stored. The resulting arrays of crypt area, circularity, and centroid 
coordinates, as well as the FOV, were returned to the main function. 
2.6.3. Image stack preparation and mosaicking 
As described in Sec. 2.4, consecutive images were acquired by slowly dragging the distal 
end over the epithelial surface for subsequent processing into mosaics. To develop a mosaic 
image, images from each location (image stack) were cleared of duplicates and images with 
obvious motion blur. The remaining images in the stack were then preprocessed by masking and 
contrast enhancement, as described in Sec. 2.5. The image stacks were then stitched together; our 
mosaics consisted of four to six consecutive images stitched together for a final FOV ranging 3 
to 5 mm in length and ∼0.7mm in height. Mosaics were created from individual images using a 
modified version of an existing algorithm [31], which requires manual input to select pairs of 
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matching points on two adjacent images, and then uses bilinear interpolation to assign 
appropriate intensity values in spaces created by stretching or shrinking the second image to 
match the selected coordinates. Once image stacks were converted into a mosaic, they were 
treated the same way as a preprocessed individual image and subject to the image segmentation 
algorithm (QFEA). 
3. Results 
Individual mages for this manuscript were acquired from histologically normal regions of 
human and porcine colorectal tissue, as described in Secs. 2.2 and 2.3. One hundred individual 
images were acquired from porcine colorectal mucosa as an algorithm training data set and were 
used in the selection of the best five contrast limit pairs for image segmentation. Thirty-nine 
images of human epithelial tissue used for automated sensitivity quantification were acquired 
from clinically normal regions surrounding grossly visible tumors, in excised tissue of eight 
patients, five diagnosed with invasive colonic adenocarcinoma, two with invasive rectal 
adenocarcinoma, and one with tubular adenoma. Images of human epithelial tissue used for 
image mosaicking included both normal and abnormal regions in the same excised tissue of eight 
patients. All porcine (100) and human (39) images were used for calculating the relationship 
between average image sensitivity and the QR ratio metric, and determining the optimal QR 
exclusion threshold value. The images with passing QR were used for quantification of human 
crypt features in a pilot study, and each individual crypt, as identified by QFEA, was considered 
a separate data point for quantitative comparison. This comparison is not comprehensive, 
considering our small sample size, but it shows the ability of QFEA to distinguish variations in 
crypt size and circularity. A few mosaics were also qualitatively described, as well as subject to 
the image segmentation and quantification algorithm as proof-of-concept. 
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3.1. Selection of Optimal Contrast Limits for Image Segmentation, Using Porcine Image 
Test Data Set 
For improved crypt detection sensitivity during image segmentation, optimal contrast 
limit pair combinations were selected using fivefold cross-validation, as described in Sec. 2.6.1. 
The average sensitivity at each of the 36 contrast limit pairs (Fig. 10) is shown in Fig. 11(a) as a 
heatmap, with color corresponding to the average percent sensitivity at each contrast limit pair. 
As described previously, multiple contrast limit pairs increase the sensitivity of 
QFEA. Figure 11(b) shows the average of the contrast limits with the highest test sensitivity 
(labeled in Fig. 11 as “1”), as calculated via fivefold cross validation, as well as the average and 
standard deviation of various combinations of contrast limit pairs. Figure 11(a) shows “1” as the 
contrast limit pair with the highest stand-alone sensitivity and “2” as the contrast limit pair with 
the second highest sensitivity; combining contrast limit pairs with the same lower contrast limit 
(contrast limits labeled “1” and “2” both have a lower contrast limit of 0.5) does not yield as 
large of an increase in overall sensitivity of the QFEA as combining the best contrast limit pair 
from each row/lower contrast limit (contrast limits labeled “1” and “3”). As seen in Fig. 11(b), 
combining the two contrast limit pairs with the highest sensitivity increases the overall test 
sensitivity by <15%, but combining two contrast limit pairs with different lower contrast limits 
[from different rows in Fig. 11(a)] yields an increase in overall sensitivity of over 35%. A 
combination of five contrast limit pairs, the highest sensitivity from each row (lower contrast 
limit) from 0.2 to 0.7, yielded the highest overall test sensitivity [Fig. 11(b)] before a plateau in 
performance. While adding more than five contrast limit pairs might slightly increase the average 
reported sensitivity of QFEA, there is the risk of overtraining the algorithm to be too specific to 
the training set. 
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Figure 11. (a) Heatmap of the average percent sensitivity for each contrast limit pair; colorbar is 
percent sensitivity. As with Fig. 10, the xx-axis displays the upper contrast limit, and the y-axis 
displays the lower contrast limit. (b) Average test sensitivity, after 10 iterations of fivefold cross-
validation, for each contrast limit pair or combination of contrast limit pairs. Maximum standard 
deviation among all points was <0.61%. Heatmap (a) has numbered the contrast limit pairs 
selected for average sensitivity calculation, for clear correlation to the x-axis in plot (b). 
3.2. Quantitative Quality Ratio and Crypt Detection Sensitivity of the Image Segmentation 
Algorithm 
All porcine (100) and human (39) microendoscopy images were quantified (QFEA) using 
the five contrast limit pairs selected in Sec. 3.1. The quantitative image quality control algorithm, 
described previously, yielded a global QR metric (peak-to-trough ratio) per image, and this 
average ratio was tabulated along with the crypt detection sensitivity of QFEA, for each image. 
In Fig. 12(a), the sensitivities and PPVs of images with a QR value equal to, or higher than, the 
specified QR value (x-axis) were averaged for an aggregate average sensitivity at that QR. The 
peak aggregate sensitivity, before the decline, was at a QR value of 1.07 [Fig. 12(a)]. Therefore, 
a QR value of 1.07 was selected as the image quality control threshold, excluding for 
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quantification any images with a QR of <1.07. QR values >1.1 used <10 images for average 
sensitivity calculation, and are not reliable indicators. 
 
Figure 12. (a) Average sensitivity and PPV of the QFEA crypt detection versus the average QR 
of images; aggregate performance plotted against QR was calculated using images with QR 
values equal to or higher to the QR labeled in the x-axis. (b) Number of images with QR values 
equal to or higher than the labeled QR values. 
3.3. Pilot Study of Quantified Crypt Morphology 
Quantified crypt data were compared between images of surrounding grossly appearing 
normal regions in patients grouped as case 1 or case 2; case 1 were patients diagnosed with 
invasive adenocarcinoma and case 2 were patients diagnosed with tubular adenoma. For 
individual images, crypt area and circularity were significantly greater for the case 2 group than 
the case 1 group. The tabulated area and circularity, displayed in Fig. 13 in arbitrary units, were 
divided by the maximum data value in area and circularity, respectively. A total number of 10 
images with 219 cumulative identified crypts were used for case 1, and nine images with 219 
cumulative identified crypts for case 2. A two-tailed Student t-test yielded pp values of <0.01 for 
the area, and <0.005 for the circularity. 
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Figure 13. Comparison of image features in individual microendoscopic images of clinically 
normal tissue in patients grouped as case 1 and case 2. Case 1 had an adjacent region diagnosed 
as invasive adenocarcinoma and case 2 had an adjacent region diagnosed as tubular adenoma. 
Error bars denote standard error, and p values were calculated using two-tailed Student t test. 
Microendoscopy images on the right are examples of quantified images. Scale bar is 0.5 mm. 
3.4. Qualitative Image Analysis and Automated Crypt Identification of Mosaics 
Mosaics were created from consecutive fields of view to demonstrate the ability to 
improve the inherently small field of view in fiber bundle microendoscopy images, and the 
image segmentation and quantification algorithm was applied to them to determine if 
quantification of the mosaics using our algorithm was viable. Figure 14 shows a qualitative 
comparison of image mosaics acquired from both normal and dysplastic regions of colonic 
epithelium. The original images were acquired over 10 s, and the new FOV was ∼3.5mm long 
and 0.7 mm wide for both mosaics. The mosaics comprise five individual consecutive images. 
Normal tissue [Fig. 14(a)] has regularly spaced crypts, surrounded by a pericryptal sheath, 
demonstrated here as a bright ring enclosing the luminal compartment (see yellow arrow). 
Neoplastic tissue [Fig. 14(b)] oftentimes demonstrates irregularly shaped crypts that are 
haphazardly arranged, and the yellow arrows point to crypts that have uneven ring structures 
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enclosing them. The crypt detection sensitivity, when applied to the mosaics in Fig. 14, was 70% 
[Fig. 14(b)] or higher [Fig. 14(a)]. 
 
Figure 14. Image mosaics showing (a) normal colon and (b) invasive adenocarcinoma. Yellow 
arrows point to crypts. Images have enhanced contrast and brightness for publishing. Scale bar is 
0.5 mm.  
Figure 15 shows an occult hyperplastic polyp in otherwise normal-appearing 
tissue, ∼1mm in diameter, whose relative size and morphology was highlighted by mosaicking. 
A stack of eight images was mosaicked using the method stated previously, with the yellow 
arrows [Fig. 15(a)] pointing to the edges of the hyperplastic polyp ∼1mm in diameter. The 
imaged region was ∼3mm in length and 0.7 mm in width—the yellow arrows on gross tissue 
[Fig. 15(b)] point to the edges of the imaged region. The white arrow [Fig. 15(b)] points to the 
grossly visible tumor, which was ∼4cm to the right of the hyperplastic polyp [yellow 
arrows, Fig. 15(b)]. 
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Figure 15. Example of occult dysplasia. (a) Image mosaic showing a hyperplastic polyp. Yellow 
arrows point to edges of hyperplastic polyp. Scale bar is 0.5 mm. (b) Context image showing 
gross view of colon epithelium and location of image mosaic at left. Yellow arrows point to 
mosaic endpoints (∼3mm). White arrow points to cancerous region (invasive colonic 
adenocarcinoma). Scale bar is 10 mm. Images have enhanced contrast and brightness for 
publishing. 
4. Discussion 
Fiber bundle microendoscopy images of ex vivo colorectal epithelium contain useful 
quantitative data that may be used to assess the tissue microstructure for evidence of occult 
dysplasia. In this paper, we have described QFEA, an approach to automated quantification of 
important features of colorectal epithelial microstructure from microendoscopy image data. One 
hundred images of normal porcine tissue were used to select, via fivefold cross-validation, the 
best contrast limit pair combinations for crypt detection sensitivity. In addition, we have also 
demonstrated a method to automatically calculate, and exclude, images with low signal-to-
background ratios (QR) in order to filter and remove images that may yield unreliable 
quantitative data. In clinical settings, the fiber bundle microendoscopy imaging system used in 
this study may acquire image data via manual placement of the probe directly into the epithelial 
surface, or remote placement onto tissue during an endoscopic procedure. In both of these 
applications, significant image quality variability may occur. The majority of the images 
demonstrated a crypt detection sensitivity of >80% following analysis via QFEA, indicating 
potentially reliable calculation of quantitative reporters of tissue microstructure. 
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A combination of contrast limit pairs was tested with the porcine image data set to 
determine the best parameters for high crypt detection sensitivity. While the contrast limits were 
iteratively increased by 10%, it is likely that smaller step increases would have provided 
increased overall sensitivity. A larger data set would be required to test if smaller iterative 
increases and contrast limit selection would generalize for microendoscopy images, or if the 
algorithm would be overtrained. The crypt identification algorithm, using the selected 
combination of contrast limit pairs, was then applied to both porcine and human images, to 
determine the aggregate performance when excluding images with low QR (Fig. 12). As seen 
in Fig. 12(b), the number of images, both porcine and human, with QR values >1.1 drops below 
20, decreasing sample size and leading to undersampling bias in the calculated sensitivities at 
those values. Figure 12(a) reveals that the PPV of human images is drastically lower than that of 
the porcine image set. We believe this is due to a more carefully controlled imaging procedure 
with the porcine tissue, since image quality of human tissue is influenced by variations in human 
preoperative procedures, and sample handling by clinicians and staff. Potential alternatives to 
improve image quality include alternative contrast agent or optical sectioning techniques such as 
structured illumination [34].  
A pilot comparison of quantified crypt morphology (Sec. 3.3) demonstrated the ability of 
our quantitative image quality control and image feature extraction algorithm (QFEA) to detect 
minor differences between two otherwise clinically normal appearing colorectal tissue 
specimens. While a conclusive statement cannot be made based on image data from eight human 
patients, it does suggest that an algorithm such as QFEA can quantify crypt features objectively 
and without significant user input. Similarly, no definite quantitative statements can be made for 
image mosaics, until a larger data set is acquired. Qualitative inspection of the image mosaics 
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shows them as a viable method for overcoming the FOV size limitations of microendoscopy, 
while image segmentation of the mosaics shows the potential applicability of QFEA to 
mosaicked images. 
In vivo inspection of gastrointestinal mucosa using high-resolution microendoscopy 
methods has been previously shown to yield clinically useful data. Recent studies examining 
manual inspection of microendoscopy images of known diagnoses have demonstrated strong 
interobserver agreement, indicating that well-trained clinicians should be able to effectively 
incorporate these methods into clinical practice [21]. Qualitative assessment of these images by a 
highly trained observer is likely to continue to yield clinically relevant data, but widespread 
adoption of high-resolution, in vivo, microendoscopy methods for improved detection of occult 
dysplasia remains a challenge. A user-independent method of image analysis could provide 
additional data to make an informed decision and reduce the burden of training required for the 
clinician at the point-of-care. The introduction of an image analysis algorithm like QFEA into 
computer-aided diagnostic methods may yield useful complementary data to make improved 
clinical decisions. In our pilot study, QFEA demonstrates an ability to detect minor differences 
between two otherwise clinically normal appearing colorectal tissue specimens, suggesting that 
discriminative quantitative crypt features can be measured objectively and without significant 
user input. 
Computer-aided diagnostic approaches have been of significant research interest in 
myriad cancer detection approaches, including imaging. Automated quantitative classification 
has been applied to breast cancer detection using ultrasound images, digitized mammograms, and 
histopathology, ovarian cancer detection using matrix-assisted laser desorption/ionization 
imaging mass spectrometry, and prostate cancer grading using ultrasound images and 
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histopathology [35-40]. Quantitative classification based on microendoscopy image texture 
features in Barrett’s esophagus and esophageal squamous cell carcinoma, specifically gray-level 
co-occurrence matrices, has been previously investigated [41-43]. A recent publication on 
automated selection of high-quality frames in microendoscopic images [44] points to both the 
need for quality control, as well as the viability of automated extraction of high-quality frames 
during video-rate acquisition. Ongoing development work with microendoscopic systems may 
enable spectroscopic data to be used in conjunction with quantitative image features, such as 
those described in this paper [45]. This quantitative data, coupled with extracted image-based 
features provided by algorithms such as QFEA, could lead to the adoption of standardized, 
objective methods of in vivo high-resolution microendoscopy image interpretation and analysis. 
In conclusion, the methods described here provide insight into the ability of fiber bundle 
based high-resolution microendoscopy imaging tools to yield clinically relevant data about the 
tissue microstructure in colorectal epithelium. Effective clinical translation and application of 
any quantitative image analysis tools applied to this imaging method will need to account for 
some unavoidable image quality variation, particularly for in vivo endoscopic application of the 
device on living, constantly moving tissue. Quantitative assessment and control of high-
resolution image quality is essential to ensuring reliable results in any future objective, 
computer-aided diagnostic algorithm development. 
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Chapter IV: Fluorescein as a topical fluorescent contrast agent for quantitative 
microendoscopic inspection of colorectal epithelium [1] 
1. Introduction  
Microendoscopy is an emerging method which can provide clinicians with in vivo 
information on tissue microstructure that is not readily visible using traditional colonoscopy and 
endoscopy. It allows for histology-level detail to be acquired in real-time, with the potential for 
in vivo guidance for the clinician, such as in targeted biopsies [2, 3]. Myriad microendoscopic 
imaging modalities have been applied to various tissues, including ovarian, esophageal, bladder, 
colonic, and oral epithelium [3-8]. We have chosen to investigate colorectal cancer, as it is 
currently the second leading cause of cancer deaths in the United States [9]. The precursor of 
colorectal malignancy is dysplasia and there is a long lag phase between the onset of dysplasia, 
and the development of malignancy [10]. Detecting these regions prior to becoming clinically 
evident will further help in preventing colorectal cancer [11]. In addition, patients with 
inflammatory bowel disease (IBD), who are frequently screened for dysplastic regions, would 
likely also benefit from early detection of suspicious lesions [12]. Several microendoscopy 
imaging studies are aimed at improving early detection of glandular epithelial dysplasia, and 
providing biopsy guidance and prognostic indicators in clinical settings [3, 13-15]. 
Currently described microendoscopic methods for in vivo imaging of gastrointestinal 
epithelium vary, including integration of the probe into conventional endoscopes [13], fiber 
bundle confocal systems for increased depth penetration [2], and portable wide field end-on fiber 
bundle approaches such as a previously developed system [5]. End-on fiber bundle systems, such 
as the one used in this manuscript, are designed to come into direct contact with the tissue, and 
image acquired is either of the tissue directly in contact with the distal end of the probe (for wide 
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field microendoscopy systems), or of varying depths below the epithelium (depth-sectioning with 
point-scanning systems). Benefits of end-on fiber bundle systems include eliminating the need 
for rinsing tissue after stain application to remove excess dye, which is required for alternative 
imaging modalities such as chromoendoscopy [16]. Eliminating the rinsing step is possible since 
end-on contact reduces specular reflection or unwanted fluorescence, with the additional benefit 
of rapid imaging after staining since there is no wait time for sufficient incubation to occur 
before rinsing. While a wide field approach does not have the depth-sectioning capabilities of a 
point-scanning system, it does not require a pinhole, laser light source and alignment, nor raster-
scanning illumination. 
Imaging typically depends on contrast between image regions, be it differences in color 
or in light intensity that highlight features of interest, and contrast can come from various 
sources, both endogenous and exogenous. Endogenous sources in endoscopic systems include 
hemoglobin absorption and inherently fluorescent molecules such as NADH and FAD, two 
prominent markers of metabolism. Exogenous sources of contrast are more commonly added 
prior to image acquisition, such as chromoendoscopy or fluorescent microendoscopy. 
Chromoendoscopy depends on the colorimetric contrast provided by stains such as Lugol's 
iodine or methylene blue [16]. These dyes are typically absorbed by the tissue in varying degrees 
depending on properties such as increased or decreased cell cytoplasm or goblet cell presence 
[16]. After these dyes are applied, they then require multiple rinses before imaging under white 
light endoscopy [17]. A benefit of exogenous fluorescent dye based microendoscopy is the 
increased signal to noise ratio, as the fluorescently stained regions are emphasized. Examples 
include fluorescence microendoscopy using acridine dyes [7] and surface magnifying endoscopy 
using the fluorescent emission of methylene blue [18]. Fluorescently stained regions will vary 
102 
depending on the dye, for example acridine-derived dyes such as proflavine will preferentially 
stain nucleic structures, whereas methylene blue will be preferentially absorbed by mucosal 
tissue [5, 16]. Proflavine has been used as a topically delivered, exogenous contrast agent with 
fluorescent microendoscopy systems due to its DNA intercalating nature. Therefore, proflavine 
predominantly highlights cellular nuclei in cytology specimens [19], as well as squamous bulk 
tissue such as oral and esophageal [5, 8]. Proflavine is an amphipathic dye comprised of a three 
carbon ring structure, and capable of intercalation within the minor groove of the DNA helix 
[20]. Broad acceptance of proflavine and its use in vivo in human subjects has been limited in the 
United States as DNA-intercalating dyes are considered potentially hazardous and mutagenic 
[21, 22]. Fluorescein, on the other hand, has a history of clinical use as an intravenous contrast 
agent in retinal angiography, as it does not intercalate DNA and tends to diffuse between cells 
rather than permeating them [23]. In addition, confocal microendoscopy modalities, such as 
Mauna Kea, have successfully used intravenous (IV) delivery of fluorescein for gastrointestinal 
imaging [24]. A limitation of fluorescein is its use as a contrast agent in squamous bulk tissue, 
such as oral epithelium, where nuclei shape and homogeneity is a main indicator of dysplasia [8]. 
On the other hand, fluorescein has been shown to have a sensitivity of 88% for detection of high-
grade intraepithelial neoplasia in Barrett’s esophagus, when using IV delivery in conjunction 
with confocal microendoscopy [25]. When imaging with wide field modalities, such as the 
microendoscopy system studied in this manuscript, we have shown that topical application of 
fluorescein is sufficient to highlight crypt structures, while topical delivery via an auxiliary 
endoscopy probe channel might minimize the amounts of systemic contrast agent [26]. 
Adequate contrast agents not only provide the clinician with in vivo qualitative insight, 
but can be used to acquire and analyze digital images. Pathology studies of biopsies or sections 
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typically depend on H&E slides qualitatively analyzed for pre-neoplastic markers such as nuclei 
size, shape, distribution, as well as crypt structure [27]. Qualitative analysis of images acquired 
with fluorescence microendoscopy by trained observers has been shown to be highly sensitive 
and specific [15]. Intraobserver agreement was high, and provided positive results for subjective 
review of microendoscopic images [15]. While there is a benefit to subjective and 
complementary image analysis, introducing a new imaging modality into an intraoperative 
setting necessitates a certain burden of training, namely additional training for the clinician. 
Image acquisition can be combined with computer-based analysis and diagnostic algorithms to 
provide complementary data to guide clinicians in their analysis of the tissue at the site of 
interest [7, 28, 29]. Automated image analysis provides an objective, replicable output to lessen 
the burden of training for clinicians. Our previous work has shown that the automated detection 
sensitivity of crypt structures in images of proflavine-stained colorectal epithelium using a 
custom algorithm ranges from 71 to 94% [30]. In addition, preliminary quantification of crypt 
area and circularity suggest that crypt quantification may provide an unbiased metric for aiding 
clinicians using fluorescence microendoscopy systems [27, 31]. 
In this study, we have evaluated the ability of topical proflavine and fluorescein to 
provide contrast in colorectal epithelium using end-on fiber bundle microendoscopy imaging of 
bulk ex vivo tissue. For qualitative comparison of topical staining, porcine and caprine bulk 
colorectal tissue was stained with proflavine and fluorescein solutions and imaged. For 
quantitative comparison, we have calculated the automated average crypt detection sensitivity of 
our custom algorithm using porcine bulk tissue stained topically with proflavine and fluorescein. 
In addition, ex vivo human colorectal tissue was imaged to quantitatively compare crypt area and 
circularity in grossly normal and grossly dysplastic regions. These quantified results provided us 
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with values in order to compare the viability of both these topical contrast agents for use in 
conjunction with fluorescence microendoscopy systems. Our results present topical application 
of fluorescein as a reasonable alternative to proflavine for fluorescence imaging of the colorectal 
tract.  
2. Materials and Methods  
2.1 Fiber bundle microendoscopy system and topical contrast agents  
The microendoscopy system has been previously described [7, 30], and consists of a 
455nm LED (Philips, USA), a filter set (Chroma Tech, USA), monochrome camera (Flea 3, USB 
3.0, Point Grey Research Inc., CA), a 10x objective (NA 0.25, Olympus, Japan), and a fiber 
bundle image guide comprised of 50,000 fibers with 3.5µm center to center spacing (FIGH-50-
1100N fiber, Myriad Fiber Imaging Tech, Inc., USA) with customized ends. The distal end has a 
modified SMA connector with rounded edges, to reduce the risk of tissue tearing as well as 
protect the fiber from chipping. Proflavine hemisulfate was prepared at a concentration of 0.01% 
(w/v) in 1x phosphate buffered saline (PBS) [30]. Fluorescein salt solution was prepared at 
0.05% (w/v) in 1x PBS. We used fluorescein sodium salt, with a reported solubility of 0.1% 
(w/v) in water (F6377, Sigma-Aldrich), therefore our study investigated at and below this 
concentration. 
2.2 Image intensity as a measure of topical contrast agent concentration  
Previous studies of clinical microendoscopy using topical proflavine have used a standard 
concentration of 0.01% (w/v); we compared three concentrations of proflavine against 
fluorescein salt solutions with equal weight-per-volumes. We sectioned 6 adjacent regions of 
porcine colorectal tissue, and stained each section with one of the following contrast agents and 
concentrations: 0.01% (w/v) proflavine, 0.05% (w/v) proflavine, 0.1% (w/v) proflavine, 0.01% 
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(w/v) fluorescein, 0.05% (w/v) fluorescein, 0.1% (w/v) fluorescein, all solutions made with 1x 
PBS. Ten images were acquired of each section, with identical camera settings; 50ms exposure 
and 5dB gain. We qualitatively inspected them, as well as quantitatively compared them by 
measuring the average image intensity. The average image intensity (N = 10 images) of each 
solution was plotted; error bars denote standard error [Fig. 5]. Statistical values were obtained 
from post-hoc testing of a one-way ANOVA using Tukey’s honestly significant difference 
(HSD), with p-value <0.05 as the criterion for significant difference.  
2.3 Animal tissue procurement  
Microendoscopic images of freshly resected caprine colorectal tissue were acquired in 
collaboration with the University of Arkansas Animal Science Abattoir, which provided tissue 
from recently slaughtered animals at their facility. 12-inch distal colon specimens were resected 
within an hour of slaughter, and imaged within an hour of resection. Siloam Spring Processing 
provided porcine colorectal tissue from recently slaughtered animals at their facility. 12 to 24-
inch distal colon specimens were resected within an hour of slaughter, and refrigerated for 
approximately an hour before imaging, and imaged within an hour of removal from refrigeration. 
Specimens were obtained from two goats and two pigs for the quantitative study in this 
manuscript. Colon sections were rinsed with water, longitudinally cut to expose the lumen, and 
the lumen was rinsed with cold PBS. For each specimen, a single region of approximately 2 
inches by 8 inches was sectioned for imaging. 
2.4 Human tissue procurement  
Microendoscopic images of freshly resected human colorectal tissue were acquired in 
collaboration with the University of Arkansas for Medical Sciences, from consenting patients 
under IRB protocol (#204651). Consenting patients, over the age of 18, with benign or 
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carcinogenic disease, were accepted under this protocol. Colorectal tissue was resected and sent 
to the pathology lab, where residents rinsed, longitudinally sectioned, and pinned the colorectal 
tissue to a paraffin block. Three specimens (two cases of benign disease and one invasive 
adenocarcinoma) were used for the data in this manuscript, with “normal” images acquired from 
grossly appearing normal mucosa from each of the three specimens, as well as images of 
neoplastic mucosa regions in the one specimen with invasive adenocarcinoma. 
2.5 Microendoscopy image acquisition  
The animal colorectal tissue was first longitudinally sectioned and then placed epithelium 
side up on a 150mm Petri dish. Colon sections of each specimen, porcine and caprine, were 
divided using a scalpel, with one section stained with proflavine and the adjacent section stained 
with fluorescein. No specimen received both contrast agents on the same tissue area. Separate 
sections of the specimen were used for multiphoton microscopy, though this separate section was 
also divided into adjacent sections for individual staining. Microendoscopy images were 
acquired immediately following topical application of proflavine (0.01% w/v in 1x PBS) or 
fluorescein salt solution (0.05% (w/v) in 1x PBS) with a cotton swab to epithelial surface, with 
occasional re-application of dye as needed. While endoscopic application of the dye would likely 
be achieved through a spray nozzle port, gently rolling the cotton swab has been previously used 
for ex vivo application without adverse effect for microendoscopic imaging [7, 8, 15]. Individual 
images were acquired by manually placing the distal end of the fiber bundle in contact with the 
epithelial surface of the tissue. Images of tissue stained with proflavine were acquired with 
100ms exposure and 5dB gain and images of fluorescein were acquired with 50ms exposure and 
5dB gain. 
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Human colorectal tissue was pinned to a paraffin block, lumen side up, and for each 
specimen, two regions of normal colon were chosen, as well as two regions of dysplastic colon. 
Microendoscopy images were acquired immediately following topical application of fluorescein 
salt solution (0.05% (w/v) in 1x PBS) with a cotton swab, with occasional reapplication of the 
dye as needed. Individual images were acquired by manually placing the distal end of the fiber 
bundle in contact with the epithelial surface. Image acquisition lasted approximately 30-40 
minutes, with 50ms exposure and 5dB gain settings.  
2.6 Multiphoton image acquisition for qualitative comparison  
Two 1cm2 sections of caprine colorectal tissue were placed on individual glass slides, 
topically stained with either proflavine (0.01% (w/v)) or fluorescein (0.05% (w/v)) solution, and 
covered with No.1 coverslips, and immediately imaged using a MaiTai (SpectraPhysics) 
Ti:Sapphire pulsed laser, coupled to a customized multiphoton microscope system with an 
emission bandpass filter of 525nm center wavelength and 45nm bandwidth (Thorlabs). Images 
from tissues stained with these two agents were acquired using 900nm two-photon excitation at 
5mW power at the sample, and a 40x (0.8 NA) water immersion objective (Nikon). Images 
comprised a 261µm by 261µm field-of-view, at 512 by 512 pixels. 
2.7 Crypt detection and quantification algorithm and optimization of parameters  
We have previously developed a custom image feature quantification algorithm (QFEA) 
for automated crypt detection and quantification of crypt morphology in microendoscopic 
images of proflavine-stained colorectal tissue [30]. This algorithm was designed to detect, 
segment, and quantify area and circularity of crypt shapes in microendoscopic images, and 
calculated automated crypt detection sensitivity at the crypt level by comparing if the algorithm 
detected a crypt at the position that the trained observer visually detected a crypt [30]. We have 
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optimized this algorithm for images of fluorescein-stained colorectal tissue, and compared the 
crypt detection sensitivity of the algorithm for proflavine versus fluorescein-stained epithelium, 
as described below. Prior to image quantification motion-blurred images were excluded from 
quantification, then the signal-to-background ratio was calculated, which we have termed the 
Quality Ratio (QR). We designed the QR metric to be a crypt-specific signal-to-background ratio 
[30], as the pixel-by-pixel signal-to-background ratio can vary and be misleading when 
calculated. The QR metric smooths individual pixel peaks and troughs, in order to calculate the 
more general signal-to-background ratio of the crypts [7]. Pixel intensity line profiles were 
extracted from the image in a grid like pattern, and the peak-to-trough ratios of the profiles were 
averaged to calculate the image’s QR [Fig. 1(a)] [30]. Figure 1(a) shows an example of the line 
profiles crossing through a crypt, with a representative example of a line profile through the 
crypt shown to the right; these line profiles in actuality cover the entirety of the image. Images 
were then contrast-enhanced for increased efficacy in image segmentation. The pixel intensities 
are normalized to a range of 0 to 1, and contrast limit pairs have an upper and lower contrast 
limit, for example [0.2 0.9]. These contrast limit pairs refer to how 1% of image pixels fall below 
the lower contrast limit (0.2) and are mapped to a normalized signal value of 0, and 1% fall 
above the upper contrast limit (0.9) and are mapped to a normalized signal value of 1. Contrast-
enhanced images were then binarized with a variable threshold automatically determined by 
Otsu’s method [32], designed to minimize variance of values in the binary image. Figure 1(b) 
shows the effect of different contrast limit pairs on binary images created for subsequent image 
segmentation. The optimal contrast limit pairs will vary depending on the initial image intensity 
and contrast, therefore need to be carefully selected for each topical contrast agent. In order to 
determine the optimal contrast limit pairs for microendoscopy images of fluorescein-stained 
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epithelium, 100 images of porcine tissue were subject to a range of contrast limit pairs, to 
determine which pairs produced the highest automated crypt detection sensitivity values [30]. 
Automated crypt detection sensitivity was determined by comparing the sensitivity (true 
positives divided by the sum of true positives and false negatives) of the algorithm to manual 
crypt identification by a trained observer. Figure 1(c) shows the contrast limit pairs used to 
optimize the crypt detection sensitivity; contrast limits were increased by 10% and ranged from 
[0.1 0.2] to [0.8 0.9]. 
 
Figure 1. (a) Example of grid pattern on close-up of individual crypt (line profiles extracted 
every 40 pixels), a single pixel intensity line profile plotted as an example, and peaks and trough 
(red arrows) labelled. (b) Example of effect of changing the contrast limit pairs on conversion 
into a binary image. (c) Table of contrast limit combinations tested for automated crypt detection 
sensitivity. Contrast enhancement scales image intensity values (0 to 255) between 0 and 1. Both 
upper and lower contrast limits were iteratively increased by 10% to cover a range from [0.1 0.2] 
to [0.8 0.9]. Gray region depicts impractical contrast limit pairs. Scale bars are 100μm. 
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3. Results  
3.1 Qualitative image comparison of topical contrast agents  
Both topical contrast agents provide similar qualitative crypt structure information in 
microendoscopic images of superficial colon epithelium. Figure 2 shows a comparison of Figs. 
2(a) and 2(b) fluorescein-stained, and Figs. 2(c) and 2(d) proflavine-stained, as well as Figs. 2(a) 
and 2(c) porcine, and Figs. 2(b) and 2(d) caprine epithelial tissue. Pathology, the gold standard, 
would use H&E staining to investigate the crypt shape, homogeneity, and nuclei shape and 
distribution [27]. The selected fiber bundle was designed in favor of a larger field-of-view, which 
inherently limits the resolution of individual nuclei. Using our system, neither proflavine nor 
fluorescein staining permit a careful study of nuclei shape and distribution, but they do highlight 
the shape and homogeneity of crypts. Both contrast agents delineate the inner crypts as dark, 
mostly homogenous, circular regions, while also providing contrast to the interstitial regions. 
While proflavine preferentially stains cell nuclei, leading to ring-like image features around the 
dark crypts (arrows in Figs. 2(c) and 2(d)), fluorescein stains the interstitial spaces more 
uniformly, while still providing contrast with the crypts (black arrows in Figs. 2(a) and 2(b)). In 
our experiments, fluorescein had an increased likelihood to pool at the center of the shallower 
caprine crypts [Fig. 2(e)], and appears as bright dot-like structures in the center of the crypts 
(yellow arrow in b). 
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Figure 2. Qualitative comparison between microendoscopic images of bulk colorectal porcine 
and caprine tissue stained with proflavine and fluorescein. (a) and (b) Tissue stained with 
fluorescein (0.04% (w/v) in PBS), imaged at 50ms exposure and 5dB gain. (c) and (d) Tissue 
stained with proflavine (0.01% (w/v in PBS)), imaged at 100ms exposure and 5dB gain. (a) and 
(c) Porcine tissue; (b) and (d) caprine tissue. All images have been equally contrast enhanced for 
publishing; colorbar shows intensity values from 0 to 255. Scale bar is 250µm. 
When imaged under a 40x 0.8NA objective for a 261µm by 261µm field of view, using 
multiphoton microscopy, the subtle differences in staining are readily apparent. Fluorescein 
stained bulk tissue [Fig. 3(a)] shows even staining of general intracellular material, as well as 
greater pooling in the center of the crypts. As expected, since proflavine intercalates DNA [20], 
proflavine-stained bulk tissue [Fig. 3(b)] preferentially stains individual nuclei. An example is 
shown in the inset of Fig. 3(b), of an individual nucleus, where the red arrows point to the 
nuclear membrane. Figure 4 shows the staining of both contrast agents at up to 100μm below the 
epithelial surface, which is more than sufficient for an end-on fiber bundle system that gathers 
data from the epithelial surface. This panel of depth sections additionally serves to exemplify 
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how topical application of these contrast agents might also be applicable for depth-sectioning 
imaging modalities such as confocal microendoscopy. 
 
Figure 3. Qualitative comparison between multiphoton images of bulk colorectal caprine tissue 
stained with (a) fluorescein and (b) proflavine. (a) Tissue stained with fluorescein (0.04% (w/v) 
in distilled water). Yellow arrow points to fluorescein pooling in the center of the crypt. (b) 
Tissue stained with proflavine (0.01% (w/v in PBS)); white box inset shows a single stained cell, 
with yellow arrow pointing to the nuclear membrane. Both images were taken at 100 cumulative 
frames, 15fps, 20mW at sample, and have been equally enhanced for publication. Red scale bar 
is 100µm. 
 
Figure 4. Qualitative comparison of multiphoton images of bulk colorectal animal tissue stained 
with fluorescein and proflavine at 20μm, 60μm, and 100μm below the epithelial surface. Caprine 
tissue stained with fluorescein (0.04% (w/v) in distilled water). Porcine tissue stained with 
proflavine (0.05% (w/v) in 1x PBS). All images were taken at 100 cumulative frames, 15fps, 
20mW at sample, and have been enhanced for publication. Scale bar is 100µm. 
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3.2 Image intensity as a measure of topical contrast agent  
Qualitative comparison of matching weight-per-volume of proflavine and fluorescein 
showed that while increasing proflavine concentration increased signal intensity, the signal of the 
interstitial tissue was not as large in comparison to fluorescein. Quantitative results [Fig. 5] 
supported this: average image intensity of fluorescein was significantly brighter than proflavine 
at each individual concentration. There was little qualitative difference between fluorescein at 
0.01% (w/v) and proflavine at 0.1% (w/v), which is supported by a quantitative lack of 
significant difference between the average image intensity of these solutions. 
 
Figure 5. Comparison of different concentrations of topical contrast agents. Three different 
concentrations of each contrast agent, fluorescein and proflavine, were prepared at 0.01% (w/v), 
0.05% (w/v), and 0.1% (w/v) in 1x PBS. Average image intensities (N = 10 images) of porcine 
colorectal tissue were plotted; error bars denote standard error. Fluorescein was significantly 
brighter than proflavine at each individual concentration, but fluorescein at 0.01% (w/v) was not 
significantly different from proflavine at 0.1% (w/v); statistical values were obtained from post-
hoc testing of a one-way ANOVA using Tukey’s honestly significant difference (HSD), with p-
value. 
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3.3 Optimization of contrast limit pairs for increased crypt detection sensitivity  
As previously stated, a range of contrast limit pairs [Fig. 1(c)] were applied to 100 
images of fluorescein-stained porcine tissue. The average sensitivity (defined as the number of 
true positives divided by the sum of true positives and false negatives, as compared to manually 
selected crypts) of each contrast limit is shown in Fig. 6 as heatmaps for 6(a) proflavine and 6(c) 
fluorescein stained tissue. The internally numbered boxes were labelled for ease of correlation of 
contrast pairs chosen to the Figs. 6(b) and 6(d) plots of average sensitivity at various 
combinations of these chosen and labeled pairs; for example, in Fig. 6(a), value 1 stands for 
contrast limit pair [0.5 0.9]. As described in our previous work [30], a combination of several 
contrast limit pairs dramatically improves the average sensitivity of our crypt detection 
algorithm. Based on the results of Fig. 6(b) we chose a combination of 5 contrast limit pairs for 
optimal crypt detection sensitivity of images of proflavine-stained tissue, as the sensitivity 
surpasses 80%. Based on the results of Fig. 6(d), we chose a combination of 3 contrast limit pairs 
for optimal crypt detection sensitivity of images of fluorescein-stained tissue, as the sensitivity 
surpasses 90% while reducing risk of overtraining. 
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Figure 6. Optimization of crypt detection sensitivity by combination of contrast limit pairs for 
porcine tissue stained with (a) and (b) proflavine (0.01% (w/v)) and (c) and (d) fluorescein 
(0.04% (w/v) in PBS). (a) and (c) Heatmaps of the average percent sensitivity for each contrast 
limit pair; colorbars are average percent sensitivity. As with Fig. 2, the x-axes display the upper 
contrast limits, and the y-axes display the lower contrast limits. (b) and (d) Average test 
sensitivity, after 10 iterations of fivefold cross-validation, for each contrast limit pair or 
combination of contrast limit pairs. Maximum standard deviation of averages among all points 
was <0.61%. Heatmaps (a) and (c) are internally numbered with the selection of the highest 
sensitivity values per row, for clear correlation of numbered contrast limit pairs to the x-axis 
combinations in plots (b) and (d). 
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3.4 Quantitative image comparison of topical contrast agents  
Our crypt quantification algorithm (QFEA) provided similar results for average crypt 
detection sensitivity in images of proflavine and fluorescein stained porcine tissue. As shown in 
Fig. 7, the QFEA was able to identify the majority of crypts for both topical contrast agents. One 
hundred images of proflavine-stained porcine epithelium and 100 images of fluorescein-stained 
porcine epithelium were quantified (QFEA) using contrast limit pairs selected using Fig. 6. As 
described in Section 2.7, a global QR value (peak-to-trough ratio) was calculated for each image 
as a metric of signal to background contrast, and the average QR of all images in a data set were 
tabulated against the average crypt detection sensitivity of QFEA. In Fig. 8(a), the sensitivities 
and positive predictive values (PPV) of images with a QR value equal to, or higher than, the 
specified QR cutoff value (x-axis) were averaged for an aggregate average sensitivity at that QR 
cutoff. The sensitivity was previously defined as true positives divided by the sum of true 
positives and false negatives. PPV was defined as true positives divided by the sum of true 
positives and false positives. The peak aggregate sensitivity for proflavine occurred at a QR 
cutoff value of 1.08 [Fig. 8(a)]. QR cutoff values higher than 1.1 averaged less than five images 
for average sensitivity and PPV calculation of proflavine-stained images, and are therefore not 
reliable indicators due to undersampling. Average sensitivity of fluorescein-stained images 
continued to increase slightly for QR values higher than 1.1, while PPV had a slight decline after 
that point (not shown). It is of interest to note that images of proflavine were overall less 
sensitive to automated crypt detection, but had a markedly greater PPV. Fluorescein had a PPV 
that barely surpassed 70%, while proflavine had a PPV close to 90%. In contrast, fluorescein 
demonstrated average sensitivities consistently above 90%, while proflavine sensitivity peaked at 
almost 85% at a QR cutoff value of 1.06. 
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Figure 7. Comparison of automated crypt detection between microendoscopy images of bulk 
colorectal caprine tissue stained with (a) fluorescein and (b) proflavine. Yellow asterisks mark 
the centroids determined with the QFEA. (a) Tissue stained with fluorescein (0.04% (w/v) in 
distilled water). (b) Tissue stained with proflavine (0.01% (w/v in PBS)). Both images have been 
equally enhanced for publishing. Scale bar is 200µm. 
 
Figure 8. (a) Average sensitivity and positive predictive values (PPV) of the QFEA crypt 
detection versus the QR cutoff value; aggregate performance plotted against QR was calculated 
using images with QR values equal to or higher to the QR cutoff value labeled in the x-axis. PS: 
Proflavine Sensitivity; PP: Proflavine PPV; FS: Fluorescein Sensitivity; FP: Fluorescein PPV. 
(b) Percentage of images with QR values equal to or higher than the labeled QR cutoff value; 
one hundred images per group. F: Fluorescein; P: Proflavine. 
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3.5 Quantification of crypt area and circularity in preliminary clinical trial  
Automated quantification of crypt area and circularity, using our quantification algorithm 
(QFEA), was tabulated for regions with grossly normal, and adenocarcinoma diagnoses. 66 
images, corresponding to approximately 25mm2 of epithelial surface, were acquired from grossly 
normal regions (no dysplasia, no benign disease), and 76 images (~29mm2) from 
adenocarcinoma regions. Figure 9 shows that there was significant difference between normal 
(N.) and adenocarcinoma (A.) regions, with a p-value of 0.035 for area, but circularity was not 
significantly different with a p-value of 0.13, using a Student t-test. 
 
Figure 9. Quantitative comparison of crypt area and circularity. (a) Example of microendoscopic 
images of normal and adenocarcinoma regions. Scale bar is 100μm. (b) Average crypt area for 
normal and adenocarcinoma regions (N = 416 crypts, N = 603 crypts, respectively). P-value = 
0.035. (c) Average crypt circularity for normal and adenocarcinoma regions (N = 416 crypts, N = 
603 crypts, respectively). P-value = 0.13. 
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4. Discussion  
Imaging of gastrointestinal epithelium via end-on fiber microendoscopy has been 
explored using DNA intercalating dyes, which so far have been used as investigational drugs in 
the United States [5, 15, 30]. A fluorescence alternative would be dyes already in clinical use, 
such as sodium fluorescein solution [33]. Our qualitative comparison of microendoscopy images 
of bulk colorectal tissue stained with fluorescein versus proflavine demonstrated that while the 
subcellular staining patterns differ [Fig. 3], fluorescein is able to provide similar information of 
crypt morphology to the previously established proflavine [Fig. 2]. An additional benefit of 
fluorescein as a contrast agent, in comparison to proflavine, includes reduced exposure time for 
images. Images of fluorescein-stained tissue were initially acquired at 100ms, for identical 
integration time of proflavine-stained tissue, but the images were over-saturated and we lowered 
the integration time until the images were of equal qualitative quality to proflavine. This resulted 
in fluorescein-acquisition at 50ms and proflavine-acquisition at 100ms. Reducing the required 
integration time has the benefit of reducing the number of motion-blurred images. Reduced 
exposure time and reduced motion-blur is an important advantage for manual or in vivo 
acquisition, allowing for the flexibility of manually holding the probe yet not requiring the 
clinician to have steady hands. While clamping the probe during image acquisition would have 
eliminated motion from unstable handheld placement, we chose to retain the potential of motion-
blurring in order to mimic in vivo imaging, where patient breathing or movement could 
contribute to motion-blur. Quantitatively, the results of automated crypt detection demonstrated a 
sharp increase in crypt detection sensitivity using less combinations of contrast-limit pairs; while 
proflavine images required a combination of five contrast limit pairs to achieve greater than 80% 
average sensitivity, fluorescein images required a combination of only three contrast limit pairs 
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to achieve an average sensitivity greater than 90% [Fig. 6]. A reduced number of contrast limit 
pairs is computationally time efficient, as well as reducing the risk of overtraining the algorithm. 
In addition to contrast limit pair combinations, the average sensitivity of the crypt detection 
algorithm is greater for the fluorescein data set. Even excluding images with low signal-to-
background contrast (at a QR cutoff value of 1.06, Fig. 8(a)), the average crypt detection 
sensitivity of the proflavine data set never reached 90%, whereas the fluorescein data set average 
sensitivity was consistently greater than 90%. Despite this, the fluorescein data set has a 
consistently lower positive predictive value (PPV) [Fig. 8(a)]. Heatmaps of the PPV (data not 
shown) showed similar results to the sensitivity heatmaps, sharing the top two contrast limit pairs 
as resulting in the highest sensitivity and PPV values. This suggests that quantitative analysis of 
fluorescein images is more sensitive in the detection of crypts, while not as adept as a diagnostic 
tool due to a higher number of false positives, thought this requires additional investigation into 
alternative reasons for this imbalance. Quantitative crypt detection results suggesting a lower 
PPV are not necessarily a critical limitation for clinical translation of a microendoscopic system. 
Given the length and size of the colorectal tract, there is minor risk in extracting multiple 
biopsies and therefore the surgical recommendations is to biopsy two to four regions each 10cm, 
with additional sampling of suspicious regions [34]. A highly sensitive, if not specific, tool 
would be useful in improving biopsy targeting of abnormal regions. While microendoscopic 
systems have achieved high sensitivity and specificity rates [15], they have not yet proven 
capable of replacing the gold standard of pathological staging of biopsies, therefore 
microendoscopy remains most useful in complementing existing endoscopy procedures. Our 
preliminary clinical results show that the automated algorithm measures a significant difference 
between crypt areas of normal and dysplastic regions, and additional work could increase the 
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accuracy and breadth of quantifiable image features. One drawback of automated quantification, 
though, is that there is usually an increased regulatory burden when a system uses computer 
based diagnosis, which is not an attractive prospect for vendors.  
Fluorescein is also more relevant as a clinical contrast agent, compared to DNA 
intercalating dyes, since it is already clinically used for intravenous injection and has 
demonstrated to pose limited risk to patient health. A drawback that should be considered is that 
intravenous fluorescein has a risk of anaphylaxis, with death from complications after 
intravenous injection during angiography procedures estimated at 1 in 220,000 patients [35]. 
Analysis of intrathecal administration of fluorescein in Europe and the United States showed that 
when a fluorescein dose of 1mL per 10kg of body weight of 5% (w/v) was used (total 50mg), 
side effects were minor and transient, with additional complications reported for higher doses 
(total 100-700mg) [35]. The side-effects of intravenous injection for confocal endomicroscopy 
have been similarly reported as minor for doses of up to 5mL of 10% (w/v) fluorescein, and 
while participants in their study experienced no severe reactions, the authors caution that 
anaphylaxis is rare but should be “anticipated and prepared for as for any drug [24]”. It is unclear 
if a topical application of the stain could possibly have reactions of equal or lesser severity. 
Alternatively, topical application of fluorescein required only the lower recorded concentrations 
of fluorescein, and could potentially pose little risk to the patient in small topical doses. Despite 
some limitations, we have described in this manuscript how topical application of fluorescein 
holds promise as a potential contrast agent alternative to proflavine for glandular tissue, 
specifically colon, since the crypt structures visible using proflavine are also visible when 
imaging with fluorescein. Using a 1mm fiber bundle, images acquired with both proflavine and 
fluorescein contrast offer similar image features for quantification, such as crypt area and 
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circularity. There was over 90% crypt detection sensitivity of porcine tissue, as well as statistical 
significance in our preliminary clinical study using topical application of fluorescein solution, 
between grossly normal and grossly dysplastic regions of colorectal tissue. 
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Chapter V: Differences in colonic crypt morphology of spontaneous and colitis-associated 
murine models via second harmonic generation imaging to quantify colon cancer 
development [1] 
1. Background 
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the 
gastrointestinal tract and is manifested clinically as either ulcerative colitis (UC) or Crohn’s 
disease [2]. While there is currently no specific histological feature that is used to definitively 
distinguish between UC and Crohn’s disease, an important distinction is the distribution pattern 
of the inflammation. UC is characterized by severe inflammation beginning at the rectum and 
continuing throughout the colon; Crohn’s disease is characterized by lesions over Peyer’s 
patches, and non-continuous regions of inflammation that span the entire depth of the intestinal 
wall [3-5]. 
Patients with UC exhibit an increased risk for colorectal cancer (CRC); approximately 
29% of UC patients develop CRC within 10 years of diagnosis, while 2.9% with Crohn’s disease 
develop CRC after 10 years of disease [6-9]. There are different types of lesions that may be 
detected in a UC patient during colonoscopy: two types associated with intraepithelial neoplasia 
are a dysplasia-associated lesion/mass (DALM) and an adenoma-like mass (ALM) [10, 11]. Flat 
or raised lesions without sharp contrast (delineation) against non-dysplastic epithelium are 
typically classified as DALMs, and are frequently associated with malignancy [11]. ALMs have 
features similar to sporadic adenomas that are observed in non-IBD patients [12]. Preliminary 
studies have suggested that standard polypectomy, a complete endoscopic resection of the ALM 
mass, followed by endoscopic surveillance is highly successful in patients with an ALM and 
could spare the patient a colectomy, since of the 34 patients in one study only one patient 
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developed an adenocarcinoma following the initial polypectomy [10-12]. Unfortunately, in 50-
80% of DALM cases the lesions are not visible during standard endoscopy [11, 13]. 
Several modalities of endoscopic imaging have emerged to improve detection of flat or 
discolored lesions [14]. Among them, multiphoton microendoscopy uses nonlinear optical 
processes to yield label-free high-resolution image data and rapid 3-dimensional image 
acquisition up to several hundred microns in depth without the need for tissue resection and 
subsequent fixation [15]. These systems have recently overcome a number of specific technical 
challenges, including obtaining uniform scans, low sensitivity, durability and reliability of the 
scanner, and miniaturization of the distal scan mechanism [16, 17]. Miniaturization of 
multiphoton laser microscopy systems greatly enhances the clinical translatability of this 
modality, leading towards in vivo imaging applications in gastrointestinal epithelial tissues [18-
20]. A form of multiphoton imaging, second harmonic generation (SHG) is a nonlinear optical 
process whereby non-centrosymmetric crystalline structures (such as collagen) interact with two 
low energy photons nearly simultaneously, resulting in the generation of a new photon at twice 
the energy (or half the wavelength of the incident photons). Multiphoton endoscopic systems 
capable of SHG imaging show great potential in improving clinical decision-making for patients 
with IBD.  In the colon, collagen structures can be used to quantify changes in the three-
dimensional crypt microstructure in the setting of IBD and associated dysplastic transformation. 
A systematic, quantitative model of these optical biomarkers of dysplasia progression could 
guide clinical translation of SHG imaging approaches for IBD patients. 
Our study was designed to further develop this biomarker model via SHG imaging and 
quantification of morphological changes that occur in the crypt structures of murine models of 
spontaneous and colitis-associated colorectal tumors. A series of azoxymethane (AOM) 
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injections is used as a murine model for spontaneous (ALM-like) tumor progression as it induces 
polypoid growth in the distal colon, similar to human CRC [21]. AOM injections followed by 
subsequent administration of dextran sodium sulfate salt (DSS) is considered to have long-term 
effects that produce cancerous flat lesions or dysplasia-associated lesion or mass (DALM-like) 
similar to those observed in humans [22]. We also acquired SHG images of epithelial tissue over 
discrete timepoints to investigate if temporal changes in crypt microstructure could be detected 
and quantified at varying stages of tumor progression. Key SHG image features could serve as 
optical biomarkers; a translatable measure towards detection of lesions and distinguishing ALM 
and DALM type lesions endoscopically in patients with known IBD.  
2. Methods 
Murine models and colorectal tissue procurement 
Two murine models were used for this study: a spontaneous colorectal carcinoma model 
and a colitis-induced colorectal carcinoma model [21]. Thirty-one A/J mice (The Jackson 
Laboratory, ME, USA) were used in accordance with the University of Arkansas Institutional 
Animal Care and Use Committee-approved protocol #18093. Mice were received at 9 weeks of 
age and allowed to acclimate for one week in a temperature and light controlled facility; mice 
were maintained on an 12 hour day-night cycle, with a bedding mixture of approximately 75% 
aspen chip bedding (7090A, Envigo, USA) and 25% paper product bedding (7099, Envigo, 
USA). All procedures were conducted in the light phase. Food (Tekland 8640, Envigo, USA) and 
water were provided ad libitum (Fig. 1). Mice were anesthetized using 1.5% isoflurane 
(IsoThesia, Henry Schein Animal Health, OH, USA) and oxygen (Compressed USP Oxygen, 
Airgas, PA, USA) from a precision vaporizer (911103, VetEquip, CA, USA), then placed on a 
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heating pad (TP700, Stryker Medical, MI, USA) with a nosecone for constant supply of 1.5% 
isoflurane.  
The spontaneous colorectal carcinoma model (referred to as the AOM model), consisted 
of a series of six weekly subcutaneous injections of AOM (A5486, Sigma-Aldrich, Inc., MO, 
USA) diluted in sterile saline, at a dose of 10 mg per kg body weight [21]. Control mice 
underwent a series of six weekly subcutaneous injections of saline (injection site over the 
shoulders). AOM and Control cohorts acclimated and were injected in parallel. The colitis-
induced colorectal carcinoma model (referred to as the AOM-DSS model) consisted of a single 
AOM injection (at 10 mg/kg body weight, subcutaneous administration), followed by several 
courses of drinking water supplemented with DSS (36,000-50,000 molecular weight, SKU 
0216011080, MP Biomedicals, OH, USA) at a concentration of 1.5% (w/v) (Fig. 1) [21]. AOM-
DSS cohorts acclimated and were injected a few months after the AOM and Control cohorts. 
Subcutaneous AOM injections were administered with 28 gauge syringe needles (BD329410, 
VWR, PA, USA) in volumes of less than 200 μL. For the AOM-DSS model, beginning on the 
day of the AOM injection, mice were provided free access to DSS solution for seven days [21]. 
On Day 8, the mice were provided untreated drinking water ad libitum for 14 days, and then the 
DSS-solution and untreated water cycle was repeated at Day 22 and Day 53 (Fig. 1) [21].  
Post treatment, mice were provided food and water ad libitum and were weighed and inspected 
daily until two weeks after concluding AOM/DSS treatment, after which they were inspected 
daily and weighed weekly. Mice were euthanized at early (20-23 weeks) or late (24-28 weeks) 
time points, representative of early or late-stage carcinoma progression (Fig. 1). Mice within 
each cohort were randomly selected for euthanizing at either early or late timepoints. Figure 1 
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notes the number of mice per cohort: Control n = 9, AOM early n = 6, AOM late n = 3, AOM-
DSS early n = 4, AOM-DSS late n = 9.  
 
Figure 1. Timeline of murine models. Day 1 is the first azoxymethane injection, for mice at 10 
weeks of age. Number of mice euthanized per time point and cohort labelled by n values.    
AOM-injected mice develop lesions and small polyps at approximately 20 weeks, with 
tumors progressing in size over the subsequent weeks; mice began to show signs of rectal 
bleeding past 28 weeks and were therefore euthanized [21]. Mice were euthanized via 
anesthetized cervical dislocation. Murine colons were resected within 15 minutes of euthanasia, 
and a 1 cm section of distal colon was longitudinally sectioned and placed on a coverslip for 
imaging. An adjacent section of tissue was fixed in formalin and paraffin-embedded for 
reference H&E staining.  
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Multiphoton microscopy imaging system 
The microscopy system comprises a titanium-sapphire ultrafast femtosecond pulsed laser 
source (Mai Tai eHP, Spectra-Physics, CA, USA), and galvo-resonant scan head scanners which 
acquires a fixed 15 frames per second (MPM-SCAN64J, Thorlabs, USA). The laser power was 
controlled via a quarter-wave plate and a polarizing beam splitter, to reduce the incoming 
excitation power at the sample to the range of tens to hundreds of milliwatts. The light was then 
circularly polarized, to reduce orientation bias of SHG in collagen, by use of a half-wave plate 
and a second polarizing beam splitter. Circular polarization was determined by measuring 
intensity of orthogonal collagen fibers at multiple regions, and selecting the optimal positioning 
of the half-wave plate for reduction of intensity variation at different orientations. Following the 
scanning optics, the illumination laser beam (at 800nm wavelength) passed through the back 
aperture of a 20x water immersion objective (0.85 NA, Nikon, NY, USA), prior to illuminating 
the sample, which was placed above the objective on an inverted microscopy stage. 
Backscattered SHG signal was collected via the objected and traveled through a 635nm long pass 
dichroic beamsplitter (Di02-R635, Semrock, NY, USA), a 447/60nm filter set (447/60nm 25mm 
dia. filter, Semrock, NY, USA), a 400nm/40nm filter set (400/40nm 25mm dia. filter, Semrock, 
NY, USA), and photomultiplier tube (H7422 PASO, Hamamatsu, Japan). The entire optical 
system resides inside an enclosure to reduce ambient light.  
Second harmonic generation image acquisition 
Freshly resected tissue was placed epithelium-down on a 24x40 mm No. 1 coverslip, then 
imaged using our non-linear optical microscopy imaging system described above. Total image 
acquisition time was approximately 1.5 seconds, with total optical power at the sample limited to 
prevent photo-damage. Individual images were acquired at 512 x 512 pixels at 14-bit depth, 
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yielding a 522 μm x 522 μm (~0.27 mm2) field of view, at approximately 20 μm from the 
epithelial surface. Image stacks were acquired at consecutive depths from the epithelial surface, 
in 20 μm steps, from 20 μm to 100 μm below the epithelial surface (Fig. 2).  
 
Figure 2. Comparison of histology and SHG images of Control murine colonic epithelium. (a) 
H&E stained transverse section of Control murine colonic epithelium; scale bar is 100 μm. 
Example of an SHG stack was shown, with images of depths at 20 μm, 40 μm, 60 μm, 80 μm, 
and 100 μm (epithelial layer), and 160 μm and 180 μm (muscularis layer), from top to bottom. 
Scale bar is 100 μm. 
Optimization of automated crypt detection sensitivity 
In previous work, we developed an algorithm for determining optimal parameters for 
binarizing grayscale images of colon epithelium [23, 24]. The image intensities were re-scaled 
between 0 and 1, and the thresholds for binarizing were optimized for maximizing the ability of 
the algorithm to segment crypts can vary depending on the strength of the SHG signal in the 
tissue (details are included in Supplemental Information). The selected optimal parameters for 
the SHG image data set was calculated to have a 67% crypt detection sensitivity (CDS), when 
compared to manual selection of crypt locations.  
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Quantification of crypt image segmentation  
Following the optimization of the threshold combinations for the algorithm’s % CDS, the 
optimized algorithm was applied to the image set and the images were converted into a binary 
image, where white objects were defined as the detected crypt structures [23, 24]. Figure 3 
summarizes the image features that were quantified, as well provides a visual representation of 
the calculation. Details of the image segmentation algorithm are included in Supplemental 
Information. Early stages of CRC typically include regions of abnormal morphology, for 
example, aberrant crypt foci (ACF) which are enlarged or non-tubular (branching) crypts, and/or 
multiple layers of cells lining a crypt [25, 26].  We chose to measure various crypt morphology 
image features related to changes viewed during histopathology, including crypt area, circularity, 
and distribution. The mean and standard deviation (referred to as variance in the results) of each 
image feature within each image were compared via a nested one-way ANOVA. The standard 
deviation of the image features within each image was calculated in order to measure the 
heterogeneity of the crypt structures; for example, tumor-adjacent regions tend to have both 
abnormally large and abnormally small crypt structures, which could produce a mean in a normal 
range, but the standard deviation of crypt areas within an image would retain the heterogeneous 
nature.  
The results of the quantification of image features were then compared across cohorts: 
AOM early time point, AOM late time point, AOM-DSS early time point, AOM-DSS late time 
point, and Control. Nested one-way ANOVA with Tukey’s post-test was used to determine 
statistically significant differences between the cohorts (JMP Pro 13). 
134 
 
Figure 3. Summary of quantitative image features. Each image feature is described with an 
equation and a visual representation of the calculation using an SHG image of normal 
epithelium; scale bar is 100 μm. For eccentricity, a represents half the length of the major axis, 
and b represents half the length of the minor axis. For nearest neighbor, (xc,yc) represents the 
centroid coordinate and (xa,ya) represent the centroid coordinates of adjacent crypts; the arrows 
represent the distance to adjacent crypts, the red arrow represents the distance selected as the 
nearest neighbor. For the centroid distance functions (CDF), (xc,yc) represents the centroid 
coordinate and (xb,yb) represent the boundary pixel coordinates. The average CDF was calculated 
by averaging all the distances to the boundary pixels (red arrows); the minimum CDF was 
calculated by selecting the distance to the closest boundary pixel (red arrow); the maximum CDF 
was calculated by selecting the distance to the furthest boundary pixel (red arrow).  
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Depth section image analysis 
Each sample was imaged from 20 μm to 100 μm below the epithelial surface in 20 μm 
increments (Fig. 2); depth stacks were acquired from each sample at one to three locations on the 
tissue section. Regions in normal epithelium were selected randomly. Regions in AOM and 
AOM-DSS epithelium were selected adjacent to tumors; tumors were characterized as epithelial 
regions with SHG signal but no discernable crypt structures. These depth section images were 
then analyzed with the algorithm to quantify the previously described image features. The results 
were then compared across depths, as well as across AOM and AOM-DSS cohorts. Nested two-
way ANOVA with Tukey’s post-test was used to determine statistically significant differences 
between the cohorts (JMP Pro 13).  
3. Results 
Qualitative comparison of second harmonic generation images 
Figure 4 shows examples of histology and SHG of both AOM and AOM-DSS murine 
models. Normal crypt structures tends to be uniform in size and general shape across the field of 
view, with crypt shape being tubular in transverse view (Fig. 4a) and roughly circular in en face 
view (Fig. 4b, h, i). Collagen distribution appears relatively even throughout the field of view 
(Fig. 4b, i). Crypt structures directly adjacent to tumor regions, or in regions of early dysplasia, 
tend to vary in size across a field of view, with one or more crypts being enlarged (Fig. 4c, d, k), 
and crypts often being oblong and/or having serrated edges in en face view (Fig. 4e). SHG 
images of grossly visible tumors do not show any discernable crypt structures (Fig. 4f, k).  
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Figure 4. Examples of traditional H&E histology and SHG images of AOM and AOM-DSS 
murine tissue. (a,b,h,i) normal epithelium, (c,d,j,k) epithelium adjacent to a tumor, and (e,f) 
tumor region; all scale bars are 100 μm. (g) Image of a longitudinally sectioned AOM murine 
colon, exposing the epithelium and a grossly visible tumor; scale bar is 0.5 cm. (d) Red arrow 
points to an abnormally large crypt; yellow arrow points to an example of a serrated edge.  (k) 
green arrow points to an enlarged crypt in the tumor-adjacent region; blue arrow point toward 
tumor edge. All images were manually contrast enhanced for display.  
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Increased mean distance between crypts in AOM vs. AOM-DSS cohorts 
Nearest neighbor and crypt circularity image features showed significant differences 
between spontaneous CRC tumor and colitis-associated tumor models. Figure 5 shows 
statistically significant comparisons of the cohorts for the mean of the nearest neighbor (a), and 
the standard deviation (variance) of the nearest neighbor (b) and circularity (c). Results for all 
image features, including non-statistically significant, are included as Supplemental Figures. 
There was statistical significance when comparing AOM and AOM-DSS cohorts using nearest 
neighbor quantification (Fig. 5 a, b). Mean nearest neighbor was greater for AOM late and 
AOM-DSS early cohorts as compared to the Control (Fig. 5 a). AOM late cohort mean nearest 
neighbor was also greater than the AOM-DSS early cohort (Fig. 5 a). When comparing the 
variance of nearest neighbor, once again AOM late and AOM-DSS early cohorts had greater 
values than the Control (Fig. 5 b). The variance of the AOM late group was also significantly 
greater than the AOM-DSS late group (Fig. 5 b). Measuring the variance of circularity of the 
cohorts showed a difference between the AOM early cohort and the Control (Fig. 5 c).   
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Figure 5. Mean values of nearest neighbor, and of the standard deviation of crypt nearest 
neighbor and circularity. Cohort n values (images): AOM early n=48, AOM late n=23, AOM-
DSS early n=45, AOM-DSS late n=24, Control n=55. Error bars are standard error; significance 
was calculated via a nested one-way ANOVA with Tukey’s HSD post-test. Significance was 
noted (*) for p values <0.05 and (**) for p values <0.01.  
Differences in circularity and mean distance between crypts in tumor-bearing vs. Control 
cohorts at varying acquisition depths 
As previously stated, images were taken at increasing depths: 20, 40, 60, 80, and 100 μm 
into the epithelial layer. We applied the image feature quantification algorithm to each depth, per 
treatment cohort. There were 43 image stacks (5 images in a stack, 20-100 μm) in total between 
all 5 cohorts. Mean and standard deviation of image features was compared across cohorts, at 
specific depths of acquisition (Fig. 6). As previously described, the mean and standard deviation 
(variance) within an image of each image feature was compared via a nested one-way ANOVA. 
Results for all image features with at least one statistically significant difference between two 
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cohorts are included as Supplemental Figures. There were significant differences between the 
Control cohort and AOM cohorts, and Control and AOM-DSS cohorts, for mean nearest 
neighbor at depth of specifically 40 μm, as well as standard deviation of circularity at a depth of 
specifically 60 μm, when comparing image stacks. No image feature showed significant 
differences between the AOM early and AOM late cohorts, nor the AOM early and AOM-DSS 
early cohorts (Fig. 6 a-c).  
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Figure 6. (a, b) Mean and standard deviation of crypt nearest neighbors at 40 μm depth. (c) 
Standard deviation of crypt circularities at 60 μm depth. (d) Standard deviation of crypt 
circularity at a range of imaging depths in microns, for AOM late cohort. Cohort n values 
(stacks): AOM early n=8, AOM late n=9, AOM-DSS early n=5, AOM-DSS late n=12, Control 
n=9. Significance was calculated via two-way ANOVA with Tukey’s post-test. Error bars are 
standard error. Significance was noted (*) for p values <0.05 and (**) for p values <0.01. 
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Decreased crypt circularity at increased acquisition depth for AOM late cohort 
As previously stated, images were taken at increasing depths: 20, 40, 60, 80, and 100 μm 
into the epithelial layer. Mean and standard deviation of image features was compared across 
depth of acquisition within each cohort (Fig. 6 d) via a nested one-way ANOVA. Results for all 
image features with at least one statistically significant difference between two cohorts are 
included as Supplemental Figures. There was no significance for mean of image features within 
cohorts; there was significance within the AOM late cohort for standard deviation of circularity 
(Fig. 6 d). There were differences between 100 μm and the more superficial 20 and 40 μm, for 
standard deviation of circularity of the AOM late cohort.  
4. Discussion 
Various modalities of endoscopic imaging have emerged with the goal of improving early 
detection of flat or discolored lesions, such as chromoendoscopy, narrow band imaging, and laser 
microendoscopy [14, 27]. Chromoendoscopy consists of spraying a colorimetric stain, such as 
indigo carmine, to provide contrast during colonoscopy [28]. Narrow band imaging has been 
described as label-free chromoendoscopy, as the optical filters only allow imaging small range of 
wavelengths, which enhance contrast in blood vessels and capillary patterns without the need for 
a contrast agent [27, 28]. While chromoendoscopy and narrow band imaging have shown 
promise for improving detection of dysplastic/neoplastic lesions, they are not able to distinguish 
between the similar structures of ALM and DALM lesions [14]. Laser confocal microendoscopy 
features high spatial resolution - able to resolve cellular and subcellular structures - providing 
more detailed imaging features that relate more closely to histopathological features [11]. The 
Cellvizio® confocal laser microendoscopy system showed potential in differentiating between 
DALM lesions and adjacent normal colorectal epithelial crypt structure in a preliminary clinical 
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trial [29].  Inserting the Cellvizio® endoscopic probe into an existing working channel during 
colonoscopy showed that DALM regions had enlarged crypts, increased irregularly in the 
distribution of crypts, increased space between crypts, as well as crypt destruction or fusion [29]. 
In contrast to confocal laser microendoscopy, multiphoton microendoscopy has additional 
benefits, including the ability to acquire label-free images of structural/morphological 
information (via SHG imaging) as well as insight into metabolic information (via 
autofluorescence of intrinsic biomolecules, such as nicotinamide adenine dinucleotide and flavin 
adenine dinucleotide, among others) up to several hundred microns in depth [30-33].  
SHG imaging, as shown in this manuscript, is well-suited for characterization of collagen 
structures, especially collagen type I which makes up much of extracellular matrix and 
connective tissues [30, 34]. SHG imaging of colorectal epithelium highlights crypt shape, as the 
collagen fibers provide structure surrounding the cellular arrangement without the need for any 
exogenous contrast agent [35]. We have described our analysis of colorectal epithelial 
microstructure from SHG images of freshly resected murine colons using automated 
quantification of morphological image features. These results - a comparison of quantified 
features of crypt morphology (especially nearest neighbor and circularity) - demonstrated the 
ability of our quantitative image feature algorithms to detect differences between spontaneous 
(AOM model) and colitis-associated (AOM-DSS model) murine colorectal tissue specimens. 
Limitations of SHG imaging include the ability to acquire structural but not cellular information, 
as well as the need for clinician/investigator judgement to recognize some additional parameters 
during imaging, such as the presence of tumors which are not detected nor measured by the 
automated quantification algorithm.  
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Future work in this area will include murine models of familial adenomatous polyposis, 
and other hereditary models, to more thoroughly investigate the morphological features of the 
most common types of CRC. A common murine model of familial adenomatous polyposis - 
featuring a deletion of the APC gene - develop spontaneous adenomas in the colon, although 
these lesions may not fully exhibit the physiological features of the disease as seen in humans 
[36]. Despite some limitations, the APC/min mouse model and other models will be included in 
future SHG imaging studies in order to expand the scope of the current work, which is limited to 
spontaneous and colitis-associated tumor development.  
The image biomarkers in this study relate to crypt morphology features that are 
analogous to conventional endoscopic biopsy and histopathology: crypt shape, size and spatial 
distribution. Statistically significant differences between spontaneous tumor (AOM) and colitis-
associated tumor (AOM-DSS) cohorts indicate that different models of tumor progression can 
potentially be quantified via SHG imaging, possibly distinguishing between early and late tumor 
progression. However, none of the image features - which are based solely on collagen-derived 
SHG signal - in this study showed statistical differences within tumor-bearing cohorts, or 
between early and late time points of AOM cohorts. It is possible that combining SHG data with 
autofluorescence imaging data could be a promising technique for acquiring intraoperative 
complementary data in order to improve endoscopic differentiation between ALM and DALM 
lesions in patients with UC, but this would require additional study. 
These results provide a quantitative model of the morphological changes that crypts 
undergo during dysplastic transformation, and can serve to guide future translational 
investigation and clinical studies in patients with IBD, with the long-term goal of reducing 
morbidity associated with prophylactic colectomy.  
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Conclusion 
A number of factors contribute to dysplastic transformation in colon epithelium, and it is 
important to fully understand disease progression in order to improve techniques and tools for 
screening, diagnosis, and treatment. While studies of collagen fiber structure using optical 
imaging in cancers such as cervical have been conducted [18], investigation of collagen 
structures in murine CRC studies has been understudied [37]. Multiphoton endoscopic imaging 
has shown to be a feasible technology for clinical translation due to its miniaturization and label-
free image acquisition. The introduction of image analysis algorithms into computer-aided 
diagnostic methods yield complementary data to conventional endoscopic procedures, which 
could lead to improved clinical decision-making for patients with known IBD. The methods 
described here provide insight into the ability of SHG imaging to yield relevant data about the 
crypt microstructure in colorectal epithelium, specifically the potential to distinguish between 
ALM and DALM murine models using quantification of crypt shape and distribution, informing 
future design of translational multiphoton imaging systems and protocols.  
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Chapter VI: Conclusion 
Optical imaging is an active field of investigation for biomedical engineers providing a 
variety of applications, from low-cost point-of-care systems to highly sensitive multiphoton 
imaging systems. Oral and colon cancer – epithelial cancers – have unique cellular morphologies 
that can be analyzed with optical imaging, ranging from histopathological imaging to 
investigative imaging systems.   
1. Proflavine as a contrast agent for oral cell cytology  
Oral cancer, specifically oral squamous cell carcinoma (OSCC), is the sixth most 
common cancer worldwide and most prevalent in low-resource countries and locations, such as 
rural Bangladesh, India, and Sri Lanka [1-4]. The prevalence of chewing betel and other 
carcinogens puts people living in these locations at high-risk of developing OSCC, contributing 
up to 25% of all new cancer cases in males [4]. There have been a variety of investigations 
designed to reach these populations, but they rely heavily on volunteers and visual inspection [2, 
5, 6]. Oral screening procedures designed to collect and analyze exfoliated cells have been 
investigated since 1963, but had poor sensitivity and specificity until the development of the 
cytobrush (designed for cervical smears) in the 1980s [7-10]. The OralCDx is an oral brush and 
computer-aided laboratory analysis based in the United States, which allows clinicians to collect 
cells from the entirety of the oral epithelium (including the basal layer) and the brush is sent to 
the laboratory for processing [11, 12]. The analysis is conducted on H&E stained cells using a 
specialized image processing system, and a cytopathologist makes the final diagnosis, and the 
OralCDx has shown over 90% specificity and sensitivity [11, 12]. A similar system could be a 
viable option for screening of oral lesions in high-risk populations.  
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We acquired images using proflavine and fluorescence imaging, and discernable 
morphological structures included clearly defined nuclei, Golgi zones, and visible cellular 
membranes. The use of proflavine in oral cell cytology and quantification of the image features 
had not been previously investigated. From a morphological standpoint, OSCC stained with 
proflavine was distinguishable due to its size, and much larger nuclear-to-cytoplasm ratio. 
Quantitative analysis of this nuclear-to-cytoplasm ratio showed that nuclear-to-cytoplasm ratio 
was significantly larger in OSCC cells than normal cells, with OSCC displaying an average ratio 
of approximately 0.8 and normal cells an average ratio of less than 0.1. Our results showed that 
proflavine was a suitable alternative for fluorescence imaging of OSCC cells; proflavine 
highlighted similar morphological features to clinical cytological stains; and quantification of 
nuclear-to-cytoplasmic ratios showed significantly larger ratios for OSCC [13].  
Limitations of many of the OSCC screening studies in low-resource locations has been 
compliance in travelling to a clinic (e.g. ~50% in the Indian sub-continent), despite the offer of 
reimbursement for time and travel [6]. In addition, exfoliation of oral cells has shown mixed 
results, and is often considered most viable when the oral brushes can collect cells deep enough 
into the epithelial layer to collect cells from the basal layer [14], however this can be painful. 
Additionally, a limitation for optical imaging is the compromise between resolution of 
morphological structure and field-of-view; imaging setups can usually either image subcellular 
level detail or image a large number of cells in a short amount of time, but not both. In order to 
ensure that OSCC cells are not undercounted due to reduced field-of-view, it would be important 
for any clinical system to test the number of basal and OSCC cells that can be acquired and 
imaged through oral exfoliation, in a clinical study. 
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Proflavine could be considered in future point-of-care optical device design with the 
incorporation of computer-aided image segmentation in order to measure image features, for 
example nuclear-to-cytoplasm ratio as we have showed, to create systems for rapid analysis of 
exfoliated oral cells. A recent study showed that 74% of subjects experienced no or mild 
discomfort due to the Orcellex cytobrush and produced on average 55,500 cells per slide, 
including cells from all layers of the epithelium, such as basal (deep), spinosal (middle) and 
superficial cells [15]. This shows that there is promise for cytobrush oral cell acquisition with 
minimal pain, high cell count, and high cell diversity. A one-step proflavine staining method 
could be used to qualitatively inspect cells in these systems via a similar approach to the 
aforementioned Orcellex, OralCDx, or in studies with additional morphological parameters such 
as a study by Remmerbach et. al. [16]. They proposed another technique, where the combination 
of cellular morphology (including nuclear-to-cytoplasm ratio) and DNA-aneuploidy (extra or 
missing chromosomes) had increased sensitivity specificity compared to the OralCDx [16]. This 
study used both Papanicolau and Feulgen staining followed by automated segmentation of 
individual nuclei [16]. Therefore, future studies could consider proflavine as an alternative 
contrast agent for the analysis of a combination of cellular and nucleic morphology.  
Automated quantification and count of OSCC could also aid in a quick read-out, and aid 
burden of training for volunteers in these high-risk settings. Also, a clear diagnosis based on 
optical image features might be a stronger motivator for compliance in going to a clinic, 
compared to the previously described study that flagged suspicious lesions, but required the 
patient to visit a hospital or clinic for biopsy and diagnosis. Advances in telemedicine also mean 
that future image acquisition could be reviewed and approved without requiring a secondary 
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visit, which could reduce the necessary workload for volunteers and reduce time between cancer 
detection and treatment.  
2. Image feature quantification and alternative contrast agent for a translational 
microendoscopy system 
Recurrence rates in colorectal cancer (CRC) are significant; 44% of stage II and III cases 
in one randomized study required additional surgery due to recurrence [17]. Due to the high risk 
of recurrence, patients who have undergone CRC-related surgery are placed under increased 
surveillance for early detection of additional tumors. Optical imaging devices that have studied 
early morphological changes include chromoendoscopy, narrow band imaging, and 
microendoscopic systems [18-23]. Fluorescence microendoscopic systems, similar to the one 
used in our studies, have shown over 90% sensitivity and specificity with trained observers 
classifying images acquired with a proflavine hemisulfate solution [24]. Automated 
quantification of images acquired with fluorescence microendoscopy could provide the clinician 
with additional parameters to make an informed decision. We designed a custom algorithm for 
crypt detection and image segmentation, and tested it using both proflavine and fluorescein – 
presented as an alternative contrast agent for microendoscopic systems [25, 26].  
Morphological structures that are quantifiable using a fluorescent dye include crypt size 
and area. Our custom algorithm had an 85% crypt detection sensitivity with proflavine, and over 
90% with fluorescein, and showed decreased area in crypt circularity for crypts in regions of 
adenocarcinoma [26]. While microendoscopic imaging studies have shown promise in 
qualitative image analysis of colorectal epithelium, quantitative analysis of crypt structure as 
biomarkers of carcinoma had not been explored for this type of system.  
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As mentioned previously, optical imaging compromises field-of-view for resolution; 
microendoscopic images can display clear crypt structures, but the field-of-view is 
approximately 1mm in diameter. In addition, microendoscopy can only image the surface of the 
epithelial layer, therefore any changes that occur in the base of the crypts are not acquired by the 
system. Future work will lie in the direction of an imaging system that combines imaging and 
another acquisition technique, such as the diffuse reflectance spectroscopy system in 
development by Greening et. al. that combines microendoscopy with diffuse reflectance for 
acquisition of hemoglobin and oxygenation biomarkers that are below the imaged surface [27].  
The results of our custom algorithm using both proflavine and fluorescein could guide the 
implementation of automated image analysis quantification in microendoscopic imaging studies, 
such as the measurement of crypt area and circularity, which showed promise for differentiating 
normal and carcinoma epithelial regions. Additional parameters that could be tested using 
automated quantification include crypt count and distribution, and crypt homogeneity by 
measuring the variance/standard deviation of crypt area, and circularity in a field-of-view, as we 
applied in our manuscript on SHG imaging [28]. In addition, the use of topical fluorescein 
should be tested in vivo for rapid staining of colorectal tissue, similar to studies that have used 
intravenous fluorescein to image colorectal epithelium in CRC patients [29, 30].  
Efficient image analysis software could be studied for future translation into in vivo 
clinical studies. Rapid quantification could provide clinicians with in vivo results for a less 
subjective determination of changes in crypt structure. Also, topical application of fluorescein 
could prove to be a more translatable fluorescent option for microendoscopic imaging systems 
designed for clinical use in complement to current imaging tools, since it is an FDA-approved 
contrast agent for intravenous use in ophthalmological imaging applications. A rapid imaging 
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system for screening of high-risk patients could aid in early detection of recurrent tumors and 
therefore improve survival rates of CRC patients.  
3. Second harmonic generation imaging of murine epithelium for crypt morphology image 
feature analysis of spontaneous and colitis-associated colorectal tumors 
Patients with ulcerative colitis (UC), a subtype of inflammatory bowel disease, have 
chronic inflammation of the gastrointestinal tract and have been considered at increased risk for 
CRC. Approximately 29% of UC patients develop CRC within 10 years of diagnosis [31-34]. 
The curative standard in UC patients are partial or complete colectomies when malignant lesions 
develop in the colorectal tract [35, 36]. Studies show that UC patients can develop polyps that 
are similar to spontaneous polyps developed in patients with no history of inflammatory disease, 
and can be treated less aggressively than colitis-associated lesions [19, 36]. Therefore, there have 
been a variety of devices and studies designed to distinguish between an adenoma-like mass 
(ALM), which can be treated with a less invasive polypectomy, and dysplasia-associated lesion 
or mass (DALM), which necessitates a more invasive surgery [19, 36]. Examples of such 
modalities include chromoendoscopy and confocal endomicroscopy systems [19, 30]. 
Multiphoton imaging systems have additional advantages, including acquisition of functional 
data acquired from endogenous autofluorescence (e.g. cellular metabolic biomarkers including 
redox ratios) instead of exogenous contrast agents. These advantages have led to the 
miniaturization of multiphoton systems, which have been designed to be used endoscopically 
[37, 38]. Multiphoton imaging allows for not only fluorescence imaging, which provides 
functional data, but second harmonic generation (SHG) imaging, which can provide information 
of structural collagen [39]. While collagen structures in various types of cancers, including 
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cervical and breast, have been investigated using SHG, there has not been extensive study in 
SHG imaging of CRC [37, 38, 40]. 
One approach to imaging of spontaneous and colitis-associated lesions is second 
harmonic imaging (SHG) for analysis of collagen structures in colorectal epithelium. We used 
A/J mice in two murine tumor models, azoxymethane (AOM) and azoxymethane followed by 
rounds of dextran sodium sulfate salt (AOM-DSS), in order to acquire preliminary results of the 
viability of using SHG for analysis of changes in crypt structure. We also acquired images from 
early and late time points (20-24 weeks and 24-28 weeks post-first-AOM injection, respectively). 
Our results showed that the nearest neighbor image feature, the distance between each crypt 
center and its nearest crypt center, was the most promising quantitative metric for distinguishing 
between cohorts [26]. The average nearest neighbor distances were greater for the AOM late 
cohort when compared to AOM-DSS early and late cohorts, while the standard deviation of 
nearest neighbor distances showed an increased heterogeneity in AOM late cohort when 
compared to AOM-DSS late and Control cohorts. Quantitative analysis of crypt features, 
specifically nearest neighbor, showed the potential for SHG imaging to be used as a 
complementary tool in distinguishing between ALM and DALM regions.   
A disadvantage of using SHG is that the signal is predominantly forward-scattering, 
therefore the backscattered signal is dim. The multiphoton imaging system is very sensitive to 
movement and can take up to three seconds to acquire an image, which, combined with a small 
field-of-view (522x522 μm), makes it difficult to rapidly scan large sections of the colon. 
Alternative approaches to scanning of two-photon excitation, such as temporally focused two-
photon endomicroscopy, have been studied in order to reduce acquisition time, but they have 
their own limitations that must be validated and implemented, such as development of custom 
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fibers (e.g. hollow core photonic crystal) that can withstand increased power without damage 
[41]. If alternatives that reduce acquisition time can be implemented in miniaturized multiphoton 
systems, multiphoton imaging would be effective when used as an optical biopsy to further 
inspect grossly suspicious regions during surveillance.  
SHG and quantitative analysis of image features, such as nearest neighbor, could serve as 
a complementary dataset in studies using miniaturized multiphoton systems. The results of our 
quantification could guide future multiphoton studies of ALM and DALM murine models, such 
as in vivo studies to determine efficacy of combining autofluorescence and SHG acquisition for 
differentiation of lesions, as well as to more thoroughly understand the morphological changes 
that occur in crypts in ALM versus DALM tumors.  
Combined with additional image features, SHG imaging could eventually aid clinicians 
in determining lesion type and optimal treatment in UC patients. Automated quantification of 
SHG image features could potentially contribute toward better-informed clinical decisions during 
screening and diagnosis of suspicious lesions and polyps during surveillance. Accurate and rapid 
assessment of lesions would decrease time in surgery, the need for additional surgeries, and 
prevent unnecessary colectomies.  
4. Concluding remarks 
Optical imaging modalities designed for imaging of epithelial cancer, specifically oral and 
colorectal, have been widely studied due to their wide range of applications. Contrast agents are 
a crucial component of optical imaging design, whether exogenous or endogenous. We analyzed 
the morphology of oral and colorectal epithelium in order to test alternative contrast agents and 
the viability of computer-aided quantification in various optical imaging modalities aimed at 
cancer detection. Cancer diagnosis, surveillance, and treatment can benefit from systems 
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designed to reduce invasiveness, turn-around time, and interobserver variability, as well as 
increase detection at early stages and therefore increase survival rates.  
References 
[1] R. Mehrotra, "The role of cytology in oral lesions: a review of recent improvements," 
Diagn. Cytopathol., vol. 40, (1), pp. 73-83, 2012.  
[2] M. C. Downer, D. R. Moles, S. Palmer and P. M. Speight, "A systematic review of 
measures of effectiveness in screening for oral cancer and precancer," Oral Oncol., vol. 42, (6), 
pp. 551-560, 2006.  
[3] S. V. K. Rao, G. Mejia, K. Roberts-Thomson and R. Logan, "Epidemiology of oral 
cancer in Asia in the past decade-an update (2000-2012)," Asian Pacific Journal of Cancer 
Prevention, vol. 14, (10), pp. 5567-5577, 2013.  
[4] S. Warnakulasuriya, "Global epidemiology of oral and oropharyngeal cancer," Oral 
Oncol., vol. 45, (4-5), pp. 309-316, 2009.  
[5] R. Akhter, N. M. M. Hassan, J. Aida, S. Takinami and M. Morita, "Relationship 
between betel quid additives and established periodontitis among Bangladeshi subjects," J. Clin. 
Periodontol., vol. 35, (1), pp. 9-15, 2008.  
[6] R. S. Wesley, V. R. Kutty, B. Matthew, R. Sankaranarayanan and M. K. Nair, 
"Economic comparison of two strategies of oral cancer screening," Health Policy Plan., vol. 7, 
(3), pp. 284-289, 1992.  
[7] B. Majer, B. Laky, S. Knasmüller and F. Kassie, "Use of the micronucleus assay with 
exfoliated epithelial cells as a biomarker for monitoring individuals at elevated risk of genetic 
damage and in chemoprevention trials," Mutation Research/Reviews in Mutation Research, vol. 
489, (2), pp. 147-172, 2001.  
[8] O. Kujan, M. Desai, A. Sargent, A. Bailey, A. Turner and P. Sloan, "Potential 
applications of oral brush cytology with liquid-based technology: results from a cohort of normal 
oral mucosa," Oral Oncol., vol. 42, (8), pp. 810-818, 2006.  
[9] H. C. Sandler, "Veterans Administration cooperative study of oral exfoliative 
cytology," Acta Cytol., vol. 7, pp. 180-182, May-Jun, 1963.  
[10] P. J. Murata, R. A. Johnson and K. E. McNicoll, "Controlled evaluation of 
implementing the Cytobrush technique to improve Papanicolaou smear quality," Obstet. 
Gynecol., vol. 75, (4), pp. 690-695, Apr, 1990.  
157 
[11] J. J. Sciubba and US Collaborative OralCDx Study Group, "Improving detection of 
precancerous and cancerous oral lesions: computer-assisted analysis of the oral brush biopsy," J. 
Am. Dent. Assoc., vol. 130, (10), pp. 1445-1457, 1999.  
[12] C. Scheifele, A. Schmidt-Westhausen, T. Dietrich and P. A. Reichart, "The 
sensitivity and specificity of the OralCDx technique: evaluation of 103 cases," Oral Oncol., vol. 
40, (8), pp. 824-828, 2004.  
[13] S. P. Prieto, A. J. Powless, J. W. Boice, S. G. Sharma and T. J. Muldoon, "Proflavine 
Hemisulfate as a Fluorescent Contrast Agent for Point-of-Care Cytology," PloS One, vol. 10, (5), 
pp. e0125598, 2015.  
[14] S. Divani, M. Exarhou, T. Leonidas-Nectarios, D. Georgantzis and H. Skoulakis, 
"Advantages and difficulties of brush cytology in the identification of early oral cancer," Archive 
of Oncology, vol. 17, (1-2), pp. 11-12, 2009.  
[15] O. Kujan, M. N. Pemberton, M. Schwarz and P. Sloan, "Evaluation of an innovative 
oral brush for potential applications using liquid based cytology," J. Oral Sci., vol. 60, (1), pp. 
45-50, 2018.  
[16] T. W. Remmerbach, H. Weidenbach, N. Pomjanski, K. Knops, S. Mathes, A. 
Hemprich and A. Böcking, "Cytologic and DNA-cytometric early diagnosis of oral cancer," 
Analytical Cellular Pathology, vol. 22, (4), pp. 211-221, 2001.  
[17] R. M. Goldberg, T. R. Fleming, C. M. Tangen, C. G. Moertel, J. S. Macdonald, D. 
G. Haller and J. A. Laurie, "Surgery for recurrent colon cancer: strategies for identifying 
resectable recurrence and success rates after resection," Ann. Intern. Med., vol. 129, (1), pp. 27-
35, 1998.  
[18] R. Kiesslich, M. Goetz, K. Lammersdorf, C. Schneider, J. Burg, M. Stolte, M. Vieth, 
B. Nafe, P. R. Galle and M. F. Neurath, "Chromoscopy-guided endomicroscopy increases the 
diagnostic yield of intraepithelial neoplasia in ulcerative colitis," Gastroenterology, vol. 132, (3), 
pp. 874-882, 2007.  
[19] H. Neumann, M. Vieth, C. Langner, M. F. Neurath and J. Mudter, "Cancer risk in 
IBD: how to diagnose and how to manage DALM and ALM," World J. Gastroenterol., vol. 17, 
(27), pp. 3184-3191, Jul 21, 2011.  
[20] H. Neumann, R. Kiesslich, M. B. Wallace and M. F. Neurath, "Confocal laser 
endomicroscopy: technical advances and clinical applications," Gastroenterology, vol. 139, (2), 
pp. 388-92, 392.e1-2, Aug, 2010.  
[21] A. Ishijima, S. Mondrik, R. A. Schwarz, N. Vigneswaran, A. M. Gillenwater and R. 
Richards-Kortum, "Automated frame selection process for analyzing high resolution 
microendoscope images," in SPIE Translational Biophotonics, 2014, pp. 91551M-91551M-4. 
158 
[22] P. M. Lane, S. Lam, A. McWilliams, M. W. Anderson and C. E. MacAulay, 
"Confocal fluorescence microendoscopy of bronchial epithelium," J. Biomed. Opt., vol. 14, (2), 
pp. 024008-024008-10, 2009.  
[23] P. M. Vila, C. W. Park, M. C. Pierce, G. H. Goldstein, L. Levy, V. V. Gurudutt, A. 
D. Polydorides, J. H. Godbold, M. S. Teng and E. M. Genden, "Discrimination of benign and 
neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer," 
Annals of Surgical Oncology, vol. 19, (11), pp. 3534-3539, 2012.  
[24] N. D. Parikh, D. Perl, M. H. Lee, B. Shah, Y. Young, S. S. Chang, R. Shukla, A. D. 
Polydorides, E. Moshier and J. Godbold, "In vivo diagnostic accuracy of high-resolution 
microendoscopy in differentiating neoplastic from non-neoplastic colorectal polyps: a 
prospective study," Am. J. Gastroenterol., vol. 109, (1), pp. 68-75, 2014.  
[25] S. P. Prieto, K. K. Lai, J. A. Laryea, J. S. Mizell and T. J. Muldoon, "Quantitative 
analysis of ex vivo colorectal epithelium using an automated feature extraction algorithm for 
microendoscopy image data," Journal of Medical Imaging, vol. 3, (2), pp. 024502, 2016.  
[26] S. P. Prieto, K. K. Lai, J. A. Laryea, J. S. Mizell, W. C. Mustain and T. J. Muldoon, 
"Fluorescein as a topical fluorescent contrast agent for quantitative microendoscopic inspection 
of colorectal epithelium," Biomedical Optics Express, vol. 8, (4), pp. 2324-2338, 2017.  
[27] G. J. Greening, H. M. James, A. J. Powless, J. A. Hutcheson, M. K. Dierks, N. 
Rajaram and T. J. Muldoon, "Fiber-bundle microendoscopy with sub-diffuse reflectance 
spectroscopy and intensity mapping for multimodal optical biopsy of stratified epithelium," 
Biomedical Optics Express, vol. 6, (12), pp. 4934-4950, 2015.  
[28] S. P. Prieto, C. L. Reed, H. M. James, K. P. Quinn and T. J. Muldoon, "Differences 
in colonic crypt morphology of spontaneous and colitis-associated murine models via second 
harmonic generation imaging to quantify colon cancer development," Manuscript Submitted for 
Publication. BMC Cancer, 2018.  
[29] G. D. De Palma, "Confocal laser endomicroscopy in the "in vivo" histological 
diagnosis of the gastrointestinal tract," World J. Gastroenterol., vol. 15, (46), pp. 5770-5775, Dec 
14, 2009.  
[30] G. D. De Palma, S. Staibano, S. Siciliano, F. Maione, M. Siano, D. Esposito and G. 
Persico, "In-vivo characterization of DALM in ulcerative colitis with high-resolution probe-
based confocal laser endomicroscopy," World J. Gastroenterol., vol. 17, (5), pp. 677-680, Feb 7, 
2011.  
[31] D. C. Rubin, A. Shaker and M. S. Levin, "Chronic intestinal inflammation: 
inflammatory bowel disease and colitis-associated colon cancer," Frontiers in Immunology, vol. 
3, pp. 107, 2012.  
159 
[32] A. J. Greenstein, D. B. Sachar, H. Smith, H. D. Janowitz and A. H. Aufses Jr, "A 
comparison of cancer risk in Crohn's disease and ulcerative colitis," Cancer, vol. 48, (12), pp. 
2742-2745, 1981.  
[33] A. Ekbom, C. Helmick, M. Zack and H. Adami, "Ulcerative colitis and colorectal 
cancer: a population-based study," N. Engl. J. Med., vol. 323, (18), pp. 1228-1233, 1990.  
[34] C. J. Karvellas, R. N. Fedorak, J. Hanson and C. K. Wong, "Increased risk of 
colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age," Canadian Journal 
of Gastroenterology and Hepatology, vol. 21, (7), pp. 443-446, 2007.  
[35] P. Munkholm, "The incidence and prevalence of colorectal cancer in inflammatory 
bowel disease," Aliment. Pharmacol. Ther., vol. 18, (s2), pp. 1-5, 2003.  
[36] T. Ullman, R. Odze and F. A. Farraye, "Diagnosis and management of dysplasia in 
patients with ulcerative colitis and Crohn's disease of the colon," Inflamm. Bowel Dis., vol. 15, 
(4), pp. 630-638, 2008.  
[37] Y. Zhang, M. L. Akins, K. Murari, J. Xi, M. J. Li, K. Luby-Phelps, M. Mahendroo 
and X. Li, "A compact fiber-optic SHG scanning endomicroscope and its application to visualize 
cervical remodeling during pregnancy," Proc. Natl. Acad. Sci. U. S. A., vol. 109, (32), pp. 
12878-12883, Aug 7, 2012.  
[38] D. R. Rivera, C. M. Brown, D. G. Ouzounov, I. Pavlova, D. Kobat, W. W. Webb 
and C. Xu, "Compact and flexible raster scanning multiphoton endoscope capable of imaging 
unstained tissue," Proc. Natl. Acad. Sci. U. S. A., vol. 108, (43), pp. 17598-17603, Oct 25, 2011.  
[39] P. Campagnola, "Second harmonic generation imaging microscopy: applications to 
diseases diagnostics," ACS Publications, 2011.  
[40] M. Bianchi, J. Adur, S. Ruff, M. Izaguirre, H. Carvalho, C. Cesar and V. Casco, 
"Analysis of the orientation of collagen fibers as a tool for the early detection of colorectal 
cancer," in VI Latin American Congress on Biomedical Engineering CLAIB 2014, Paraná, 
Argentina 29, 30 & 31 October 2014, 2015, pp. 365-368. 
[41] H. Choi and P. T. So, "Improving femtosecond laser pulse delivery through a hollow 
core photonic crystal fiber for temporally focused two-photon endomicroscopy," Scientific 
Reports, vol. 4, pp. 6626, 2014.  
  
  
160 
Chapter VII: Appendix 
IBC, IRB, IACUC approvals 
 
161 
 
162 
 
 
163 
Supplementary Information for Chapter 5 [1] 
S1. Optimization of automated crypt detection sensitivity 
In previous work, we developed an algorithm for determining optimal contrast-enhancing 
parameters for binarizing grayscale images of colon epithelium [2, 3]. The acquired second 
harmonic generation (SHG) images were re-scaled between 0 and 1, and the thresholds for 
binarizing were optimized for maximizing the ability of the algorithm to segment crypts, which 
can vary depending on the strength of the SHG signal in the tissue. Figure S1 shows an example 
of how different thresholds are optimal for different images. A range of thresholds were applied 
to the images, and the percent crypt detection sensitivity (% CDS) of each group was calculated 
against the manual selection of crypts by the authors, as done in previous work [2]. An example 
of the % CDS of various thresholds on SHG images of murine colonic tissue from 
azoxymethane-injected mice is shown in Fig. S1(e). The thresholds were values between 0 and 1, 
used to determine binarization based on all intensities greater than the threshold being converted 
to white and all intensities less than the threshold being converted to black. The thresholds we 
tested are smaller than 0.01 since the raw image intensities are low for back-scattered SHG 
signal. The threshold with highest overall % CDS was 0.0035 with 38% CDS.  
Figure S1, specifically (a-d), also shows an example of how different thresholds are 
optimal for different images, thus affecting % CDS when a single threshold is chosen. Previous 
work showed that applying a range of thresholds to the images increased the % CDS of the 
algorithm [2, 3]. The detected crypts for each threshold were compared to the detected crypts of 
the previous threshold, and duplicates were excluded while newly-detected crypts were stored. In 
order to determine the optimal combination of thresholds, the algorithm applied various 
combinations of thresholds to the image set and calculated the % CDS of each combination. 
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Since thresholds between 0.003 and 0.005 showed % CDS higher than 20%, the range of tested 
combinations included thresholds between 0.0025 and 0.0055, in 0.0005 incremental steps. 
Thresholds were tested in combination of two, three, four, and five thresholds. The optimal 
combination of thresholds was determined to be a combination of three thresholds: 0.003, 
0.0035, and 0.0045 was calculated to have a 67% CDS. Combinations of four or more thresholds 
increased % CDS to almost 69%, but also carry the potential for overtraining the algorithm with 
our data set, therefore the combination of three thresholds was selected. The selected optimal 
parameters for the SHG image data set was calculated to have a 67% crypt detection sensitivity 
(CDS), when compared to manual selection of crypt locations.  
 
Figure S1. (a-d) Example of two images from Control mice, binarized using different thresholds. 
Yellow is SHG signal, blue is background. Red arrows point to crypts with uncertain definition 
at a given threshold; black arrows point to matching crypts that have clear definition at a 
different threshold. (e) Plot of percent crypt detection sensitivity (% CDS) of the algorithm at 
different threshold values. 
 
S2. Selection of quantifiable image features 
 Crypt and cellular morphology are image features used by pathologists when determining 
a diagnosis for both spontaneous and colitis-associated tumors. Image features include enlarged 
or non-tubular crypt shapes, and/or crypts with more than a single layer of cells surrounding it. 
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Based on the crypt morphology changes that occur during tumor development, we tested various 
image morphology parameters for viability as indicators of colon cancer, specifically crypt 
shape, size, and distribution. We tested various image features in order to provide additional 
information for investigations using multiphoton endoscopic systems, but we acknowledge that 
there are limitations to SHG imaging and crypt morphology when analyzed independent of 
additional factors. For example, Figure S2 shows SHG images of Control tissue, as well as of 
AOM-DSS early and AOM-DSS late cohorts. Our crypt detection algorithm is designed to detect 
and analyze crypts, but tumors, such as the ones labelled with yellow arrows, are not recognized 
during automated analysis. There is still the need for the judgement of a clinician/investigator 
during the imaging process.  
 We describe SHG as a complementary optical imaging process to autofluorescence 
multiphoton imaging. There have been a number of studies on cancer imaging using 
autofluorescence imaging using endoscopic multiphoton systems [4]. An example of the 
combined effect of SHG and autofluorescence imaging of a Control tissue sample is shown in 
Figure S2. Autofluorescence imaging can acquire cellular and subcellular detail, while SHG 
imaging acquires detail of collagen structures. Autofluorescence in Fig. S2 was acquired using a 
multiphoton microscopy system (described on page 7 of the main manuscript) which uses a 
titanium-sapphire ultrafast femtosecond pulsed laser source (Mai Tai eHP, Spectra-Physics, CA, 
USA) which was set to 750nm excitation, and the signal was collected using a 466/40 bandpass 
filter (Semrock, NY, USA) and photomultiplier tube (H7422 PASO, Hamamatsu, Japan). We 
believe that the combination of SHG and autofluorescence imaging in endoscopic multiphoton 
studies of colorectal cancer could elucidate additional morphological changes and markers of 
neoplasia and cancer.  
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Figure S2. Example SHG images of Control, AOM-DSS early, and AOM-DSS late tissue; 
yellow arrows point to tumor edge. Also, example of the combination of SHG and 
autofluorescence imaging, using Control epithelium. Scale bar is 100 μm. 
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S3. Image segmentation and quantification of crypt structures  
After the selection of the optimal thresholds, the images were binarized, and the objects 
in the binary image were then eroded and dilated (5 pixel diameter disk) to discard objects too 
small to be crypts as well as reduce rough edges stemming from image noise.  
The segmented objects, or detected crypt structures, were then analyzed for quantification 
of the following image features: crypt area, circularity, eccentricity, perimeter, distance to the 
nearest neighbor (distance from each centroid to the closest centroid), and average of a centroid 
distance function (distance from the centroid to each boundary pixel). Previous work details 
specifics of automated crypt area and circularity quantification [2, 3]. For automated crypt area, 
circularity, and perimeter quantification (Fig. S3), the automated quantification of area (A) and 
perimeter (P), and therefore by default circularity variables, were converted into microns.  
 
Figure S3. Summary of quantitative image features. Each image feature is described with an 
equation and a visual representation of the calculation using an SHG image of normal 
epithelium; scale bar is 100 μm. 
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Additional image features included: eccentricity, where a is half the length of the major 
axis and b is half the length of the minor axis, and distance to the nearest neighbor, which was 
calculated by measuring the Euclidean distance between the centroid of a crypt to the centroid of 
every other crypt in the image, and selecting the minima, where the (xc, yc) are the coordinates of 
the centroid and (xa, yaa) represents the coordinates of all other centroids (Fig. S4). The average 
centroid distance function was calculated by measuring the Euclidean distance between the 
centroid of a crypt to each of the boundary pixels, and taking an average of the distances per 
crypt, where (xc, yc) are the coordinates of the centroid and (xb, yb) are the coordinates of a 
boundary pixel, and n is the number of boundary pixels in the object (Fig. S4).  
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Figure S4. Summary of quantitative image features. Each image feature is described with an 
equation and a visual representation of the calculation using an SHG image of normal 
epithelium; scale bar is 100 μm. 
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S4. Additional results of image segmentation and quantification of crypt structures  
A full set of the results of the one-way ANOVA comparison, including those not shown 
in the manuscript and those which are not statistically significant, are shown below. In general, 
for both individual images acquired at a fixed depth (20 μm) and image depth stacks, the mean 
and standard deviation of each image feature (Fig. S3 and S4) within each image were quantified 
using an adaptation of a previously developed algorithm [2, 3]. The standard deviation of the 
image features within each image was calculated in order to measure the heterogeneity of the 
crypt structures; for example, tumor-adjacent regions tend to have both abnormally large and 
abnormally small crypt structures. A global average across these values would yield a mean 
value similar to that derived from normal tissue, but the standard deviation of crypt areas within 
an image would report this variance in a more representative manner. 
The results of image feature quantification were then compared across cohorts: AOM 
early time point, AOM late time point, AOM-DSS early time point, AOM-DSS late time point, 
and Control. Nested one-way ANOVA with Tukey’s post-test was used to determine statistically 
significant differences between the cohorts (JMP Pro 13). For all images, total image acquisition 
time was approximately 1.5 seconds, with total optical power at the sample limited to prevent 
photo-damage. Individual images were acquired at 512 x 512 pixels at 14-bit depth, yielding a 
522 μm x 522 μm (~0.27 mm2) field of view, at approximately 20 μm from the epithelial 
surface.  Image depth stacks were acquired at consecutive depths from the epithelial surface, in 
20 μm steps, from 20 μm to 100 μm below the epithelial surface.  
S5. Fixed image depth results (20 μm) 
The comparison of the means (Fig. S5) and standard deviations (Fig. S6) for each of the 
image features discussed previously (Fig. S3 and S4) are shown: crypt area, nearest neighbor, 
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circularity, perimeter, crypt count, eccentricity, average centroid distance function, minimum 
centroid distance function, and maximum centroid distance function. For mean (Fig. S5), the two 
image features with statistical significance between cohorts were nearest neighbor and crypt 
count. For standard deviation (Fig. S6), the image features with statistical significance were 
nearest neighbor, circularity, and eccentricity. They all showed a difference between the Control 
cohort and one or more of the tumor-bearing cohorts, but this is not outside of what has been 
shown with confocal laser microendoscopy systems such as the Cellvizio® (which differentiated 
between colorectal lesions and adjacent normal colorectal epithelial crypt structure in a 
preliminary clinical trial) [5].   
The differences of interest are in the distinction in mean (Fig. S5) of nearest neighbor 
between the AOM late and AOM-DSS early cohorts, as well as the AOM late and the AOM-
DSS late cohorts. For standard deviation (Fig. S6), the difference of interest is also for nearest 
neighbor, between AOM late and AOM-DSS late cohorts. These results suggest that 
morphological biomarkers in SHG images of colorectal epithelium could be used to distinguish 
between spontaneous tumor development (AOM model) and colitis-associated tumor 
development (AOM-DSS model). While the alternative image features did not show statistical 
significance in our study, this does not conclusively rule them out as incapable of providing 
additional information about the morphological differences between cohorts. Further study into 
these or similar features could prove useful in development of clinical imaging systems and 
guides for interpreting the acquired images.  
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Figure S5. Mean values of various image features: crypt count, crypt area, crypt circularity, 
crypt eccentricity, nearest neighbor, average centroid distance function (CDF). Cohort n values 
(images): AOM early n=48, AOM late n=23, AOM-DSS early n=45, AOM-DSS late n=24, 
Control n=55. Error bars are standard error; significance was calculated via a nested one-way 
ANOVA with Tukey’s HSD post-test. Significance was noted (*) for p values <0.05 and (**) for 
p values <0.01.  
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Figure S6. Standard deviation values of various image features: crypt count, crypt area, crypt 
circularity, crypt eccentricity, nearest neighbor, average centroid distance function (CDF). 
Cohort n values (images): AOM early n=48, AOM late n=23, AOM-DSS early n=45, AOM-DSS 
late n=24, Control n=55. CDF = centroid distance function. Error bars are standard error; 
significance was calculated via a nested one-way ANOVA with Tukey’s HSD post-test. 
Significance was noted (*) for p values <0.05 and (**) for p values <0.01 
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S6. Image depth stack results 
The comparison of the means and standard deviations for each of the image features 
discussed previously (Fig. S3 and S4) were calculated across a fixed depth (20 to 100 μm) and 
compared across cohorts. The image stacks were also compared within cohorts (fixed groups) 
across varying acquisition depth for the means and standard deviation of each of the image 
features. Due to the extensive number of comparisons, as well as due to the majority not showing 
statistical significance, only the image features with at least one statistically significant 
difference between two cohorts are shown below. For comparison of means across cohorts (Fig. 
S7), the image feature with statistical significance between cohorts was nearest neighbor at 40 
μm. To compare standard deviation values across cohorts (Fig. S8), the image features with 
statistical significance were area, perimeter, and nearest neighbor at 40 μm, and circularity at 60 
μm. To compare mean values across acquisition depths there are no figures, as no image feature 
showed statistical significance between cohorts. For comparison of standard deviations across 
acquisition depths (Fig. S9), the image features with statistical significance were circularity 
within the AOM late cohort, and circularity and eccentricity within the Control cohort.   
Several of the image features, including nearest neighbor, area, perimeter, circularity, and 
eccentricity showed a difference between the Control cohort and one or more of the tumor-
bearing cohorts. While these results corroborate that there are morphological differences between 
regions of dysplasia and healthy epithelium, they do not show clear usefulness in distinguishing 
between spontaneous tumor development (AOM model) and colitis-associated tumor 
development (AOM-DSS model). Though this does not prove them incapable of providing 
additional information about the morphological differences between cohorts, further study into 
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depth section and/or volumetric analysis of crypt morphology is needed to better understand any 
differences between spontaneous and colitis-associated tumor development.  
 
Figure S7. Mean values of crypt nearest neighbor at 40 μm of acquisition depth across cohorts. 
Cohort n values (stacks): AOM early n=8, AOM late n=9, AOM-DSS early n=5, AOM-DSS late 
n=12, Control n=9. Significance was calculated via two-way ANOVA with Tukey’s post-test. 
Error bars are standard error Significance was noted (*) for p values <0.05 and (**) for p values 
<0.01. 
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Figure S8. Standard deviation values of area, perimeter, and nearest neighbor at 40 μm of 
acquisition depth across cohorts, and of circularity at 60 μm of acquisition depth across cohorts. 
Cohort n values (stacks): AOM early n=8, AOM late n=9, AOM-DSS early n=5, AOM-DSS late 
n=12, Control n=9. Significance was calculated via two-way ANOVA with Tukey’s post-test. 
Error bars are standard error Significance was noted (*) for p values <0.05 and (**) for p values 
<0.01. 
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Figure S9. Standard deviation values of crypt circularity of AOM late cohort across acquisition 
depths, and of crypt circularity and eccentricity of Control cohort across acquisition depth. 
Cohort n values (stacks): AOM late n=9, Control n=9. Significance was calculated via two-way 
ANOVA with Tukey’s post-test. Error bars are standard error Significance was noted (*) for p 
values <0.05 and (**) for p values <0.01. 
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